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CHAPTER Introduction
VWm H/M Verstappen
CHAPTER I
Introduction
To bridge the gap between evidence-based medicine and practice,
we need to learn more about factors and interventions which are
important for the implementation of research findings in clinical
practice.'"' This thesis focuses on factors and interventions that may
play a role in the improvement of test ordering behaviour in primary
care. The aim of the study reported in this thesis was the systematic
development and assessment of an innovative and multifaceted strategy
to improve general practitioners'(GPs') test ordering behaviour.
Test ordering in general practice
Test ordering is an important aspect of medical care in general practice.
Most GPs in the Netherlands order laboratory, imaging and function
tests at the laboratories or imaging and function departments of the
regional hospitals. *"'* GPs themselves can also perform certain
laboratory tests, like Hb, ESR, glucose, cholesterol and urinary tests
by using desktop analysers available in their own practice." Some GPs
also perform function tests, such as ECGs and lung function tests,
in their own practice setting.
During the last five years, about a quarter of the Dutch hospitals have
set up diagnostic centres for GPs. In some large cities in the Netherlands,
GPs can also order tests at regional so-called 'GPs' diagnostic centres'
that are not affiliated to a hospital. The files of such diagnostic centres
allow data on numbers of tests ordered by GPs to be retrieved, and
providing feedback on test-ordering behaviour to the collaborating
GPs is one of the main activities of these centres. Table 1 shows the
tests that GPs can order in most of the diagnostic centres. In ordering
laboratory tests, GPs collaborating with diagnostic centres use a nation-
ally developed problem-oriented laboratory order form, with all tests
grouped in categories of relevant clinical problems; the selection of
these tests is based upon national evidence-based guidelines." GPs
regularly receive such guidelines for optimal test ordering from the
Dutch College of General Practitioners and the national College for
Health Insurers."
Over the years, the use of tests has increased in many countries,
although inter-doctor variation has been shown to be large." '"°
General practitioners order these laboratory, imaging and function
tests for various medical as well as non-medical reasons.^' ^
For instance, GPs may not want to miss important diagnoses or they
may want to reassure patients. Test ordering is also important for
monitoring chronic diseases or for screening purposes. The increase
in the numbers of tests ordered can probably be explained by the
ageing of the western population, by rapid advances in diagnostic test
technology, by the shifting of care from secondary to primary care,
by the growing demand from patients actively asking for tests, by GPs'
test ordering routines that are difficult to change and by GPs being
more defensive, for fear of making medical mistakes. On the other
hand, underuse of diagnostic tests has also been reported." ** These
findings indicate that some patients receive sub-optimal care in terms
of test ordering, and that there is room for new strategies to achieve
improvement.
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TABLE 1
LABORATORY TESTS
Alanine aminotransferine
Aspartate aminotransferase
Lactate dehydrogenase
Alkalic phosphatase
Allergic screening test
Amylase
Bilirubin
Blood urea nitrogen
C-Reactive protein
ESR
Haemoglobin
Haemoglobin indices
Haematocrit
White blood count
TESTS THAT GPS CAN ORDER AT A DIAGNOSTIC CENTRE
IMAGING TESTS
Glucose
HbAic
Thyroid stimulating hormone
Free thyroid hormone
Potassium
Prostate specific antigen
Serum creatinine
Sodium
Serum uric ucid
Y-Glutamyltransferase
Cholesterol
Cholesterol indices
Immunoglobulin E
Chest X-ray
X-ray of cervical spine
X-ray of hip
X-ray of knee
X-ray of lumbar spine
X-ray of shoulder
X-ray of skull
X-ray of sinus
Double contrast barium enema
Ultrasound of hepatobiliary tract
Ultrasound of female genital tract
Ultrasound of the kidney
FUNCTION TESTS
ECG
Exercise ECG
Lung function test
IVP
Gastroscopy
Sigmoidoscopy
0/ test ordering be/javzoMr
To improve the quality of test ordering behaviour, it is important
to gain detailed insight into the determinants of GPs' test ordering
behaviour, but it must be admitted that much remains unknown
about these determinants.""^"^ An improved understanding
of these determinants can be used to develop better measures and
strategies for change. In everyday medical practice, the decision-
making process may be biased by professional-related determinants
of test ordering behaviour, such as risk-taking attitudes *' ^ or other
personality aspects "; knowledge about the appropriate use of tests "
** and routines.''* ** Other determinants of test ordering behaviour are
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to be found in the interaction between the professional and his or her
direct environment, with one of the factors steering the diagnostic
decision-making process being peer influence. Patients' wishes are
important as well, as patients have personal views about the value of
diagnostic testing." Other contextual determinants have also been
reported in the literature.**™' The availability of test ordering facilities
in the region, the way the test ordering procedure is organised, differ-
ences in quality improvement programmes, the remuneration system
and financial incentives or regulatory sanctions all seem to determine
test ordering behaviour in a complex interaction.
To establish determinants of the GPs' actual test ordering behaviour
and its variations we decided that it was important to study determi-
nants not only at the individual GP level, as had been done earlier, but
also at the level of the local and regional context. These determinants
could be used to identify facilitators of and barriers to change, which
could be used in designing new strategies.
Effectiveness of strategies to improve test ordering
These facilitators of and barriers to change could help us develop more
tailored strategies, as our present knowledge is too limited to decide
which strategy would be most effective in improving GPs' test ordering
behaviour. Literature reviews have shown that the effectiveness of
interventions to influence test ordering has been variable, and results
have by no means been unambiguous, due to differences in the type,
intensity or setting of the intervention, and methodological differ-
ences between studies.' * '" " Some consistent findings have been
observed, however. Among the professional-oriented interventions,
audit and feedback were effective both in reducing general overuse
of tests and in improving the appropriateness of test use according to
specific guidelines. Reminders by computer decision support systems
seemed to be effective in improving the appropriateness of test use,
while organisational interventions proved to influence the general
overuse of tests. More studies are required on combinations of
professional-oriented and organisation-oriented interventions, e.g.
those combining organisational changes, such as changes in the order
form, and direct economic incentives for specific test ordering actions.
Another promising option is that of interventions using the interaction
between the professional and the social network, such as interactive
quality improvement meetings in small groups, educational interven-
tions by experts and opinion leaders, and interventions to achieve
improvement through patients. It seems desirable to experiment with
different combinations of interventions, but it remains hard to predict
which combination will be successful. Applying and evaluating the
various elements of such interventions separately may reveal the added
value of combined strategies.
To add to our knowledge in this field and to evaluate whether our
strategy was in line with literature findings, we performed a systematic
review of interventions focusing on test ordering behaviour at the
request of the EPOC (Effective Practice Organisation Committee)
of the Cochrane Collaboration.
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A new strategy to improve GPs' test ordering behaviour
On the basis of a preliminary literature study, the council of the
Dutch College of Health Insurances recommended the development
of a strategy involving feedback and small group quality improvement.^
In the Netherlands, feedback on test ordering has become a common
strategy, with generally positive results, and small group quality improve-
ment sessions within local GP groups have been widely used to discuss
prescription behaviour." Local GP groups are an existing part of the
infrastructure of Dutch GPs collaborating in a specific region, and
sharing patient care outside office hours. Meetings and educational
sessions in local GP groups provide a structure for small group quality
improvement. An estimated 80-90% of the GPs in the Netherlands
meet regularly in their local GP group for some form of continuous
medical education. Unfortunately, the effects of this strategy have never
been thoroughly assessed.
Based on previous experience with feedback and small group quality
improvement and on an overview of the current literature on principles
of effective change of clinical performance, we devised a multifaceted
strategy. *""" This strategy involves a systematic, step-by-step approach,
starting with raising awareness of the GPs test ordering performance by
individualised, comparative feedback. In the next step, the GPs have to
gain a clear understanding of the guidelines on test ordering.
Finally, they have to draw up concrete plans for change. Interaction with
colleagues can play a role in this process. The combination of feedback,
dissemination of evidence-based guidelines and small group quality
improvement discussions about the feedback report and the guidelines,
within the context of a safe local GP group, is best described as a
continuous, systematic and critical reflection by collaborating peers
on a GP s own performance and that of others.*' The hypothesis in our
study was that insight into and discussion of ones own performance
in a safe group of respected colleagues would be a powerful instrument
to improve the quality of test ordering.
Box I gives a detailed overview of our improvement strategy.
The effects of this new strategy were studied in a well-designed
experiment. In addition, it was important to evaluate the individual
elements of the strategy: were they all necessary or would a simpler
intervention suffice? The latter aspect was also important from an
economic point of view. Further, it was crucial that such a strategy
fits in well with GPs' daily routine. Assessing the actual adoption of
the intervention by the GPs required a thorough process evaluation,
which could also provide insight into barriers to and facilitators of a
large-scale implementation of our strategy. Using existing local GP
groups to improve patient care was also in line with the increasing
collaboration between GPs in local settings. These local groups are
also increasingly becoming parties to agreements with hospitals or
to negotiations with health insurers. We expected that making use of
such existing structures would make large-scale implementation of
the new test ordering strategy relatively easy.
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/nfervenf iow: f/ie improvement str BOX I
The intervention included the following elements: personalised
graphical feedback, including a comparison of each GP's own test
ordering data with those of colleagues; guideline dissemination and
continuous quality improvement meetings in small groups, organised
and chaired by the medical coordinator. The strategy was patient
care oriented rather than test oriented, in that it did not focus on
the volume of specific tests, but on specific clinical problems and
associated laboratory, imaging and function tests relevant to every-
day GP practice. GPs received three different feedback reports per
year on three different clinical problems, together with the national,
evidence-based guidelines on test ordering for these specific clinical
subjects. This was followed by a 90-minute structured meeting about
two weeks later, at which one of the clinical problems was discussed.
These small group meetings consisted of three major components.
The first was mutual personal feedback by peers, who worked in
pairs at the start of the meeting. This was assumed to be a method
of peer review that would create a sense of safety. Ihe second com-
ponent was the introduction and discussion of national guidelines,
while the third was the development of individual and group plans
for change. This schedule was repeated a year later, using the same
three clinical problems, to assess whether a GP or GP group had
implemented the plans for change and to initiate further improve-
ments. This iterative aspect was an important feature of the strategy.
Study design
We first studied the determinants of test ordering in a cross-sectional
survey of test ordering behaviour among our study population.
In addition to characteristics of the professionals and their practice,
we were especially interested in the determinants at the local GP group
and regional levels. Because the study population was located in various
districts and belonged to various local GP groups, multilevel analyses
could be performed at the local GP group and regional levels. The next
step was the systematic review of interventions focusing on test order-
ing behaviour. Finally, to determine the effectiveness of our strategy we
conducted a randomised controlled trial, at the same time evaluating
the strategy's practicability in everyday GP practice. In particular, we
evaluated a minimal and a complete variant of the strategy, to deter-
mine the added value of the small group quality improvement meetings
compared with the feedback only.
Of course, in times of limited resources for health care, costs aspects
of new strategies to improve the quality of health care delivery are also
important to evaluate. Not only the direct cost effects of such a strategy
must be assessed, but also various other costs, such as personnel and
co-ordination costs, the time necessary for acquiring the data, analysis
and distribution of feedback data and transport costs." ^  It is vital to
focus not only on the purely financial costs and cost savings, but also
on the strain such a strategy puts on the professional in terms of time
and energy.
Further, a process evaluation of this quality improvement strategy
seems a necessary addition to effect studies to identify important
12
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determinants of change, and to gain insight into barriers to and
facilitators of a broader implementation. ** Finally, evaluating imple-
mentation strategies requires a rigorous methodology." ™ Randomised
experiments with a block design are regarded as powerful instruments
in quality improvement research, because they can ensure that non-
specific effects are equal in the intervention arms." ™ We evaluated
whether our design could be applied in other implementation research,
and whether it provided a solution to the Hawthorne effect, that is the
phenomenon whereby the fact that professionals are taking part in a
trial and are being observed may induce them to perform better or
more in accordance with what is considered desirable.
Objective and research questions
The main objective of the research project was the systematic
development and evaluation of the model for influencing GPs' test
ordering behaviour by means of feedback, guidelines and small group
quality improvement within local GP groups. We tried to answer the
following research questions:
1. a. What is the magnitude of inter-doctor variation in GPs'
test ordering behaviour?
b. Which determinants could explain differences in test
ordering by GPs?
2. What is the effectiveness of various strategies to improve
doctors' test ordering behaviour: results of a systematic review
for the Cochrane Collaboration?
3. What is the effect of a multifaceted strategy on GPs' test
ordering behaviour?
a. What is the effect on the quantity and quality of test
ordering by GPs?
b. What is the surplus value of the complete strategy
compared to written feedback only?
c. What are the costs and cost savings, and what
organisational and financial conditions and repercussions
are associated with large-scale implementation?
4. Is the strategy applicable in everyday GP practice? Is the
improvement strategy actually being implemented in accordance
with the protocol and if so, to what degree do the GPs accept it?
5. Can our block design be usefully applied in implementation
research, and does it allow non-specific effects, such as the
Hawthorne effect, to be controlled for?
Structure of this thesis
The answers to the above-mentioned research questions are presented
in this thesis. Chapter II presents the results of the survey which was
conducted before the intervention. All participating GPs were asked
to give their opinion on test ordering within the practice and experi-
ence with feedback and quality improvement. The survey was linked
to the numbers of tests ordered by the various GPs, derived from the
baseline measurement. Chapter III provides a systematic literature
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review for the Cochrane Collaboration to describe the different approaches
and to assess the effectiveness of strategies aimed at influencing test use.
In total 98 studies with 118 comparisons were included.
To evaluate (cost) effects, in a clustered trial GP teams were randomised
to three arms and they received a quality improvement intervention
concerning test ordering on either tests for group A clinical problems
(A tests) or tests for group B problems (B tests).(Figure 1, Table 2) In
all arms the volume of ordering of all A and B tests was monitored.
Three 2-armed comparisons were possible. In the trial with the block
design we compared the complete intervention in both arms on either
the A (arm I) or B tests (arm II); the arms acted as blind controls for
each other. In the second trial the complete strategy was compared with
a partial strategy. In the classical trial the complete intervention on B
tests (arm II) was compared with a control arm without any intervention
on B tests (arm III). Chapter IV focuses on the outcomes of the two
arms in the block design. In this chapter we pay attention to the effects
of the total strategy: feedback, group education on guidelines and small
group quality improvement. In addition, it discusses the effects of the
intervention on various clinical problems, as well as the question
whether the numbers of some tests described in the guidelines as
'irrational' had decreased. Chapter V describes the second effect evalua-
tion, assessing the added value of small group quality improvement to
written feedback after one year of intervention. One arm received
feedback as well as taking part in small group quality improvement
activities, while the other received feedback only. This chapter also deals
in more detail with one of the clinical problems. Chapter VI discusses
the costs and cost reductions. A real cost-effectiveness analysis was not
possible because of the lack of clinical patient data. The chapter discusses
FIGURE 1. STUDY DESIGN
I. Written feedback + small group quality improvement
meeting on clinical problems A1, A2 and A3 (blinded
control for B1, B2, B3)
^Participating GP groups
Randomisation
II. Written feedback + small group quality improvement
meeting on clinical problems B1, B2 B3 (blinded control
for A1, A2, A3)
II. Written feedback on clinical problems A1, A2, A3
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TABLE 2 CLINICAL PROBLEMS AND TESTS USED INTHETRIAL.
CLINICAL PROBLEMS / TESTS
A1 Cardiovascular topics
Cholesterol, subfractions, potassium, sodium, creatinine,
(exercise) ECG, BUN
A2 Upper abdominal complaints
SGPT, v-glutamyltransferase, ultrasound scans of hepatobiliary tract,
SGOT, LDH, amylase, bilirubin, alkalic phosphatase
A3 Lower abdominal complaints
Prostate-specific antigen, CRP, renal ultrasound, IVP, double contrast
barium enema, sigmoidoscopy
CLINICAL PROBLEMS / TESTS
B1 COPD/Asthma
Allergic screening test, chest X-ray, immunoglobulin E
B2 General malaise / Vague complaints
ESR, Hb + indices, Ht, TSH, monospot, leucocyte count
B3 Degenerative jo int complaints
ESR, uric acid, rheumatoid factors, X-rays of lumbar spine,
cervical spine, shoulder, knee, hip
not only costs and cost reductions, but also focuses on a new framework
to calculate costs and profits in these types of intervention. The process
evaluation is dealt with in Chapter VII. Such a process evaluation is
regarded as a necessary addition to effect studies to learn about impor-
tant elements of change, and process data can be very useful for a possible
large-scale implementation of the strategy. The block design we used
for the effect evaluation is regarded as one of the most powerful designs
for investigating quality improvements. Chapter VIII pays detailed
attention to the method and the study design and evaluates whether or
not our study design lived up to expectations. Should this type of design
be used more often in future, or do simpler designs suffice? Chapter IX
presents the general conclusions of the study and the lessons to be learnt
from it for the national implementation of this new method. The general
conclusion is that the new strategy is an innovative and practicable
quality instrument which can be usefully integrated within local and
regional quality improvement programmes in an attempt to consis-
tently improve GPs' test ordering behaviour in a practicable, efficient
and cost-efficient way.
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Abstract
Ob/ecfive
To describe GPs' test ordering behaviour, and to establish professional
and context-related determinants of GPs' inclination to order tests.
single-handed and two-person practices) and'more than one year of
experience working with a problem-oriented laboratory order form'
(yes versus no) were associated with 27%, 18%, and 41% lower num-
bers of tests ordered, respectively.
Cross-sectional analysis of the combined number of 19 laboratory
and 8 imaging tests ordered by GPs, collected from five regional
diagnostic centres. In a multivariable multilevel regression analysis,
these data were linked with survey data on professional characteristics
such as knowledge about and attitude towards test ordering, and with
data on context-related factors such as practice type or experience
with feedback on test ordering data.
229 GPs in 40 local GP groups from five regions in the Netherlands.
Main outcome measure
Percentage point differences associated with professional and context-
related factors.
In addition to professional determinants, context-related factors
appeared to be strongly associated with the numbers of tests ordered.
Further studies on GPs' test ordering behaviour should include local
and regional factors.
Key words
Family practice, utilisation, physician's practice patterns, test ordering,
inter-doctor variation, quality assurance; health care.
Total median number of tests per GP per year was 998 (interquartile
range 663 to 1500), with significant differences between the regions.
The response to the survey was 97 %.
At professional level 'individual involvement in developing guidelines'
(yes versus no), and at context-related level 'group practice' (versus
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Introduction Methods
The use of laboratory and imaging tests by general practitioners (GPs)
is increasing in many countries and inter-doctor variation has been
shown to be large." The reasons for the increase in the numbers of
tests ordered are still imperfectly understood, and probably complex.
Possible explanations include the expansion of modern diagnostic
technology, increased fear of litigation and lack of knowledge about
appropriate test use. *"' Furthermore, monitoring of chronic diseases
is increasingly performed by GPs, due to a shift of care from hospital
to primary care/
Improving the quality of test ordering requires a thorough under-
standing of the causal determinants of test ordering behaviour.® "
Previous studies into determinants of test ordering have, in general,
yielded inconsistent conclusions. Various professional or practice-
related factors have been held responsible for the inter-doctor variation
(GP's age, years of experience as a GP, GPs attitude towards risk-taking,
practice size and practice type), but no single determinant has been
found to be very influential across all of these studies. '*"'* The present
study attempted to investigate the influence of context-related deter-
minants not only at practice level but also at the level of local GP
groups, such as differences between GP groups in patterns of collabo-
ration, and at the regional level, such as differences between regions in
quality improvement programmes or ways of organising test requests.
We studied the variation in actual test ordering behaviour among a large
group of GPs, to assess determinants of inter-doctor variation, at both
the professional level and the level of the local and regional context.
We performed a cross-sectional study of the numbers of tests ordered
by GPs, and linked these test ordering data with data from a survey
among the study population. Test data were retrieved from the files
by staff members of five participating diagnostic centres. A diagnostic
centre is an institute, usually associated with a hospital, where GPs
can order tests without referring the patient to an outpatient clinic.
One of the tasks of the medical coordinator of such a centre is to
provide feedback to the GPs about their test ordering. The five different
diagnostic centres included in the study used similar problem-oriented
test ordering forms for laboratory tests with tests categorised into groups
based on clinical problems. The study population consisted of GPs
associated with these regional diagnostic centres and whose individual
test ordering data could be retrieved. Dutch GPs collaborate with
colleagues in so-called local GP groups. They share patient care outside
office hours and most groups provide continuing medical education
as an important activity. GPs consented to having their individual
data on test ordering behaviour used for research purposes.
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a) The dependent variable for the multivariable regression analysis
was the total number of tests that the GP requested in one year
(1997). Data of 27 tests (19 laboratory and 8 imaging) were
retrieved (Table 1). Data on the desktop tests that many GPs
regularly perform in their own practice (ESR, haemoglobin,
glucose and cholesterol) could not be retrieved, and these tests
were therefore excluded.
b) The GPs in the study population were surveyed on the following
professional and context-related determinants:
-Professional characteristics: age, number of years of experience,
working full time (5 days) or part time, knowledge of diagnostic
accuracy measures e.g. sensitivity, predictive value, involvement in
guideline development and personal opinions on test ordering. The
latter variable was measured on a five-point scale, with options ranging
from disagree to agree.
- Context-related determinants: At practice level, we determined
practice type, size and location of practice, fraction of privately
insured patients (compared to sick fund-insured patients)", the
fraction of patients older than 65, level of computerisation, distance
to the laboratory and imaging facility, and use of desktop equipment.
Use of desktop equipment was measured on a four-point scale ranging
from never to always. At the local GP group level, we measured quality
improvement activities in the GP group setting (yes/no), presence of
at least one member who participated (or had participated) in guide-
TABLE 1 TESTS RETRIEVED FROM DIAGNOSTIC CENTRES
Packed Cell Volume
White Blood Count
C-Reactive Protein
Thyroid Stimulating Hormone
Potassium
Creatinine
Blood Urea Nitrogen
Sodium
Uric acid
Prostate Specific Antigen
Alanine Aminotransferase
Aspartate Aminotransferase
y-Glutamyltransferase
Alkalic Phosphatase
Lactate Dehydrogenase
Amylase
Bilirubin
Immunogiobulin E
Allergic screening test
Chest X-ray
Double contrast barium enema
Ultrasound of hepatobiliary tract
X-ray of cervical spine
X-ray of lumbar spine
X-ray of hip
X-ray of knee
X-ray of shoulder
1 2
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line development for the Dutch College of General Practitioners (yes/
no) and presence of a joint strategy on medication and test ordering
in the local GP group (yes/no). At the regional level, we assessed the
experience with feedback from the regional diagnostic centre (yes/no)
and whether respondents had at least one year experience with the
problem-oriented laboratory form (yes/no).
Afla/ysz'5
Descriptive analyses were performed on test ordering data relating
to the 27 tests selected, both for all 27 and for laboratory and imaging
tests separately; differences in test ordering data between regions were
tested with the Kruskal-Wallis test. To obtain a normal distribution
of the dependent variable, all regression analyses were performed with
the log-transformed total number of tests ordered. As a consequence,
r^egression coefficient reflects a relative risk, and results are reported as percent-
age point changes associated with the various independent variables.
As an initial step in the regressions analysis, we first conducted a
stepwise backward linear regression analysis for each region separately.
This approach shows which variables predict best the number of test
orders for each region. In these analyses, all variables are initially
entered into the model. The regression algorithm then removes
- taking into account the effects of others - those variables that do not
have a strong independent association with the number of test ordered.
Using robust variance estimation, we took into account that - even
within the same region - the numbers of test orders GPs' requested
cannot be assumed to be statistically independent from each other,
because the test ordering behaviour of two GPs within the same GP
group may be more similar than that of two GPs from different GP
groups. In this initial step of the regression analyses we adjusted for
working full time or part time, and the practice size, that is, these
variables were forced into the model and were never omitted. The effect
of any other variables should be seen in the context of these two.
In accordance with the statistical literature, the p-values for entry into
or removal from the multivariable model were set at 0.15, and 0.20.
In an effort to avoid the selection of too many variables and over-
fitting of the data set, only those variables that were selected in each
region by this stepwise procedure were eligible for entry into the
multilevel multivariable analysis.
In the final regression model, the data had a clear hierarchical
structure, with GP groups operating under single regional diagnostic
centres and GPs collaborating within GP groups. Again, one should
assume that test ordering behaviour of two GPs within the same GP
group may be more similar than that of two GPs from different GP
groups. The same holds for GP groups within a region being perhaps
more similar than two GP groups randomly chosen from different
regions. Therefore, the data were modelled in a three-level multilevel
analysis model using the Stata commandgl/amm (Generalized Linear
Latent and Mixed Models) with GP group and region as the random
coefficients. Eligible for the multilevel model were the variables
selected by the previously described stepwise procedure for each
region separately. In addition, all context-related factors measured
at local GP group and regional level, were entered.
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Thus, the initial multilevel model contained 11 independent determi-
nants (Table 3). To adjust for practice size, the natural logarithm of
practice size was entered as an offset variable. '* Briefly, this was done
because it was the number of tests ordered that was essential, rather
than the order rate, that is, the number of orders per potential patient
who triggered the order by his or her visit to the GP. No tests for
interactions were performed to avoid the risk of false-positive associa-
tions in subgroups before the theoretical mechanisms underlying test
ordering are better understood. The likelihood ratio test was used to
decide which levels would be retained. All analyses were carried out
using Stata statistical software (Release 7.0. College Station, TX: Stata
Corporation).
Results
Individual test ordering data were retrieved for 229 GPs, working in
40 local GP groups in the five selected regions in the Netherlands
(Table 2). Figure 2 demonstrates the large variation between regions
in the total number of tests ordered (p<0.001). In region III, the median
number of tests ordered proved to be more than twice that in region II.
Of the 229 GPs, 221(97 %) returned the questionnaire. Compared
with all Dutch GPs, the study population included more male GPs
and more GPs working in urban practice locations. Two-person
practices were underrepresented while relatively more GPs practised
in group practices. (Data not shown) Table 3 presents some character-
istics of the study population at GP, practice, and local GP group levels.
Eighteen GPs were actually involved in developing guidelines.
A knowledge question, involving the application of Bayes' theorem to
a patient case, was correctly answered by 16% of the study population.
One hundred and eleven GPs (55%) answered that they would feel
uncomfortable if it appeared that they clearly ordered more tests than
their colleagues. By contrast, nine GPs (4.1%) would be uncomfort-
able if they ordered fewer tests. There was a desire to discuss personal
test ordering behaviour in local GP groups, and to receive feedback
on test ordering from the diagnostic centre. At the local group and
regional levels, 22 local GP groups had experience of discussing their
test ordering behaviour in the local GP group, which had led to (group)
plans for change. At regional level, there was only one region (region I)
where the diagnostic centre was already providing individualised
feedback on test ordering behaviour, while two of the five regions had
introduced the problem-oriented form more than one year ago
(regions I and II).
o/fesf ordering
Table 3 also shows the professional and context-related variables that
were eligible for entry in the multilevel model. The variable location
of practice, whose omission had a negligible effect on the coefficients
of the remaining variables, was omitted. The random variation due to
the local GP group level proved to be small and insignificant after the
three GP group level variables had been omitted. Therefore, the local
GP group level was omitted, and our final multilevel model contained
7 variables. Our final two-level model explained about 30% of the
variation in test ordering. Two of the variables of the final multilevel
model were at the professional level: working full time or part time,
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TABLE 2 DISTRIBUTION OF NUMBERS OF TEST ORDERED BY 229 GPS IN FIVE REGIONS
REGION II REGION III REGION IV REGION V
Total numbers of tests ordered PS
P25
P50
P75
P95
P5
P25
P50
P75
P95
P5
P25
P50
P75
P95
364
663
998
1500
2648
303
565
839
1271
2297
40
99
146
218
370
261
576
860*
1436
1960
322
499
666*
847
1293
617
1085
1742*
2781
3805
349
694
891*
1344
2413
577
1125
1273*
1608
2674
Total numbers of laboratory tests ordered 157
456
691*
1116
1732
250
400
568*
730
1104
498
942
1469*
2498
3445
332
569
799*
1194
2071
448
903
1078*
1398
2249
Total numbers of imaging tests ordered 57
110
159*
245
470
34
61
90*
132
254
74
173
243*
316
379
*=p<0.001 KruskalWallis
P represents percent/7e of the distribution. For example P25, means that 25% of
all values are lower than this value.
P50 is identical to the median.
35
96
142*
175
382
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FIGURE 1. BOX PLOT SHOWING THE DISTRIBUTION OF THE NUMBERS OF LABORATORY AND IMAGING
TEST ORDERED BY 229 DUTCH FAMILY PHYSICIANS IN EACH OF FIVE REGIONS IN 1997.
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The horizontal line shows the overall median number of tests (998) ordered. The horizontal lines
within the boxes represent the medians for each respective region. The lower and upper ends of
the boxes are the lower and upper quartiles. The antennas' sticking out from the boxes delineate
where 95% of the observations lie. Dots represent the number of tests ordered by physicians who
ordered extremely many tests compared to colleagues within their region. The graph shows the
large interregional differences with respect to the average number of test orders as well as with respect
to the variation in the numbers of tests ordered. For example, 50% of physicians in region II ordered
between 499 and 847 tests, whereas these numbers are 1085 and 2781 for the physicians in region III.
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and participation in the production of a guideline. Three variables
were at context-related practice level: type of practice, distance to an
imaging facility, and distance to a laboratory facility. Two variables
were at context-related regional level: feedback on test ordering and
experience with the problem-oriented form. Table 4 shows detailed
results of the final two-level model. At the professional GP level,
having been actively involved in national guideline setting was
associated with a 27% lower volume of tests ordered compared with
non-active GPs. The practice type contributed significantly to the
variation in test ordering: GPs working in group practices ordered
about 18% fewer tests than those in single-person or two-person
practices. At context- related regional level, having had at least one
year of experience with the problem-oriented laboratory form was
associated with a 41% lower volume of tests ordered. The intra-class
correlation coefficient at region level was 0.304, meaning that the
variation between regions was large compared to the variation within
regions, which supports the assumption that variability in test order-
ing is strongly correlated with a region factor.
Discussion
To our knowledge, the present study is the first to explicitly include
context-related variables at GP group and regional level. This enabled
us to focus on the variation in GPs' test ordering behaviour in relation
to both professional and context-related determinants. We found, to
our surprise, a large variation in test ordering between the regions, and
we determined three variables that were independently and strongly
associated with the volume of tests, namely involvement in developing
guidelines, working in a group practice, and having had more than one
year of experience with a problem-oriented form.
At the level of the professional, GPs who were involved in developing
national clinical guidelines (in the context of the Dutch College of
GPs programme for guideline setting) ordered clearly fewer tests than
other GPs. Although this subgroup represents a minor and probably
selected proportion of the GPs, discussing guidelines and the under-
lying medical evidence might be an important part of a strategy to
improve test ordering behaviour.^"" Secondly, at context-related
practice level, working in a group practice was associated with a
considerably lower number of tests ordered as well. This finding,
which probably results from general discussions of and reflections
on practice behaviour in such group practices, is in line with earlier
findings related to prescription behaviour." " Finally, at the regional
level, it was particularly the level of experience with a problem-
oriented test ordering form that appeared to have a large impact on
the numbers of tests ordered. It is not so much the influence of the
order form itself that is surprising, but rather the magnitude of this
effect.^ ** The present study was unable to explain all of the interre-
gional variation. Of course, disease-related factors are also important
in the variation of test ordering. Although there might be slight differ-
ences in morbidity between the regions, it is unlikely that differences
in case-mix play an important role, because a total of about 550.000
patients were involved. Explaining this interregional variation will
require more research, which should include patient-related, organisa-
tional and socio-cultural determinants.
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TABLE 3 INDIVIDUAL AND CONTEXT-RELATED DETERMINANTS OF THE NUMBER OF TESTS ORDERED BY 221 GPS IN 1997
STUDY POPULATION CHARACTERISTICS ELIGIBLE FOR INITIAL MULTILEVEL MODEL
DETERMINANTS RELATED TO GPS (N = 221)
Male
Age (SD)
GP's number of years of experience in years (SD)
GPs answering questions on diagnostic accuracy correctly
Don't want to order more tests than colleagues (scale 1 -5)*
Desire to discuss test ordering in local groups (scale 1 -5)*
Desire to receive feedback on test ordering (scale 1-5)*
Attitude to risk taking (scale 1-5)'
Desire to have direct access to MRI facility (scale 1-5)"
CONTEXT-RELATED DETERMINANT LEVEL PRACTICE
% Privately insured (SD)
% Older than 65 years (SD)
Number of GPs working in computerised practice
Number of GPs using medical module information system
Work time factor 5 days
> 4'A days
4 days
< 4 days
Involved in developing guidelines
Practice size (SD)
Practice location:
Practice type:
Urban
Semi-urban
Rural
Single-person
Two-person
Group practice
Reference
-0.0756
0.2333
-0.1031
-0.2300
Offset variable
Reference
-0.0195
-0.0804
Reference
-0.0989
-0.1641
0.1201
0.1158
0.098
0.1269
0.1022
0.1132
0.0954
0.1052
221
191
46.1 (6.2)
15.5 (7.6)
169
25
26
18
16
3.2
4.1
4.1
2.7
2.1
2545 (525)
35.4 (11.2)
14.4(6.8)
206
146
108
57
56
103
41
77
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TABLE 3 INDIVIDUAL AND CONTEXT-RELATED DETERMINANTS OF THE NUMBER OF TESTS ORDERED BY 221 GPS IN 1997. (CONTINUED)
% of GPs using desk top testing always for Hb, ESR and glucose
LOCAL GP GROUP (N = 40)
REGION (N = 5)
Distance to imaging facility in km
Distance to laboratory facility in km
Number of local GP groups receiving feedback on test ordering
Number of local GP groups making group plans for change
At least one GP in the GP group is involved in developing guidelines
Number of diagnostic centres providing feedback on test ordering
0.0004
0.0120
0.0678
0.0508
0.1220
0.0087
0.0130
0.2157
0.0994
0.1033
12.8
6.2 (5.3)
2.3 (2.5)
22
26
12
-0.4776 0 1251
Abbreviations: (3 = Regression coefficient;
SE = Standard error;
SD = Standard deviation;
MRI = Magnetic Resonance Imaging
The second column shows the 11 determinants eligible for the initial multilevel model analysis,
including practice size (offset variable).
* Personal opinions of GPs on test ordering 1 = disagree....5= agree
Our study population differed from the total population of GPs in the
Netherlands in some features, but we do not think that these differences
influenced our results. Further, in the Netherlands diagnostic facilities
only perform tests, when a physician orders them. Sometimes, however,
diagnostic centres perform test cascades, depending on the results of the
previous test. Further, only data from the diagnostic facility were available,
so the tests that were ordered but not performed, e.g. because the
patient did not visit the diagnostic centre, were not included. However,
both situations probably constitute a small part of the ordered tests.
Based on the present results, it is tempting to recommend the intro-
duction of problem-oriented forms in diagnostic facilities for GPs,
however further study to replicate our findings is necessary. The
problem-oriented form was developed as a quality improvement
instrument, aimed at efficient and cost-efficient use of tests. Of course,
it is also important to study patient-related factors, such as whether
patients are actively demanding tests, and how to 'sell' such a cost-
conscious approach to such demanding patients? These patient factors
should be discussed with colleagues, as probably some of them may
29
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have developed effective strategies for dealing with them. Despite the
small influence of the local GP group in our study, many GPs men-
tioned social influence of colleagues as an important determinant of
test ordering.
The medical coordinators of the diagnostic centres, who provide the
feedback on test ordering and may as such be regarded as experts on
this topic, could function as opinion leaders in these discussions. *'"
Based on the strong correlations we found between several factors
and test ordering patterns, we conclude that a quality improvement
programme, consisting of discussions on guidelines and feedback
reports in a local GP group, and collaborating with a diagnostic centre,
that uses problem-oriented test ordering forms and provides the
feedback, appears to be a promising intervention to decrease overuse
of GPs' test ordering.
TABLE 4
Professional
RESULTS OF FINAL TWO-LEVEL MULTIVARIABLE ANALYSIS
DETERMINANT
5
4.5 days
4 d
1.5-3.5 d
no
yes
single-person
two-person
group
no
yes
no
yes
DIFFERENCE (%)
(0) reference
-13.5
15.7
-14.3
(0) reference
-26.9
(0) reference
-5.9
-18.0
-9.4
19.1
(0) reference
24.1
(0) reference
-41.0
P
.210
.204
.105
.013
.516
.022
.168
.142
.311
.001
95% Cl
-31.0; 8.5
-7.6; 45.0
-28.9; 3.3
-43.0; -6.4
-21.8; 13.1
-30.9; -2.8
-21.9; 3.2
-7.4; 43.5
-18.2; 88.3
-57.2;-18.7
Context-related practice
Context-related regional
Working full time or part time
Actively involved in developing guideline(s)
Practice type
Distance to imaging facility (per 10 km)
Distance to laboratory facility (per 10 km)
Diagnostic centre providing feedback
Problem-oriented form > 1 yr.
Differences are percentage point changes compared with a reference category.
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Abstract
Many different approaches have been adopted to improve health care
providers' use of diagnostic tests. The objective of this systematic
literature review is to describe the different approaches and to assess
the effectiveness of the strategies aimed at influencing test use.
We searched Medline (1966 to 1997), the Cochrane Collaboration
Effective Practice and Organisation of Care trials register (searched
2001) and snowballed reference lists of relevant articles. Published
(quasi-)RCTs, controlled before and after studies, and interrupted
time series analyses of any type of intervention to influence the test
ordering behaviour of any type of health care professional, using tests
to diagnose or monitor patient complaints, were included. Assessment
of trial quality and data extraction was executed by two independent
reviewers.
flesu/fs
In total 98 studies with 118 comparison groups were included.
Seventy-one studies with 86 comparisons described results on chang-
ing absolute rate of test use. Twenty-seven studies with 32 comparisons
focused on improving appropriateness of test use. Overall, results are
heterogeneous due to differences in type or intensity of the interven-
tion, the setting, or methodological differences between studies, such
as differences in measurement periods (during or after intervention)
or in correction for baseline differences. Probably, different strategies
are needed for modifying overuse of tests versus improving appropri-
ateness of test ordering behaviour. It is not clear that single strategies
have less impact versus multifaceted strategies, but it seems important
to focus the intervention at both the professional and the context.
Audit and feedback seems effective for both decreasing absolute test
rate and improving appropriateness of test use. Reminders by computer
aided decision support improve the appropriateness of test use.
Outreach visits, patient-mediated interventions and small group
quality improvement deserve more attention.
Ccmc/us/oMs
There is no rule of thump for the choice of the intervention in effec-
tively influencing test ordering behaviour. Next to generally accepted
rules such as tailoring the intervention to the barriers for change, the
aim of the intervention (modify overuse or improve appropriateness)
should be considered in. In addition to professional-oriented inter-
ventions it seems important to consider the use of interventions that
focus on organisational factors.
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Introduction
Diagnostic tests (i.e. diagnostic procedures other than those performed
in usual doctor-patient consultations, such as physical examination)
are an important aspect of medical care in many areas of clinical prac-
tice. As doctors do not want to miss important diagnoses, the rapid
advances in diagnostic technology has led to increased use
of diagnostic tests. Overuse of diagnostic tests is a realistic danger
in health care. It represents a potential threat to patient health, as
false-positive findings can lead to harm from invasive diagnostic
interventions (e.g. colonoscopy used to follow-up on patients with
false-positive haemoccult tests), unnecessary treatment, or anxiety
and labelling effects. In addition, it is a waste of resources.
According to diagnostic decision making theories the decision to order
a test should at least be based on the pretest chance of the patient
having the disorder and the seriousness of the suspected disorder.
Other important considerations include, the diagnostic value of the
test, the consequences of the test result for further decision making
such as therapy, and the risk or financial costs accompanying use of
the test. In daily medical practice, diagnostic decision making may be
biased by professional factors or by structural aspects of the practice
environment (context-related factors)' Well-known professional-
related determinants of test ordering behaviour are the risk taking
attitude " , bias towards action ", or other aspects of personality',
as well as routines.'' They may also be found in the interaction of the
professional with the direct environment such as pressure of peers
through social influence *•?; or of patients. "•'
Examples of context-related determinants of test ordering behaviour
are the differences in quantity of test ordering between countries'",
between regions", or between academic and non-academic hospi-
tals'-. Workload", availability of diagnostic facilities", the organisation
of the test ordering procedure^, the remuneration system" and its
impact on supplier-induced demand '*•", and, finally, financial incen-
tives or regulatory sanctions, are all examples of structural aspects of
the practice environment.
In view of this knowledge this review describes the different approaches
that have been reported in influencing test ordering behaviour in
rigorous designs, and attempts to investigate the effectiveness of all
interventions to influence diagnostic test use. In an attempt to reduce
heterogeneity of studies, test ordering as part of delivering preventive
services in patients without clinical uncertainty, which might imply
different beliefs, attitudes, reactions and judgements of the care
provider were excluded. In this review we hypothesised that changing
absolute rate of test use (most often reducing general overuse of
diagnostic tests) and improving appropriateness of test use (most often
by explicit guidelines for certain disease-defined patient categories)
are different behaviours that need different strategies. We hypoth-
esised that single-faceted strategies in general have less impact than
multi-faceted strategies.'" And we hypothesised that studies that
evaluated strategies that were context-oriented interventions have
more impact than exclusively professional-oriented interventions.
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Methods
Inclusion criteria for studies: only randomised (RCTs), and quasi-
randomised controlled trials (CCT) controlled before and after (CBA)
studies, or interrupted time series (ITS) with at least three measure-
ment points before and after the intervention were considered for this
review. Studies on any health care professional responsible for patient
care are included. This review was targeted at all diagnostic testing;
laboratory tests, imaging techniques, and function tests. The scope of
this review is restricted to the use of diagnostic tests that are requested
to confirm or to exclude a diagnosis, or monitoring patients with
disease, signs or symptoms. Studies about tests used in situations
without clinical uncertainty, which generally attempt to enhance test
use (such as screening or pre-operative tests), were not included. Any
type of (professional-oriented, organisational, financial, or regulatory)
intervention aimed at influencing the use of diagnostic tests was
considered. Objective measure of quantity (absolute rate) or quality
(appropriateness) of test ordering behaviour in daily practice had to
be reported in the study.
Search strategy: Medline was searched from 1966 to August 1997.
The following mesh terms were combined to define 'quality assurance':
quality-assurance-health-care, quality control, physicians-practice-
patterns, education-medical-continuing, guidelines, medical-audit,
peer review, reminder-systems, physician-incentive-plans, feedback,
health-services-research, algorithms, cost-control. A combination of
mesh and free text terms was used to define 'test ordering behaviour':
diagnosis/education-standards-utilization, diagnostic-tests-routine,
laboratory near test$, laboratory near use$, laboratory near ordering,
test$ near use$, test$ near ordering. In addition, the Cochrane
Collaboration EPOC Register of Trials was searched until 2001.
Finally, all reference lists of identified studies and reviews were checked
for relevant articles. Each abstract of all retrieved citations was checked
by at least two of the authors independently on the inclusion criteria
(TvdW/MW/WV).
Studies were screened for inclusion and data were extracted indepen-
dently by at least two of the authors (TvdW/MW/WV/GT), using a
standardised form developed in collaboration with the Cochrane
Effective Practice and Organisation of Care (EPOC) Group. Reporting
results separately for two subgroups of studies optimised comparability
between studies. The subgroups were studies characterised by changing
absolute rate of test use and studies targeting on improving appropri-
ateness of test use. Some studies report on the effects of more than
one intervention, and therefore comparison groups were the unit of
analysis in describing the effects of the interventions. If outcomes were
reported on separate (subgroups of) tests instead on the total number
of diagnostic tests, they were summarised by calculating the sum of
separate numbers of tests. This could not be done for qualitative out-
comes because the denominators of the proportions of performance
that was according to the guidelines varied widely. If more than one
measurement point was reported at follow-up the average of the results
on the various measurement points was calculated. If available, both
the immediate effects (measurement during the intervention period)
and the lasting effects of the interventions (measurement during the
follow-up period) were analysed.
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Results are reported in descriptive tables. For each individual study
the effect was translated into a rough outcome scale on the difference
in relative change between groups:
the difference in relative change between the intervention
versus the control group was in the opposite direction than
expected/desired;
0 the difference in relative change between the intervention
versus the control group was between -2% and +2%;
+ the difference in relative change between the intervention
versus the control group was between +2% and 10%;
++ the difference in relative change between the intervention
versus the control group was between +11% and 20%;
+++ the difference in relative change between the intervention
versus the control group was between higher than 20%.
Example: Table 2, first study (Eisenberg 1977): Relative change in
number of tests ordered per admission in intervention group:
717 - 830 = -113 divided by 830 = -14%. Relative change in control
group: 905 - 900 = +5 divided by 900 = +1%. The difference in relative
change between groups is -14% -1% = -15%
In case no comparable baseline data could be extracted from the
reported results the relative difference between intervention versus
the control group was calculated.
Results
C/iaracferisfics o/m
Strictly applying the inclusion criteria generated 98 studies (with 118
comparisons) for inclusion in this review. All included studies reported
on test ordering by physicians. Table 1 shows the distribution of the
type of studies along some crude criteria. The details of the studies
are reported in Tables 2-6.
Most trials were conducted in the United States of America (n=60),
11 in the United Kingdom, three in Canada, 18 in continental Europe
including Ireland, and six in Austral-Asia (Australia, New Zealand,
Korea, Thailand, Bangladesh). The earliest trial was published in 1975.
In 41 studies the practice setting was inpatients, 49 studies took place
in outpatient care (both family medicine and outpatient clinics), in six
studies it was mixed (Gama's study was executed both in the in and
outpatient setting, and therefore two outcomes were reported: number
of test per admission, and number of tests per patient-visit), and the
setting was unclear in the remaining studies.
Seventy-one studies with 86 comparisons focused on changing absolute
rate of test use, the "modify overuse" group. Twenty-seven studies with
39 comparisons targeted the improvement of appropriateness of test use,
the "improve quality" group. In the "modify overuse" group the inter-
ventions were focused on one or a few disease-specific tests only in 15%
of the studies (n=ll), whereas this was 67% (n=18) for the "improve
quality" group of studies. In the first group the authors reported explicit
guidelines underlying the desired test ordering behaviour for 32% of
these studies, whereas this was 88% in the second group of studies.
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The number of published trials increased throughout the years
(until 1980: n=l 1/81 -'90: n= 38,'91 -'00: n=49). The aim of the
studies and the type of strategies also changed throughout the years.
The proportion of studies aiming at modifying overuse of tests increased
through the years (until 1980: 55%,'81 - '90: 70%,'91 - '00: 76%).
The proportion of studies evaluating multi-faceted strategy at least in
one arm increased only in the eighties (until 1980:0%,'81 - '90: 24%,
'91 - '00: 14%). The proportion of studies evaluating context-oriented
strategies increased in the nineties (until 1980: 27%,'81 - '90: 24%,
'91 -'00:49%).
There is some risk of methodological bias in all of the included trials.
Over half of the studies (n=56) were randomised controlled trials. In
16 of these trials, we were confident that randomisation was properly
executed at central level; in the remaining 39 trials the randomisation
procedure was not clearly described. The allocation procedure was
clearly concealed in 9 studies, clearly not concealed in 38 studies, and
this criterion was scored as unclear in the remaining 51 studies. In 44
studies it was unlikely that the control group received the intervention,
in the other 54 studies it was either unclear or likely that the control
group received the intervention. Outcomes were assessed blindly in
18 studies, in 45 studies this was not the case, and in the remaining
35 studies this criterion was not clear. The number of professionals
participating in the studies varied from 2 to 1483, but was not given in
half of the studies (n=49) studies. Information on dropouts was also
sparse. In 35% of the studies there was disagreement between the unit
of analysis and the unit of randomisation. The clustering by physician
was most often not taken into account in the analysis; therefore the
results of the studies should be interpreted with caution because of
bias towards effect.
Most studies compared the effect of the intervention with that of a
control group without any intervention (usual care). In 6 studies (10
comparisons) the intervention was compared with another intervention.
For reasons of comprehensiveness studies with multifaceted interven-
tions (combinations of different type of interventions) were not
described in a separate table. Nearly all interventions described educa-
tional materials or meetings as a component of the intervention.
In this review, educational materials or meetings were regarded upon
as a logical or necessary condition for an intervention to influence test
ordering behaviour, not as a separate component of a multifaceted
intervention. The category of organisational interventions typically
shows a high rate of combinations with professional-oriented inter-
ventions.
o/sfrafegzes
There was large variation in the duration of the interventions.
Interventions varied from two weeks to as long as 9 years (median 8
months, interquartile range 3-12 months). Most comparisons, namely
79, were on professional-oriented interventions, and 39 on context-
oriented interventions (Table 1). Overall, a quarter (26%) of the inter-
ventions were aimed at'improving quality'; 29% (23 out of 79) of the
comparisons evaluating professional-oriented interventions, and 21%
(8 out of 39) of comparisons evaluating context-oriented interventions
respectively. The intervention types audit and feedback, reminders,
and structural organisational interventions were evaluated most often.
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PROFESSIONAL-ORIENTED INTERVENTIONS
Dz'sfribufzon o/educafz'ona/ maferia/s/educafzona/ meefz'«^ 5 (TaWe 2A +2B)
For both type of studies on influencing test ordering behaviour,
'modify overuse' group and 'improve quality' group, the effects were
small to moderate. Eisenberg's, Davidoff's and Stross' 1980 study
showed a relevant decline at follow-up, after the intervention had
stopped. The number of participants of the educational intervention
might explain the magnitude of the effect; the study had only a small
number of participants, it is therefore likely that the attention given
to the participants was intensive. Davidoff's and Stross '80 study were
also characterised by a small number of participants.
(Tafr/e 3A + 3BJ
Generally speaking, a consistent positive effect is seen in the
'modify overuse' group without a clear trend towards a specific content
of the feedback given. Strong effects are seen e.g. in Winkens' study
published in 1996, for which the long duration of the intervention
(9 years) is striking. A strong rebound effect was seen in Cohen's
study. Reason given: "Simple cost feedback mechanisms will not by
themselves assure reduction in test usage; it requires effort to prepare
physicians to use these data". Reason given for the opposite effect in
Wones' study: "Perhaps the medium, e.g. a respected teacher, is more
important than the message". Audit and feedback and information
transfer also shows a consistent, and somewhat stronger effect.
Chassins study focussed on one test only. Only two studies, on audit
and feedback including information transfer, are reported for the
'improve quality' group, with a strong effect in Kroenke's study.
(Table 4A +
Varying effects are seen in the 'modify overuse' group. The effect of
computer aided decision support (studies of Thomas, Tierney, and
Holleman) is disappointing for reducing overuse of tests. The effects
of reminders in the 'improve quality' group seem less varying than
reminders aimed at modifying overuse and more encouraging, also
for computer aided decision support.
Of/jerpro/es5z'ona/-orze«fed zttfervettfroMS (Tab/e 5A + 5BJ
In the 'modify overuse' group two small studies on educational
outreach visits show reasonable effects during intervention, but the
effect does not last in one study.
The availability of the patient's depression score before consultation,
but not after the consultation, reduces laboratory testing. This is the
only example of a patient-mediated intervention. Although the number
of studies on small group quality improvement is limited, positive
effects are shown in the 'modify overuse' group, but less so in the
'improve quality' group.
CONTEXT-ORIENTED INTERVENTIONS (Tab/e6A
In the 'modify overuse' group, both the professional-related organisa-
tional interventions and the structural organisational interventions
showed a rather consistent picture of positive results. The professional-
related organisational interventions were most often characterised by
demanding justification for test ordering by changing the organisation
in such a way that an attending physician or a team was given a sort of
supervising role. The structural organisational interventions typically
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showed a more steering character, e.g. by applying strict protocols,
or by changing the procedure of test ordering, or shifting responsibili-
ties care setting. The three studies on financial interventions did not
seem to lead to the desired effect, but the combined financial and
organisational interventions seem more effective. Although numbers
of studies are small.
'TABLEI SUMMARY OF MAIN CHARACTERISTICS OF THE 1 1 8 COMPARISON GROUPS
A: studies aimed at 'modify overuse'. B: studies aimed at 'improve quality'
TYPE OF STRATEGY IMBEROF STUDIE~
PROFESSIONAL-ORIENTED INTERVENTIONS
educational strategies 13 see Table 2
audit and feedback
reminders
other
SUBTOTAL
CONTEXT-ORIENTED INTERVENTIONS
professional-related organisational strategies
structural organisational strategies
financial strategies
combined organisational and financial
strategies
24 see Table 3
22 see Table 4
12 see Table 5
7 1 *
n = 9s«eTable6
n = 21 see Table 6
n = 3seeTable6
n = 3seeTable6
A
B
A
B
A
B
A
B
A
B
A
B
A
B
9
6
27
2
11
12
8
4
8
1
17
7
3
0
3
0
3 (33%)
5 (83%)
11 (41%)
0 (0%)
8 (73%)
8 (75%)
4 (50%)
3 (75%)
4 (50%)
1 (100%)
7 (41%)
3 (43%)
2 (66%)
0 (0%)
2 (22%)
4 (67%)
8 (30%)
2(100%)
2 (18%)
8 (67%)
2 (25%)
4 (100%)
3 (38%)
1 (100%)
4 (24%)
4 (57%)
0 (0%)
0 (0%)
0 (0%)
0 (0%)
0 (0%)
0 (0%)
1 (9%)
1 (8%)
2 (25%)
2 (50%)
* some studies reported both on professional and context-oriented comparisons
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Discussion
In this review we explored the variety and effectiveness of various
interventions to influence test-ordering behaviour of physicians
dealing with patients with signs or symptoms. An increasing number
of studies have been executed, with modifying overuse of tests being
the most common aim of the studies. Context-oriented strategies are
increasingly evaluated in this set of studies. It was hypothesised that
changing absolute rate of test use (most often reducing overuse of
diagnostic tests) and improving appropriateness of test use (most
often by following explicit guidelines) would require different inter-
ventions. The different findings for reminders (seem more effective
for improving quality) and small group quality improvement (seem
more effective for modifying overuse) seem to confirm this hypothesis
for these type of strategies. No clear answer can be given on the hypo-
thesis that multifaceted strategies are superior to single strategies.
Interventions aimed at the contextual aspects of the practice environ-
ment seem to have more consistent effects than interventions aimed
at direct professional-related issues such as attitude and knowledge
exclusively. But, these context-oriented interventions are relatively
more often multi-faceted. Although no clear conclusion can be drawn,
facilitating the preferred diagnostic behaviour seems most potent
through combined interventions aiming at both the professional and
the context.
Overall, results are heterogeneous probably due to methodological
differences between studies, such as differences in measurement
periods (during or after intervention) or in correction for baseline
differences. Distribution of educational materials and educational
meetings should be looked upon as (necessary) parts of a multi-
faceted intervention. Audit and feedback, both with and without
information transfer, show consistent and sometimes even strong
effects on both changing the absolute rate of test use ("modifying
overuse") as well as on improving appropriateness of test use
("improving quality"). There is no clear trend towards a specific
content of the feedback given. Reminders show sometimes relevant
but inconsistent effects on changing the absolute rate of test use.
Reminders and computer aided decision support seem more suitable
for improving the appropriateness of specific test use than for chang-
ing general overuse of tests. Small group quality improvement seems
especially effective in changing the absolute rate of test use, perhaps
because of the social influence that professionals can have on each
other in applying this method. Context-oriented interventions show
positive results, but there might be some bias; the type of designs is
less rigorous (less RCTs) and they are quite often mixed with multi-
faceted strategies. Little is known about the effect of financial inter-
ventions, but the three studies were not promising in their results.
Many of the studies lacked power because we extracted only the data
on test ordering behaviour whereas the power was calculated on broader
outcomes. But in a literature review we look for trends in effects over
categories of studies. A problem in data-extraction was the extent of
reporting of the methods in the papers. Often very little information
was given on how precisely the intervention was designed and executed.
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It was also often not described if the intervention was based on insight
on actual care and barriers for working according to guidelines.
A standardised format should be given in reporting about the inter-
vention in these trials.
Recommendations based on this review should be considered in the
context of the heterogeneity and methodological problems in the
studies. The best choice among interventions to modify use of tests
appears to be audit and feedback, small group quality improvement,
or combinations of professional oriented interventions and organisa-
tional interventions. Appropriateness of test ordering can be improved
by reminders, and combinations of professional oriented interventions
and organisational interventions. Promising interventions, such as
outreach visits, patient mediated interventions, small group quality
improvement and combinations with organisational interventions,
should be studied in well-designed randomised trials.
We thank Roberto Grilli, Jeremy Grimshaw, Cynthia Fraser for their
useful comments.
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TABLE 2 EDUCATIONAL MATERIALS AND EDUCATIONAL MEETINGS
2A. Studies with the objective to change absolute test rate ('modify overuse')
TYPE OF TESTS, (NO. OF TESTS) INTERVENTION TYPE, DURATION (MONTHS).
Eisenberg 77
Schroeder 84
Marton 85
Berwick 86
Davidoff89
Axt-Adam 93*
Oakeshott 94*
Stross 80*
Stress 83
White 85"
Bearcroft 94*
Larsson 99
prothrombin time (1)
laboratory tests + radiology (?)
printed materials + lecture (1.5)
- printed + audiovisual materials + course (for medicals)
- same programme for surgeons (12)
outpatient laboratory utilisation (?) printed materials inclusive list of charges (8)
common blood test + X-rays (13) printed materials + lecture (2)
little ticket tests (?)
all (?)
thyroid + kidney (2)
all X-ray (?)
printed materials + lecture (2)
- printed materials
- printed materials + lecture (1)
printed materials (?)
CBA
CBA
RCT
CBA
RCT
CBA
RCT
114/114 no tests/admission
?/? test costs/ physician/ year
57/? no tests/ patient visit
35/35 no tests/ 1000 patient
contacts/ physician
24/24 no test/admission
507/507 no tests/ physician/ month
62/62 no tests/ practice/ month
2B. Studies with the objective to improve the appropriatness of test use ('improve quality')
I VERSUSC I VERSUSC
830 vs 900 717 vs 905 ++
563 vs 592' +
380 vs 372' 0
1.61 vs 1.63 1.07 vs 1.34 ++
%<hange:-jO12 +
44.8 vs 43.4 32.0 vs 38.3' ++
31.4vs31.1 34.9VS31.0'
31.0vs31.1 32.1VS31.0'
12.3 vs 15.3 8.1 vs 12.2' ++
ESR, joint X-ray, latex test (3) printed + audiovisual materials + lectured 2)
X-chest, pulm. function, sputum (4) printed+audiovisual materials+workshop for educational
influentials (?)
CPK-enzyme (1) printed materials + lecture (<1)
X-chest (1) printed materials (1)
laboratory tests (14) printed material + lecture (?)
RCT
RCT
RCT
RCT#
CBA
31/22
?/?
?/103
210/?
63/63
(testsdone/indicatedtests).100 34vs28% 51vs30% ++
(testsdone/indicatedtests).100 42vs47%- 45vs44% +
(tests done/indicated tests). 100 92vs72% 98vs72% +
(tests done/indicated tests). 100 - 94vs92%' +
ratio's meant to increase - desired change: +
ratio's meant to decrease 11 out of 14 vs
6 out of 14
STUDIES WITH AN INTERVENTION IN THE CONTROL GROUP
Wirtschafter 86* blood glucose +gases, X-chest (3) printed materials + lecture versus printed materials RCT ?/? (testsdone/indicatedtests).100 31vs38%
* paper reports that explicit guidelines were available
# high quality randomisation: clear description of central randomisation
'p-value < .05
follow-up measurement not after, but during the intervention period
The last column gives a standardised outcome for each individual study on the difference
in relative change between intervention and control group
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TABLE 3 CHARACTERISTICS AND RESULTS OF STUDIES WITH PROFESSIONAL-ORIENTED INTERVENTIONS / AUDIT AND FEEDBACK
3A. Studies with the objective to change absolute test rate ('modify overuse')
AUDIT AND FEEDBACK
Eisenberg 77 • LDH + Ca (2)
Forrest 81
Cohen 82
Sherman 84
Marton 85
Berwick 86
Tierney 87
Wones 87
Pugh 89
Winkens 92 '
Gama 92*
Winkens 95*
MacGowan '96
Winkens 96 '
laboratory tests + radiology (?)
total lab + imaging tests (?)
ECG holter monitoring (1)
outpatient lab. utilisation (?)
common blood tests + X-rays (13)
blood/urine, ECG, X-chest/abd. (8)
commonly ordered tests (25)
diagnostic studies (?)
laboratory tests (46)
On quantity (1)
On costs (1.5)
On costs (1)
Informed consent only (1)
On costs (8)
- on costs of tests
- on yield of tests (2)
On test results (4)
- on quantity + costs
- same feedback + group data for comparison (9)
On daily costs (8)
On test quality (60)
haematology + din. chemistry (?) On quantity + costs (12)
X-ray, ECG, ultrasound (13)
microbiological testing (?)
common tests (44)
On quantity and quality (30)
On quantity and yield of tests (24)
On quantity and quality (108)
CBA
CBA
RCT
CBA
RCT
CBA
RCT
RCT
CBA#
CBA
CBA#
RCT
CBA#
CBA
?/?
?/?
?/?
?/?
57/?
35/35
111/76
?/21
?/84
85/?
5/5
79/?
?/?
?/?
(non-indicated tests/
tests done). 100
test costs/ ward/ day
no of tests/ admission
no of tests/ hospital/ month
no of tests/patient contact
no of test/ 1000 patients
no of tests/ patient contact
no tests/ patient/ day
mean test costs
no tests/ group physicians/
year
no tests/ admission
no tests/ patient contact
no tests/ physician/ year
no tests/ group physicians/
year
no tests/ group physicians/
year
51 vs60
29.2 vs 28.0
20.7 vs 26.4
27 vs 42
1.49 vs 1.63
-
0.61 vs 0.63
-
-
-
66250 vs
68750
8.4 vs 8.1
5.1 VS1.4
110VS125
15596vs
12806
114747 vs
191698
65 vs 77
28.4 vs 28.1
20.5 vs 13.0'
32 vs 91
1.04 vs 1.34
-15.2%'
3.1% change
0.51 vsO.56
3.27 vs 2.89
3.1 Ovs 2.89
1488 vs 1592
50200 vs
73500'
8.8 vs 10.4
4.0 vs 1.4
105 vs 142'
14880 vs
14484
63062 vs
276401
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TABLE 3 CHARACTERISTICS AND RESULTS OF STUDIES WITH PROFESSIONAL-ORIENTED INTERVENTIONS / AUDIT AND FEEDBACK
3A. Studies with the objective to change absolute test rate ('modify overuse') CONTINUED
AUDIT AND FEEDBACK + INFORMATION TRANSFER
Marton 85 outpatient lab. utilisation (?)
Chassin86 X-pelvis(1)
Fowkes86" X-chest(1)
Billi 87 laboratory tests + radiology (?)
Ruangkan. 93* laboratory tests (?)
Freeborn 97 imaging tests lumbar spine (..}
Barwitz 99
Kerry 00
lab, X-chest (..)
imaging tests
INTERVENTION TYPE, DURATION (MONTHS).
On costs + printed materials (8)
On quantity + printed materials + lecture (4)
On quantity + printed materials (12)
On hospital charges + printed materials (12)
- on quantity + educational course
- giving feedback to others- on quantity
+ educat. course -fgiving feedback to others (6)
On quantity + printed materials + lecture
DESIGN ROFESS. OUTC
RCT
RCT
CBA
RCT#
RCT
CBA
self-audit + printed materials + guideline development (12) RCT
On quantity + printed materials RCT
STUDIES WITH AN INTERVENTION IN THE CONTROL GROUP
Schectman 91* thyroid function (1) feedback on quantity/quality + printed materials (2)
versus printed material
CBA#
57/? no tests/ patient contact
1483/? no tests/ 1000 patients
?/? no tests/ 1000 patients
132/132 test costs/admission
36/? no tests/ admission
95/95 no tests/1000 patient contacts
1/1 no tests/ patient contact
175/175 no tests/group physicians/
year
30/? (tests done/indicated
tests). 100
1.31 VS1.63
73.4 vs 76.8
326 vs 229
3.43 vs 3.44
3.34 vs 3.83
3.32 vs 3.27
11.5 vs 11.6
16.1 VS12.5
0.39 vs 0.40
11960 vs
10300
53 vs 49%
1.03 vs 1.34
10.6 vs 36.4'
223 vs 199
119VS168
3.63 vs 3.33
3.37 vs 3.21
3.36 vs 3.44
11.9 vs 10.4
14.7 vs 10.2
0.24 vs 0.41'
11025VS
10493
64vs81%
38. Studies with the objective to improve the appropriateness of test use ('improve quality')
Kroenke" '87* sputum, urine cult., urinalysis (3) on quantity and quality + lecture (2.5)
Oosterhuis" '95* 9 common indications (?) on quality + printed materials (8)
CBA ?/? (indicated tests/tests done).100 45vs43%
CBA 78/28 (indicated tests/tests done).100 -
65vs40%
35vs26%
+++
+
* paper reports that explicit guidelines were available
# unit of analysis unequals unit of allocation
' p-value < .05
follow-up measurement not after, but during the intervention period
The last column gives a standardised outcome for each individual study on the difference
in relative change between intervention and control group
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TABLE 4 REMINDERS
4A. Studies with the objective to change absolute test rate ('modify overuse')
INTERVENTION TYPE, DURATION (MONTHS).
REMINDERS WITHOUT COMPUTERISATION
Wexler 75 all (?)
Wilson 82 laboratory tests + radiology (?)
Tierney 90 outpatient diagnostic tests (?)
Williams 86* 11 serum tests + X-chest (12)
REMINDERS WITH COMPUTERISATION
Thomas 83 laboratory. X-ray, ECG (?)
Tierney 88- blood, ECG, urine, X-chest (8)
Holleman 96 all (?)
Bates 97 laboratory + imaging tests (..)
Harpole 97 abdomen X-rays (..)
Bates 99 laboratory tests (..)
STUDIES WITH AN INTERVENTION IN THE CONTROL (
Pollack 91 lab. + radiology (?)
Implicit reminder; 0 0 print out (12)
Immediate access to computerised medical record (?)
Implicit reminder on test charges (6)
Inter visit reminders + feedback + pr. materials + lecture (6)
Computer aided decision support (12)
Comp. aided decision support; prediction of abnormal test result (6)
Computer aided decision support (3)
Computer aided decision support, display of test charges (4)
Computer aided decision support + printed materials (4)
Computer aided decision support about redundant tests (4)
IP
implicit reminders on patient's survival probability +
audio-visual materials (7) versus audio-visual materials
RCT
RCT#
RCT
CBA
RCT
RCT
CBA
RCT#
ITS
RCT#
RCT
?/?
?/182
121/74
143/?
7/?
112/?
?/?
?/?
236/236
?/?
?/94
no tests/ admission
no unnecesary tests/ admiss.
no tests/ admission
No. tests/ patient contact ???
(indicated tests/tests done).!00
test costs/ patient/ year
test costs/ patient contact
no tests/ patient contact
no tests/ admission
% cancelled tests
% cancelled tests
no tests/ patient/ day
-
-9.6'
1.81 vsi.72
38 vs 42%
-
-
55.9 vs. . .
3% vs.. .
-
13.6 vs 13.7
1.3 vs 2.3
-
1.56vsl.82'
47vs60%
101.4 vs 92.3
11.2 vsl2.3'
1.8 vs 1.8
48.4 vs 51.1
4% v s . . . '
51 vs27%'
37.1 vs 33.2
* paper reports that explicit guidelines were available
* high quality randomisation: clear description of central randomisation
' p-value < .05
follow-up measurement not after, but during the intervention period
The last column gives a standardised outcome for each individual study on the difference
in relative change between intervention and control group
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REMINDERS WITHOUT COMPUTERISATION
Bulpitt 76 urea, electrolytes (2)
McDonald 80 tests ordered (?)
White 84*
concurrent report (12)
- concurrent report
- concurrent report + printed materials (2.5)
ECG, serum potassium +digoxin (3) concurrent report (3)
Winickoff85*
Stiell 94' X-ankle, X-foot (2)
Auleley 97* X-ankle, X-foot (2)
REMINDERS WITH COMPUTERISATION
McDonald 76* mixed blood tests (>30)
McDonald 76 renal/liver funct, electr., Hb/Ht (7)
Rogers 82* renal function, pyelogram (5)
Overhage 97 laboratory (..)
Hb creat pot chol urine ECG X-chest (7) inter visit reminders + feedback on quality of tests (12)
concurrent report + printed -(-audiovisual mat. + lecture (5)
concurrent report + printed +audiovisual mat. + lecture (5)
computer aided decision support (4)
computer aided decision support (8)
computer aided decision support (24)
computer aided decision support (7)
STUDIES WITH AN INTERVENTION IN THE CONTROL GROUP
Mazzuca 90 ' glycolysed.Hb, fasting blood sugar, computer aided decision support* pr. materials+lecture
home-monitoring glue. (3) versus printed materials + lecture
RCT ?/? no tests/patient/year
RCT 31/31 (tests done/indicated tests).1OO
RCT# ?/? no tests/1000 patients/ year
(tests done/indicated tests).100 86vs84%
no tests/ admission 1.14 vs 1.21
(patients tested/all patients).100 98 vs 99%
(tests done/indicated tests).100 -
(indicated tests/tests done).100 -
(tests done/indicated tests).1OO -
(tests done/indicated tests).100
CBA 114/? (indicated tests/tests done).100 -
RCT
CBA
RCT
CBA
RCT#
RCT
RCT#
?/?
?/?
91/?
9
10/10
?/?
86/86
1.5 vs 1.5
37 vs 15%
37vs15%
Ecg: 36 vs 29
Pot:117vs89'
Dig: 48 vs 17'
87 vs 87%
0.87 vs 1.27
79 vs 99%'
61 vs 22%'
36vs11%'
51 vs40%
46 vs 22%
2 4 v s 2 1 %
* paper reports that explicit guidelines were available
# high quality randomisation: clear description of central randomisation
' p-value < .05
follow-up measurement not after, but during the intervention period
The last column gives a standardised outcome for each individual study on the difference
in relative change between intervention and control group
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OUTREACH VISITS, PATIENT MEDIATED INTERVENTIONS, AND SMALL GROUP QUALITY IMPROVEMENT
5A. Studies with the objective to change absolute test rate ('modify overuse')
EDUCATIONAL OUTREACH VISITS
Everett 85 laboratory tests (?)
Everett 83 laboratory tests (?)
PATIENT MEDIATED INTERVENTIONS
Linn 82 laboratory tests (?)
SMALL CROUP QUALITY IMPROVEMENT
Schroeder 84 laboratory tests + radiology (?)
Fowkes 86* 9 common indications (?).
Fowkes86* X-chestd)
STUDIES WITH AN INTERVENTION IN THE CONTROL <
Martin 80 lab. + radiology (?)
Academic detailing (5)
Individual instruction and feedback on quantity +costs (5) RCT
- depression score available before consultation
• depression score available after consultation (?)
Small group quality improvement +feedback (12)
Small group quality improvement + lecture (2.5)
Small group quality improvement + lecture (12)
p
- small group quality improvement + pr. materials + lecture
versus printed material + lecture
RCT
R
RCT
CBA
CBA
CBA
RCT
16/?
30/24
?/?
?/?
?/?
?/?
24/?
no tests/ patient visit
no tests/ admission
no tests/ patient visit
test costs/ physician/ year
no tests/ admission
no tests/ 1000 patients
no tests/ admission
-
-
-
6.4 vs 6.1
290 vs 229
107 vs 102
4.8 vs 4.3
102 vs 120
3.3 vs 4.3
5.8 vs 4.3'
544 vs 592
3.8 vs 4.8
196 vs 199
51 vs78'
SB. Studies with the objective to improve the appropriateness of test use ('improve quality')
SMALL GROUP QUALITY IMPROVEMENT
Palmer 85* Ht, glucose, urine (3)
Gullion 88* K, Ca, uric acid, glucose (4)
small group quality improvement + feedback (9) RCT
small group quality improvement + feedback on RCT
quantity/quality (2)
small gr. quality impr. on consensus between GPs and RCT#
specialists (4)
STUDIES WITH AN INTERVENTION IN THE CONTROL GROUP
Hartmann95* glue, HbAic, alb, creat, lipids (7) small group quality improv. (9) versus feedback on quality CBA
548/? (tests done/indicated testsl.100 69vs67%
111/106 (tests done/indicated tests).100 59vs57%
Jones 93* gastric endoscopy + X-ray (2) 179/179 no tests/physician/year 10.3 vs 8.8
17/17 (tests done/indicated testsl.100 39vs49%
* paper reports that explicit guidelines were available
* high quality randomisation: clear description of central randomisation
' p-value < .05
69 vs 68%
50 vs 49%
9.7 vs 8.3
46vs44%
follow-up measurement not after, but during the intervention period
The last column gives a standardised outcome for each individual study on the difference
in relative change between intervention and control group
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TABLE 6 CONTEXT ORIENTED INTERVENTIONS
PROFESSIONAL-RELATED ORGANISATIONAL INTERVENTIONS
Marcy 81
Fowkes 86*
Wachtel 86*
non-routine tests on admission (?)
X-chest(i)
laboratory + X-rays + ECG (?)
Wachtel 90 ' laboratory + X-rays + ECG (12)
Gottlieb 97 body imaging tests (?)
Naughton 94 all (?)
White 94 all (?)
Koopmans 96 lab +imaging low back pain (..)
STRUCTURAL ORGANISATIONAL INTERVENTIONS
Chambers 77 laboratory tests + radiology (?)
Novich 85
Fowkes 86*
Simmer 91
Zaat 92*
Gilio 93
Tierney 93*
Smithuis 94*
Ashworth 97
Murphy %
Etter 97
PT/PTT, +common tests (15)
X-chest(i)
laboratory tests + radiology (?)
all (?)
all diagnostic services (?)
all (?)
HDL+LDL, alk.fosf, total IgE (3)
laboratory and Imaging tests (..)
blood and imaging tests (J
laboratory and imaging tests (..)
Dahler-Eriksen 99 blood tests (..)
attending physician reviewing rationale of test orders (.5)
discussing justification of test orders + pr. materials (12)
attending physician reviewing rationale of test orders +
small group quality improvement (3)
local consensus devel. + demanding justincat. for orders (18)
radiologist reviewing the rationale of test orders (2)
interdisciplinary geriatric team available (9)
interdisciplinary geriatric team available (6 beds) (?)
routine psychiatric consultation for low back pain patients
introduction of practice nurse with expanded role (12)
demanding written justification of orders + pr. materials (1)
change of test order form + printed materials(12)
residents replaced by experienced staff (10)
change of test order form + printed materials +
educational course(7)
provision of desk top analysers (2)
Comp. protocols, display former tests + charges (17)
change of test order form (6)
day care versus hospitalisation
home care versus hospitilisation (11)
GPs managing non-emergent patients at emergency
department (13)
managed care versus care without controlling access (12)
introduction of near patient CRP-testing (4)
RCT
CBA
CBA
CBA
CBA
RCT#
RCT#
RCT#
13/13
?/?
42/?
161/?
8/?
?/?
?/?
4/4
no tests/ admission
no tests/ 1000 patients
test costs/ admission
test costs/ admission
no tests/1000 patients
test costs/ admission
no tests/admission
no tests/ patient/ year (GPs)
(specialists)
CBA
CBA
CBA
RCT#
CBA
RCT
RCT
RCT
CBA
?/?
?/?
75/?
26/19
?/?
63/63
?/?
no tests/1000 patients
no tests/ patient/ day
no tests/1000 patients
test costs/ admission
no tests/ 1000 patients
no tests/ patient contact
test costs/ admission
no tests/ patient contact
test costs/ patient
CBA 5/28 no tests/ patient contact
CBA ?/? test costs/ patient/ year
CBA 64/? no tests/1000 patients/
month
18.2 vs 16.4
290 vs 229
831 VS695
534 vs 670
1190VS955
781 VS1257
245 vs 229
72.5 vs 75.8
1.8 vs 2.0
594 vs 566
135 vs165
16.6vs21.2'
206 vs 199
580 vs 629
403 vs 554
1127 vs 1204
585 vs 897
4.4 vs 16.9'
1.16VS0.85
1.16VS1.20
1349 vs 1837
2.6 vs 3.5
202 vs 199
1315VS1649
59.3 vs 88.1'
1.7 vs 1.6
1621 VS1852'
182vs567'
12.3 vs 13.4
10.1 vs13.4
0.43 vs 0.65'
96vs178'
31.8 vs 33.7'
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TABLE 6 CONTEXT ORIENTED INTERVENTIONS (CONTINUED)
6A. Studies with the objective to change absolute test rate ('modify overuse') (CONTINUED)
STRUCTURAL ORGANISATIONAL INTERVENTIONS
Board 00 laboratory I..)
Helgesen 00 lab, imaging.function tests (15)
Lindley-Jones 00 imaging tests
re-engineered clinical pathway (12) RCT
introduction of specialised nurse versus urologists (?) RCT#
introduction of triage X-ray requesting system nurse (2) RCT#
change in order policy, no daily routine tests (26) ITSPrice 00 X-chest
FINANCIAL INTERVENTIONS
Perkoff 76 laboratory tests + radiology (?) Change of salary: from fee for service to prepaid practice (37) RCT
Krasnik 90 all diagnostic services (?) Change of sal.: to capitation based + mixed fee per item (12) CBA
STUDIES WITH AN INTERVENTION IN THE CONTROL GROUP
Martin 80 lab. + radiology (?) gift certificates if test ordering reduces + pr. materials + RCT#
lecture (4) versus printed materials + lecture
COMBINED ORGANISATIONAL AND FINANCIAL INTERVENTION
Kerr96 all (?)
Walraven 98 laboratory (11)
Makela 98 laboratory and imaging tests (..)
change of test order form + budget holding + feedback on CBA
quantity/costs (9)
change test order from + change to top funding policy + ITS
printed materials (24)
change in capitation + change of working patterns towards CBA
local population responsibility (48)
no tests/ patient contact
no tests/ patient/ year
no tests/100 patients
test yield/100 patients
no tests/ patient/ day
no tests/ patient/ year
no tests/1000 patients
no tests/admission
-
-
-
-
1.0 SD 0.3
112vs102
5.5 vs 8.3' +++
1.6 vs 2.3 +++
68 vs 76' ++
54vs48' +
0.7 SD 0.2' +++
1.4 vs 0.7
% change: 424' -
100vs78
426/?
24/?
170/? test costs/ patient visit
?/? no tests/ 1000 patients
?/? no tests/ patient/ year
9.9 vs 9.3 6.6 vs 7.2
12-96%drop'
3.8 vs 4.0 3.7 vs 3.6
* paper reports that explicit guidelines were available
« high quality randomisation: clear description of central randomisation
'p-value <05
follow-up measurement not after, but during the intervention period
The last column gives a standardised outcome for each individual study on the difference
in relative change between intervention and control group
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TABLE 6 CONTEXT ORIENTED INTERVENTIONS
6B. Studies with the objective to improve the appropriateness of test use ('improve quality')
TYPE OF TESTS, (NO. OF TESTS) INTERVENTION TYPE. DURATION (MONTHS).
PROFESSIONAL-REATED ORGANISATIONAL INTERVENTIONS
Jin 93 ' X-chest+sputum (2)
structural organisational interventions
Bass 86* urine, electrolytes, IVP (3)
intensive supervision + feedback on quantity + feedback on RCT
quality by patients (12)
RCT#
Emslie 93"
Isouard99
Saint 99
3 lab. tests + semen analysis (4)
laboratory tests (..)
urine tests (2)
expanded role of med. assistant + inter visit remind. +
patient reminders (60)
semen analysis packs available + concurrent report reminder RCT
+ printed materials (8)
TQM + feedback on test use + change in test order form + CBA
printed materials (IS)
small group quality improvement + organisational change + CBA
printed materials (?)
STUDIES WITH AN INTERVENTION IN THE CONTROL GROUP
Wirtschafter 86* blood glucose +gases, X-chest (3) individual instruction by toll-free telephone line + printed RCT
materials + lecture (8)
versus printed materials
Mazzuca 90* glycolysed.Hb, fasting blood sugar, - computer aided decision support + printed materials + CBA
home-monitoring, glucose (3) lecture + provision of desk top analysers, self care forms
versus pr. materials + lecture + computer aided dec. support
- idem + on call patient educator available (11)
versus /dem + analyser + forms
?/34
OUTCOME
(tests done/indicated tests).lOO
(tests done/indicated tests).1O0
(tests done/indicated tests).1O0
(tests done/indicated tests).1OO
(tests done/non-indicated
tests).1OO
BASELINE
1 VERSUSC
X-chest:
sputum:
-
-
78 vs 82
85 vs..
FOLLOW-UP
1 VERSUS C
98vs80%
98vs70%
63vs65%
58vs26%'
88 vs 80
64vs80'
(tests done/indicated tests).100
114/? (indicated tests/tests doneJIOO
45 vs 38%
37 vs 24%'
25 vs 37%'
* paper reports that explicit guidelines were available
• high quality randomisation: clear description of centra! randomisation
p-value < .05
follow-up measurement not after, but during the intervention period
The last column gives a standardised outcome for each individual study on the difference
in relative change between intervention and control group
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Abstract
Contexf
Numbers of diagnostic tests ordered by primary care physicians are
growing and many of these tests seem to be unnecessary according to
established, evidence-based guidelines. An innovative strategy that
focused on clinical problems and associated tests was developed.
Ofr/ecfive
To determine the effects of a multifaceted strategy aimed at improving
the performance of primary care physicians' test ordering.
Design
Multicenter, randomized controlled trial with a balanced, incomplete
block design and randomization at group level. Thirteen groups of
primary care physicians underwent the strategy for 3 clinical problems
(arm A; cardiovascular topics, upper and lower abdominal complaints),
while 13 other groups underwent the strategy for 3 other clinical
problems (arm B; chronic obstructive pulmonary disease and asthma,
general complaints, degenerative joint complaints). Each arm acted as
a control for the other.
Seffmg
Primary care physician groups in 5 regions in the Netherlands with
diagnostic centers recruited from May to September 1998.
Sfudy Parfzripanfs
Twenty-six primary care physician groups, including 174 primary care
physicians.
Jnfervewficm
During the 6 months of intervention, physicians discussed 3 consecu-
tive, personal feedback reports in 3 small group meetings, related them
to 3 evidence-based clinical guidelines, and made plans for change.
Outcome Measure
According to existing national, evidence-based guidelines, a decrease
in the total numbers of tests ordered per clinical problem, and of some
denned inappropriate tests, is considered a quality improvement.
fiestas
For clinical problems allocated to arm A, the mean total number of
requested tests per 6 months per physician was reduced from baseline
to follow-up by 12% among physicians in the arm A intervention, but
was unchanged in the arm B control, with a mean reduction of 67 more
tests per physician per 6 months in arm A than in arm B (P = .01).
For clinical problems allocated to arm B, the mean total number of
requested tests per 6 months per physician was reduced from baseline
to follow-up by 8% among physicians in the arm B intervention, and
by 3% in the arm A control, with a mean reduction of 28 more tests
per physician per 6 months in arm B than in arm A (P = .22).
Physicians in arm A had a significant reduction in mean total number
of inappropriate tests ordered for problems allocated to arm A, whereas
EFFECT OF A PRACTICE-BASED STRATEGY
the reduction in inappropriate test ordered physicians in arm B for
problems allocated to arm B was not statistically significant.
In this study, a practice-based, multifaceted strategy using guidelines,
feedback, and social interaction resulted in modest improvements in
test ordering by primary care physicians.
Introduction
In many countries, the number of diagnostic tests ordered by primary
care physicians is growing, while according to established evidence-
based guidelines, many of these tests are seen as unnecessary.'"'
Possible explanations are test ordering routines that are difficult to
change, a more defensive attitude among primary care physicians out
of fear of medical errors, or a lack of knowledge about the appropriate
use of tests.* ^  Moreover, patients more actively ask for tests and often
attach greater value to test results than is justified by the facts."'
Unfortunately, little is yet known about the negative effects of per-
forming such tests, in terms of, for example, unnecessary exposure to
radiation or false-positive results, that may induce fear and anxiety in
patients or may result in a cascade of unnecessary further testing.
Given these problems it is challenging to learn how to change test
ordering performance effectively and bring it into line with existing
evidence or guidelines on optimal testing. Many such attempts have
been made with mixed results, showing that successful strategies
require a well-balanced combination of interventions.""^ We have
developed a multifaceted strategy combining personal feedback and
guideline dissemination with quality meetings in small groups of
primary care physicians. Social interactions were used as an important
motivator for change, as physicians learned how colleagues were
handling test ordering problems and as they obtained information
about the consequences of medical decision making in daily practice.'* '"*
The aim of this strategy was to achieve sustained improvements in test
ordering, for example, working in line with the national, evidence-based
guidelines. The present article describes the changes in test ordering
performance resulting from this innovative strategy in a large popula-
tion of primary care physicians.
Methods
Our study was conducted in 5 regions in the Netherlands, each of
which made use of the services of a diagnostic center. A diagnostic
center is an institute, usually associated with a hospital, where primary
care physicians can order tests without referring patients to the hospital.
Thirty-seven local groups of primary care physicians linked to 1 of
these 5 diagnostic centers were eligible for the study. These groups are
a common feature of Dutch general practice, involving teams of primary
care physicians collaborating in a specific region. These teams share
patient care outside office hours and many of them also engage in
continuing medical education. From May until September 1998 the
coordinators of the 5 diagnostic centers recruited local groups in their
regions to participate.
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The strategy consisted of the following elements: personalized graphi-
cal feedback, including a comparison of each physician's own data with
those of colleagues; dissemination of national, evidence-based guide-
lines; and regular meetings on quality improvement in small groups.
The strategy focused on specific clinical problems and the diagnostic
tests used for these problems (Table 1). These tests covered about 90%
of all tests a primary care physician can order in a diagnostic center.
For the tests used in the trial, national guidelines for optimal test
ordering had to be available.
During the first 6 months of 1999, each of the recruited physicians
received by mail 3 consecutive feedback reports on 3 different clinical
problems, together with concise information on the 3 evidence-based
clinical guidelines for these problems, developed by the Dutch College
of Primary Care Physicians.
Each postal contact was followed by a 90-minute standardized small
group quality improvement meeting about 2 weeks later, supervised
by the medical coordinator of the diagnostic center. At the 3 meetings,
physicians were asked to discuss and compare their feedback reports
with colleagues and to relate them to the national guidelines. They also
discussed Bayesian decision rules to help them understand the prob-
ability of false-positive results in low-prevalence disorders. Another
important topic of debate was how to deal with the frequent requests
by patients to have inappropriate tests performed. This discussion of
the guidelines was followed by a thorough discussion of the difficulties
of achieving changes at the individual primary care physician level,
the practice level, or at the patient level. The next step was to try to
implement the guidelines in their own practice, and at the end of each
session, plans were drawn up for change, both at individual and group
level. Subsequent meetings were used to evaluate whether targets had
been met.
Measurements
The effect of the intervention was evaluated in a multicenter, random-
ized controlled trial that was conducted in the first 6 months of 1999
with a balanced, incomplete block design, consisting of 2 arms, with
the local group of primary care physicians as the unit of randomiza-
tion (Figure 1). One group of local groups (arm A) underwent the
strategy with respect to tests associated with the 3 clinical problems
allocated to arm A (Table 1), while the other group of local groups
(arm B) underwent the strategy with respect to tests associated with
the 3 problems allocated to arm B (Table 1). The groups in arm A acted
as blind controls for the groups undergoing the arm B intervention,
and vice versa. This rigorous design was used to balance the influence
of nonspecific effects on the test ordering performance between the
2 arms and to neutralize the Hawthorne effect, that is, the effect that
physicians might change their test ordering because they were aware
of taking part in a trial."" After stratification for region and group
size, randomization was performed centrally with Duploran, a random
numbers program. The physicians gave informed consent for the
retrieval of anonymous data on the numbers and results of all tests
ordered. To avoid seasonal influences, the numbers of tests for effect
evaluation were assessed during the last 6 months of 1998 (the baseline
period) and the last 6 months of 1999 (the follow-up period).
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TABLE 1 C L I N I C A L P R O B L E M S A N D D I A G N O S T I C T E S T S U S E D I N T H E T R I A L .
CLINICAL PROBLEMS/TESTS ARM A
A1 Cardiovascular diseases
Cholesterol, subtractions, potassium, sodium, creatinine, ECG (exercise), BUN*
A2 Upper abdominal complaints
SGPT, y-glutamyltransferase, ultrasound scans of hepatobiliairy tract, SGOT*,
LDH\ amylase*, bilirubin*, alkaline phosphatase*
A3 Lower abdominal complaints
Prostate-specific antigen, CRP, ultrasound of the kidney, IVP, double contrast
barium enema, sigmoidoscopy
CLINICAL PROBLEMS /TESTS ARM B
B1 COPD/Asthma
Allergic screening test, chest radiography, immonoglobulin E*
B2 General malaise / Vague complaints
ESR, Hb with or without indices, Ht, TSH, monospot, leucocyte count*
B3 Degenerative joint complaints
ESR, uric acid, rheumatoid factors, X-rays of lumbar spine*, cervical spine*,
shoulder*, knee*, hip*
* Tests that are inappropriate according to the national evidence-based guidelines
Measures
Characteristics of primary care physicians and local groups were
collected by means of a written questionnaire. Two effect measures
were used to evaluate intervention effects:
1. A decrease in the total numbers of requested tests per 6 months
per physician: since most of the recommendations in the national,
evidence-based guidelines advise ordering fewer tests, a decrease
in the total numbers of tests ordered was regarded as an improve-
ment in patient care. Separate analyses were performed for the 6
different clinical problems.
2. A decrease in the numbers of inappropriate tests as defined in
the guidelines (Table 1 and Box I): these tests were regarded as
inappropriate for the associated clinical problems for various
reasons, for example, because the results of these tests seldomly
have an influence on the treatment, because the high likelihood
of false-positive results can occur, because better alternatives are
available, or because adverse effects to some tests can occur
(eg, radiology tests).
Star isf tea/ Afia/ysis
Differences in individual characteristics of the primary care physician
were tested for significance with Pearson x^  test. In the evaluation
of intervention effects, the unit had to be the local group of primary
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care physicians because this unit was also the unit of randomization.
To account for clustering within local groups, a 3-level model was
used with the local group as level 3, individual physicians as level 2,
and numbers of tests as level 1. The analysis was carried out with
SAS PROC MIXED, release 8.2 (SAS Institute, Cary, NC). Power
calculations based on the baseline data showed that each arm needed
approximately 85 physicians to detect a 10% difference in mean total
numbers of tests with 80% power, and a risk of type 1 error of .05.
All effects were analyzed with analysis of covariance using the numbers
of tests during the follow-up period as the dependent variable and the
numbers of tests at baseline and the region, which appeared to be an
important determinant, as independent variables.
Results
One hundred seventy-four primary care physicians, belonging to 26
local groups, expressed their willingness to participate on first request,
so no further recruitment was necessary. After randomization, both
arms included 13 local groups (Figure l).No differences were found
among the characteristics of our individual study primary care physi-
cians (Table 2). Likewise, no differences were found in the characteris-
tics of the local primary care physician groups (data not shown).
The mean size of the local groups and experience with continuing
medical education in small groups of colleagues did not differ between
the 2 arms, nor was there any statistically significant difference
STUDY POPULATION CHARACTERISTICS AT PRIMARY CARE PHYSICIAN LEVEL
No. of physicians
Age, mean(SD), y
Female, No. (%)
Mean no.(SD) of patients per physician*
Patients > 65y, % mean (SD)
Working time factor**, %, (SD)
Physicians with a solo practice, No.(%)
Physicians who use computerized registration system. No. (%)
85
46.2 (6.6)
14(16)
2587(641)
15 (6.8)
91 (15)
43(51)
66(78)
89
45.8 (5.4)
15(17)
2637(519)
13 (7.1)
91 (16)
48(54)
61 (69)
• Total practice population for whom the primary care physician is responsible. *• Part-time factor is the working time. A full-time factor is 100%, each half of the day is 10%, so the part-time factor of 80% is a physician who works 4 days.
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37 Local Primary Care Physician Groups Eligible
11 Groups Declined Participation
26 Groups Randomized (174 Primary Care Physicians)
13 Groups Assigned to Arm A
(85 Primary Care Physicians)
Received Entire Strategy
3 Feedback reports
3 Quality Meetings
On 3 Clinical Problems
Cardiovascular Topics
Upper Abdominal Complaints
Lower Abdominal Complaints
1 Group Lost to Follow-up
(Practice-Related Data
Registration Problems)
(4 Primary Care Physicians)
6 Primary Care Physicians Lost to
Follow-up
(Absence or Change of Job)
12 Groups Completed Trial
(75 Primary Care Physicians)
13 Groups Assigned to Arm B
(89 Primary Care Physicians)
Received Feedback Strategy
3 Feedback reports
3 Quality Meetings
On 3 Clinical Problems
COPD/ Asthma
General Malaise / Vague Complaints
Degenerative Joint Complaints
0 Groups Lost to Follow-up
1 Primary Care Physician Lost to
Follow-up
(Absence or Change of Job)
FIGURE 1. FLOW OF RANDOMIZED TRIAL
13 Groups Completed Trial
(88 Primary Care Physicians)
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TABLE 3
CLINICAL PROBLEM
ARM A TESTS
EFFECTS OF THE STRATEGY BY ANALYSIS OF COVARIANCE ADJUSTED FOR NUMBERS OF DIAGNOSTIC TESTS AT BASELINE
AND FOR THE REGION ON THE MEAN (SD) NUMBERS OF TESTS, PER PRIMARY CARE PHYSICIAN PER 6 MONTHS
rfsrs
Cardiovascular/hypertension
Upper abdominal complaints
Lower abdominal complaints
ARM B TESTS
TO77U TESTS
COPD/asthma
General complaints
Lower abdominal complaints
Degenerative joint compliants
BASELINE FOLLOW-UP % CHANGE
MEANISDI MEAN (SO)
ARM A (INTERVENTION)
478 (309)
293(189)
165(125)
20 (20)
640 (394)
39(31)
548(340)
54 (38)
422 (234)
276(157)
128(82)
18(19)
ARM A (CONTROL)
624 (357)
31 (25)
544(310)
49 (36)
-12
-6
-22
-10
-3
-20
0
-9
BASELINE FOLLOW-UP -% CHANGE B (SE)'
MEAN ISD) MEAN (SD)
507 (293)
290(182)
192(128)
25 (25)
ARM B (CONTROL)
503(281)
302(184)
174(114)
27 (29)
0
+4
-9
+8
ARM B (INTERVENTION)
724 (386)
53 (27)
599(340)
72(43)
664 (356)
38(19)
568(321)
58 (37)
-8
-28
-5
-19
-67(19)
-35(13)
-28(9)
-5(2)
-104 to-30
-61 to-10
-45 to-10
-9 to -1
.01
.01
.01
.02
-28 (23)
-1(2)
-19(21)
-3(4)
-74 to 14
-5 to 3
-61 to 22
-10to4
.22
.58
.36
.34
Abbreviations: Cl, confidence interval; COPD, chronic obstructive pulmonary disease; SE, standard error.
*p is the intervention effect (analysis of covariance) from which the follow-up numbers of tests are the
dependent variable and the baseline numbers and the region are the independent variables.
between the 2 arms in the mean numbers of tests during the baseline
period (data not shown). In multilevel analyses, the point estimation
and SD were about the same as in the analysis of covariance at indi-
vidual physician level and therefore no correction for local groups was
needed, even though the intraclass correlation coefficient for block A
tests was .12 and that for block B tests was .10.
p reflects the total change between baseline and follow-up in mean (SD) numbers of tests in the
intervention group minus the total change between baseline and follow-up in mean numbers of tests
in the control group, adjusted for baseline and region.
Decreases in Numbers o/ Tesfc
All the changes in the intervention group were in agreement with the
national evidence-based guidelines (Table 3), that is, the represented
reductions in the numbers of tests ordered.
The number of tests ordered were always larger in the intervention
arm than in the control arm. The primary care physicians in arm A
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decreased the total mean numbers of tests relating to problems
allocated to arm A by 12% between baseline and follow-up, while no
change in the numbers of these tests occurred for primary care physi-
cians in arm B (blind control arm). The decrease for physicians in
arm A was 67 tests more per physician compared with the decrease
for the physicians in arm B (P = .01). The physicians in arm B achieved
a decrease of 8% in total number of tests ordered for the problems
allocated to arm B between baseline and follow-up, while a 3% decrease
was achieved in the numbers of these tests by physicians in arm A
(blind control arm).
These results correspond with an additional decrease in the total
numbers of tests for problems allocated to arm B of 28 compared with
the physicians of arm A (P = .22). The results per clinical problem also
are shown in Table 3. The mean change in numbers of tests ordered
for the 3 clinical problems allocated to arm A was statistically signifi-
cant (cardiovascular,P = .01; upper abdominal, P =.01; lower abdominal,
P = .02), while the change in the numbers of tests ordered for the 3
clinical problems allocated to arm B was in agreement with the recom-
mendations in the national guidelines, although each failed to reach
statistical significance.
Inappropriate tests as aV/ined in evutence-basedguide/i BOX I
Upper abdominal complaints General malaise, fatigue, and vague complaints
2.
3.
There is no reason to order liver function tests for vague upper
abdominal complaints without jaundice. The risk of false-positive
results is too large because of the low prevalence of patients with
liver diseases in general practice
If screening is necessary, order serum glutamic-pyruvate trans-
aminase and y-glutamyltransferase in patients without jaundice
Order total bilirubin, serum glutamic-pyruvate transaminase,
and Y-glutamyltransferase in patients with jaundice
1. Order hemoglobin and erythrocyte sedimentation rate in patients
with general fatigue that has persisted for longer than 1 month
2. Do not order leukocyte counts in cases of general fatigue
Degenerative joint complaints
Do not order radiographs of the joints since the results of these tests
have no influence on the treatment
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Decreases in Numbers o/7rta/>propriafe Tesfs
The reduction in the total numbers of inappropriate tests is shown in
Table 4. After the intervention, significantly fewer total inappropriate
tests for the problems allocated to arm A were ordered by the primary
care physicians in this arm (P = .01). The total numbers of inappropriate
tests for the problems allocated to arm B ordered by the primary care
physicians in arm B also tended to decrease, which was in agreement
with the recommendations in the guidelines, but the reduction failed
to reach statistical significance (P = .11). A significant reduction in the
numbers of tests ordered, compared with the control group, was found
for 4 of the tests for upper abdominal complaints: amylase, bilirubin,
lactic dehydrogenase, and alkaline phosphatase.
TABLE 4
EFFECTS OF THE STRATEGY BY ANALYSIS OF COVARIANCE ADJUSTED FOR NUMBERS OF DIAGNOSTIC TESTS AT BASELINE AND
FOR THE REGION ON THE MEAN (SD) NUMBERS OF INAPPROPRIATE TESTS, PER PRIMARY CARE PHYSICIAN PER 6 MONTHS
CLINICAL PROBLEM
ARM A TESTS
TO M L TEST'S
BUN
SGOT
LDH
Amylase
Alkaline phosphatase
Bilirubin
ARM B TESTS
ror/u rtsrs
Immunoglobulin E
Leukocyte count
Total imaging testst
BASELINE FOLLOW-UP
MEAN ISO) MEAN (SD)
ARM A (INTERVENTION)
63 (75)
8.7(19)
7.7(11)
13(27)
5.3(13)
11 (25)
20 (27)
134(81)
3.6(5.3)
95 (63)
36 (26)
45(41)
7.2(15)
5.5 (7.7)
8.8(16)
3.6 (6.9)
7.0(11)
15(19)
ARM A (CONTROL)
126(74)
2.8 (4.7)
92 (57)
31(22)
BASELINE FOLLOW-UP
MEAN (SD) MEAN ISD)
66(55)
6.3 (7.2)
8.3(13)
12(20)
3.4(4.9)
9.3(13)
31 (43)
A
163 (89)
3.0 (5.3)
110(69)
50(34)
ARM B (CONTROL)
63 (56)
6.6 (8.3)
7.5(14)
11(18)
4.5(10)
9.0(15)
27 (35)
RM B IINTERVENTIO
138(74)
1.5(2.7)
96(58)
41 (26)
-16(4.8)
-1 (1.3)
-2(1.4)
-3(1.5)
-2(1.1)
-3(1.5)
-6 (2.6)
-8(5.0)
-1 (0.42)
-6(4.0)
-1 (2.7)
-27 to 07
-4 to 2
-5tol
-6to- l
-4 to-0.1
-6 to -0.3
-11 to-0.3
-18to2
-1 toi
-4 to 2
-4 to 6
.01
.37
.13
.01
.04
.03
.04
.11
.14
.11
.70
"1
Abbreviations: Cl, confidence interval; COPD, chronic obstructive pulmonary disease;
BUN, blood urea nitrogen; LDH, lactic dehydrogenase; SE, standard error;
SGOT, serum glutamic-oxaloacetic transaminase.
•See footnote in Table 3 for the intervention effect p.
tTotal imaging tests include chest radiography, radiographs of the lumbar spine, cervical spine,
shoulder, knee and hip.
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Comment
A new strategy to influence test ordering performance was evaluated
in a trial with a large group of primary care physicians in 5 diagnostic
center regions in the Netherlands.
The relatively short intervention period resulted already in a substantial
reduction in the total numbers of tests ordered and in the number of
inappropriate tests ordered. Although the effects may seem not very
large, it is important to realize primary care physicians in the Netherlands
already order fewer tests than their colleagues in other countries.' This
further reduction can be regarded as quality improvement in terms of
test ordering because these changes were in agreement with the recom-
mendations in national evidence-based guidelines.
There are some methodological considerations. We have no reason to
believe that the large study population differs from the Dutch primary
care physician population. Items relevant for the determinants of test
ordering performance of primary care physicians were distributed
equally over both arms.'^ However, maybe only motivated, well-function-
ing groups of physicians participated, and it is therefore questionable
if the strategy will work for all groups. Secondly, our study only evalu-
ated effects on volume of tests, because patient data were not available
from the diagnostic centers. However, available empirical evidence
shows that a general reduction in test ordering in primary care does
not lead to more referrals or substitution of care.'" Furthermore,
despite that the guidelines state that a reduction in total test ordering
equals quality improvement, this does not implicate that each separate
test should always decrease. Finally, the duration of the study is too
short to determine long-term effects on test ordering.
Our study underlines that multifaceted interventions are superior to
single interventions."^" Significant changes in numbers of tests were
not found for all clinical problems included, so conclusions about the
effectiveness of our strategy are not straightforward. Some clinical
problems may require additional strategies, for example, electronic
reminders may be necessary to achieve further improvement.*'
Nevertheless, our strategy would seem to be a powerful effective and
tailor-made strategy,which fits in well with routine primary care
physician practice in many western countries, is linked to the every
day general practice routine, and gives primary care physicians the
opportunity to discuss their test ordering performance with colleagues
on the basis of actual performance data, making discussions less
non-committal. Discussing feedback reports and guidelines provides
physicians the opportunity to change their performance by learning
from each other and by learning to implement new strategies. Thus,
social influence by peer interaction can be an important motivator
for change.'" Our strategy could also be used for in-hospital teams or
other groups of collaborating physicians, as well as for other topics,
such as prescription or referral behavior.
77ns sfudy was supporfet/ by f/ie Dufc/i Hea/f/i Care /nswrance COMMCI/.
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Abstract
Numbers of tests ordered by primary care physicians (PCP) are
growing and many of these tests seem to be unnecessary according
to established, evidence-based guidelines.
Ofcyecfive
Evaluation of the added value of small peer group quality
improvement meetings compared with simple feedback as a strategy
to improve test ordering behavior.
Design
Cluster randomized trial with randomization at local primary care
physician group level.
Seffmg
194 PCPs organized in 27 local PCP groups in 5 regions (5 diagnostic
centers).
An innovative, multifaceted strategy, combining written comparative
feedback, group education on national guidelines and social influence
by peers in quality improvement sessions in small groups.
Measurements
The mean number of tests per PCP per six months at baseline and
the PCPs' region were used as independent variables, and the mean
number of tests per PCP per six months as the dependent variable.
Kesu/fs
The new strategy was executed in 13 PCP groups, while 14 groups
received feedback only. In the intervention arm the decrease of the
mean total number of tests was far more substantial (on average 51
tests less per PCP per half year) compared with the feedback arm
(p=0.0049). Five'inappropriate'tests for the clinical problem'upper
abdominal complaints' decreased in the intervention arm with 13 tests
more per PCP per 6 months than in de feedback arm (p=0.0015).
Inter-doctor variation decreased more in the intervention arm.
Conc/usioMS
Compared to only disseminating comparative feedback reports to PCPs,
the new strategy, involving peer interaction and social influence, improved
the PCPs' test ordering behavior. In order to be effective, feedback
needs to be integrated in an interactive, educational environment.
Key words:
Quality assurance, health care; test ordering behavior; feedback;
small group quality improvement.
The authors gratefully acknowledge the financial contribution to the
study provided by the Dutch College for Health Insurances.
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Introduction
Numbers of tests ordered by primary care physicians (PCPs) are
growing in many countries, and inter-doctor variation is shown to be
large, while according to established guidelines many of these tests
can be seen as unnecessary' •* It is as yet unclear, however, what would
be the best method to influence PCPs' test ordering behavior. Several
studies evaluating different types of interventions to change this
behavior have, so far, shown heterogeneous results. One of these widely
investigated strategies with mixed results is feedback."* ^ Many authori-
ties in western countries, such as health insurers, regularly disseminate
feedback reports about test ordering, prescription or referral rates to
physicians or practices, often without substantial impact.® ^
The literature shows that multifaceted strategies in general are superior
to single methods when it comes to influencing behavior.""* Success
rates of specific strategies seem to be strongly influenced by the extent
to which they fit within the local and organizational context and the
physicians'everyday work routine."''' Favorable experiences have
been gained particularly with small group education and interactive
quality improvement sessions for primary care physicians. "•'*
We therefore decided to develop a multifaceted strategy, combining
transparent, individual graphical feedback on test ordering routines,
education on clinical guidelines for test ordering and small group
quality improvement meetings among PCPs, in which test ordering
behavior and changes in routines are discussed, using social influence
and peer influence as important motivators of change. Social influence
from respected colleagues or opinion-leaders seem to have more effect
on changing practice routines than traditional medical education
activities, focusing on changing professional cognitions or attitudes.'^'
Therefore, our strategy seemed promising, since it is closely linked to
the everyday setting of many PCPs, who tend to work more or less in
isolation and have limited contact with peers about subjects like test
ordering behavior.
In a multicenter randomized trial with a block design this strategy
actually had a favorable effect on the test ordering behavior of PCPs."
Since classic feedback is an increasingly routine quality improvement
strategy, we were interested to assess the added value of this innovative,
multifaceted strategy compared with standardized feedback only, one
of the elements of the strategy.
Methods
Overa// design and popw/afiow
A multicenter RCT was conducted during the first six months of 1999
in five regions with a diagnostic center. A diagnostic center is an institute,
usually associated with a hospital, where PCPs can order laboratory,
imaging and function tests. All five diagnostic centers used nationally
developed indication-oriented forms for laboratory orders. In the 5
regions 37 local PCP groups with 294 PCPs were eligible for participa-
tion, since they made use of one of these five diagnostic centers. Local
PCP groups are an existing part of the infrastructure of Dutch PCPs
collaborating in a specific region, and sharing patient care outside office
hours. Continuous medical education, for example by means of quality
meetings about prescribing, is an important activity in most groups.
One of the tasks of the medical coordinators of diagnostic centers is
to give feedback to PCPs on their test ordering behavior, and they are
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considered as opinion-leaders concerning test ordering. From May
1998 until September 1998 the coordinators of the five diagnostic
centers recruited local PCP groups in their regions to participate in
the trial.
Intervention
The new strategy consisted of the following elements: personalized
graphical feedback, including a comparison of each PCP's own data
with those of colleagues, dissemination of and education on national,
evidence-based guidelines, and continuous quality improvement
meetings in small groups. The improvement strategy concentrated on
three specific clinical subjects (cardiovascular topics, upper abdominal
complaints and lower abdominal complaints) and the tests used for
these clinical problems, since it was felt that PCPs would prefer to
discuss specific clinical topics rather than specific tests (Table 1).
During the first half year of 1999 each PCP received three different
feedback reports (Figure 1) on these three clinical problems by mail,
together with concise information on the evidence-based clinical
guidelines for these specific clinical subjects, developed by the Dutch
College of Primary Care Physicians. Each postal contact was followed
by a 90-minute standardized small group quality improvement
meetings about two weeks later, at which one of the clinical problems
was discussed, based on the feedback reports and the guidelines
(Figure 2). In these meetings social influence was an important vehicle
to reach improvement on test ordering, and consisted of the following
major components. The first was mutual personal feedback by peers,
who worked in pairs at the start of the meeting. The second compo-
nent was an interactive group education in which national guidelines
were related to the individual PCPs' actual test ordering behavior, and
to reach a kind of group consensus on the optimal test ordering
ILE1 CLINICAL PROBLEMS AND ASSOCIATED TESTS USED IN THE TRIAL
Cardiovascular topics
Cholesterol, subfractions, potassium, sodium, creatinine, BUN, ECG (exercise)
Lower abdominal complaints
Prostate-specific antigen, CRP, ultrasound of the kidney, IVP,
double contrast barium enema, sigmoidoscopy
Upper abdominal complaints
SGPT, SGOT*, LDH*, amylase*, y-glutamyltransferase, bilirubin*,
alkaline phosphatase*, ultrasound scans of hepatobiliary tract
Tests that are inappropriate according to national evidence-based guidelines on upper abdominal complaints, (see Box)
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FIGURE 1. AN EXAMPLE OF A FEEDBACK REPORT
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Upper abdominal complaints 07/1999 t/m 12/1999 GP: Mr. P.H. - W.
I
alk.pho SGPT amylas SGOT bilirubi ultras.hep. LDH y-glutam.
FIGURE 2. STRUCTURE OF THE 90MINUTES SMALL GROUP QUALITY MEETNG
In white:
numbers of tests ordered
by PCP during 6 months
In gray:
mean numbers of tests of
PCP group
In dark:
mean numbers of tests per
PCP in the region
Z
Explaining the method / looking back on the last meeting
Critical look at own numbers
Pair-wise talk about inter-individual differences and explain them to each other
Plenary discussion: relate the test ordering performance to the guidelines
Pair-wise talk about difficulties in changing test ordering behavior
Plenary discussion on difficulties, resistance to change, learn from each other
Making individual and group work agreements / Evaluation
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behavior. The third was the development of individual and group
plans for change to stimulate PCPs to really put their plans into daily
practice. As a critical follow-up, meeting the plans' targets was discussed
at the next meeting. The medical coordinators disseminated the
feedback reports, organized and supervised the quality meetings, and
their use as respected regional opinion leaders concerning test
ordering behavior was another important component in the social
influence strategy.
Design
PCPs gave informed consent for the retrieval of anonymous data
on the numbers of tests ordered. To avoid seasonal influences,
the numbers of tests for effect evaluation were assessed over the
last six months of 1998 (the baseline period), and the last six months
of 1999 (the follow-up period). The strategies were evaluated in a
multicenter randomized controlled trial, consisting of two arms,
with the local PCP group as the unit of randomization (Figure 3).
After stratification for region and group size, randomization was
performed centrally with Duploran, a random numbers program.
(Dept. of Epidemiology, Maastricht University, F. Kessels, methodologist).
Local PCP groups of the intervention arm received the entire inter-
vention, while the local PCP groups of the feedback arm only received
the feedback reports on their test ordering behavior for the same
clinical problems.
r TABLE 2 STUDY POPULATION CHARACTERISTICS AT INDIVIDUAL PRIMARY CARE PHYSICIAN LEVEL
No. of physicians
Age, mean(SD), y
Female, No. (%)
Mean no.(SD) of patients per physician*
Patients > 65y, % mean (SD)
Working time factor**, %, (SD)
Physicians with a solo practice, No.(%)
Physicians who use computerized registration system, No. (%)
85
46.2 (6.6)
14(16)
2587(641)
15(6.8)
91(15)
43(51)
66(78)
109
46.2 (6.6)
11 (10)
2444(416)
15 (6.5)
92(12)
44(40)
75 (69)
* Total practice population for whom the primary care physician is responsible.
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38 Local Primary Care Physician Groups Eligible
11 Groups Declined Participation
27 Groups Randomized (194 Primary Care Physicians)
13 Groups Assigned to Arm A
(85 Primary Care Physicians)
Received Entire Strategy
3 Feedback reports
3 Quality Meetings
On 3 Clinical Problems
Cardiovascular Topics
Upper Abdominal Complaints
Lower Abdominal Complaints
1 Group Lost to Follow-up
(Practice-Related Data
RegistrationProblems)
(4 Primary Care Physicians)
6 Primary Care Physicians Lost to
Follow-up
(Absence or Change of Job)
14 Groups Assigned to Arm B
(89 Primary Care Physicians)
Received Feedback Strategy
3 Feedback reports
On 3 Clinical Problems
Cardiovascular Topics
Upper Abdominal Complaints
Lower Abdominal Complaints
0 Groups Lost to Follow-up
10 Primary Care Physician Lost to
Follow-up
(Absence or Change of Job)
12 Groups Completed Trial
(75 Primary Care Physicians)
FIGURE 3. FLOW OF RANDOMIZED TRIAL
14 Groups Completed Trial
(99 Primary Care Physicians)
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E^ecf measures and rweflswrmg m
Characteristics of PCPs and local PCP groups were collected by a
written questionnaire. To evaluate intervention effects the following
effect measures were denned:
a. The total number of requested tests per six months per PCP
for the three clinical problems in total and per clinical problem.
Consistent with national, evidence-based guidelines for test
ordering for the included clinical problems a decrease in the
numbers of tests was considered as better patient care.
b. In view of the large inter-doctor variation in the numbers of test
ordered, a reduced inter-doctor variation was also considered to
represent an improvement in performance.
c. For one specific problem, upper abdominal complaints, the
effects on total numbers and on defined inappropriate upper
abdominal tests.
Differences on individual PCP characteristics were tested for signifi-
cance with the Pearsons x^-test. To evaluate intervention effects the
unit should be the local PCP group because the unit of randomization
was the local PCP group. A 3-level model was used with the PCP
group as level 3, PCPs as level 2, and numbers of tests as level 1. This
model was analyzed using SAS PROC MIXED Release 8.2 (SAS
Institute, Cary, NC). The region appeared to be an important determi-
nant of the between group variance and was used as independent
variable together with the baseline numbers of tests. All effects were
analyzed with analysis of covariance with the follow-up numbers of
tests as dependent variable and the baseline numbers of tests and the
region as the independent variables. Inter-doctor variation was
calculated by the coefficient of variance, the standard deviation (SD)
divided by the mean.
Results
Twenty-seven local PCP groups, including 194 PCPs, expressed their
willingness to participate, so no further recruitment actions were
needed. After randomization, the intervention arm included 13 local
PCP groups, while the feedback arm included 14 groups (Figure 3).
Each PCP received feedback on the three clinical problems.
Table 2 describes the characteristics of the study population. Mean
group size in the intervention arm was 6.9 (SD 2.1), vs. 7.8 (SD 4.2)
in the feedback arm. There was a large, but statistically not significant
difference in mean total numbers of tests per GP per 6 months between
the two arms at baseline; intervention arm: 478 (SD 309), feedback
arm 541 (SD 337). An intention-to-treat analysis was not possible for
10 PCPs in each arm, including one entire local PCP group in the
intervention arm. Data for the follow-up measurements for these PCPs
were lacking, due to absence, change of jobs or practice-related data
registration problems. Multilevel analyses showed that the point estima-
tion and standard deviation were the same at group level as in the
analysis of covariance at individual PCP level and therefore no correc-
tion for local PCP groups was needed.
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PCPs received the feedback report on tests ordered in case of upper
abdominal complaints two weeks before the small group quality meeting,
together with the evidence-based guidelines on upper abdominal com-
plaints (Figure 1). These guidelines recommend, first of all, that there is
no reason to order liver function tests for non-specific upper abdominal
complaints without jaundice. The risk of false-positive results is too large,
because of the low prevalence of patients with liver diseases in primary
care (4-5 per 1000 patients). If PCPs think screening is necessary, they
are advised to order SGPT and y-glutamyltransferase in patients without
jaundice, and to order total bilirubin, SGPT and y-glutamyltransferase in
patients with jaundice. In short, there is never an indication to order more
than two liver function tests in patients with upper abdominal complaints
without jaundice, so the following 5 tests: SGOT, LDH, amylase, bilirubin
and alkaline phosphatase, are seen as 'inappropriate' for patients with
non-specific upper abdominal complaints.
At the meetings, PCPs discussed their reports, compared them with each
other's results and with the guidelines, and also discussed Bayesian decision
rules to help them understand the probability of false-positive results in
low-prevalence disorders. Another important topic of debate was the
frequent requests by patients with non-specific upper abdominal com-
plaints to have blood tests. It took quite some effort and discussion to
convince the PCPs they had to change their routine for these cases. The
next step was to try and implement the guidelines. Many PCPs made plans
for changes on this item, such as T will order less liver function tests,
because I understand that these tests do not add useful information to
what I know'. Some local PCP groups stated that they would use the same
information brochure about non-specific upper abdominal complaints.
The intervention arm PCPs ordered on average 24 'upper abdominal test'
less per PCP per half year, compared with the feedback PCP (p=0.0031).
The number of 'inappropriate' tests for this clinical problem decreased
from 55 (SD 60) to 39 (SD 32), while in the feedback arm the number
decreased from 60 (SD 63) to 56 (SD 54), meaning that the intervention
PCPs ordered 13 inappropriate tests less than the feedback PCPs
(p=0.0015)(Table3).
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Table 3 shows results of these analyses at individual PCP level for
all tests and per clinical problem. The total number of tests ordered
decreased in both arms. For the intervention group PCPs the decrease
was 51 tests more per PCP per half year than for the feedback PCPs
(p=0.0049). The differences in changes were significant, except for
cardiovascular topics that decreased with marginal significance. The
Box I describes the intervention and its effects in more detail for the
clinical problem "upper abdominal complaints": the differences for the
defined inappropriate tests were also significant, meaning that the
intervention PCPs ordered 13 inappropriate tests less than the feedback
PCPs per PCP per half year (p=0.0015). Table 3 also shows that the
coefficient of variance decreased more in the intervention arm, meaning
that the variation in test-ordering between intervention PCPs decreased
more than in the feedback arm. Figure 4 depicts the results for all
tests at aggregated local PCP group level in graphical format, and
shows that effects in the intervention arm were more straightforward.
EFFECTS OF THE STRATEGY BY ANALYSIS OF COVARIANCE ADJUSTED FOR NUMBERS OF DIAGNOSTIC TESTS AT BASELINE
AND FOR THE REGION ON THE MEAN (SD) NUMBERS OF TESTS, PER PRIMARY CARE PHYSICIAN PER 6 MONTHS
478 (309) 0.65
293(189) 0.65
20 (20) 1.00
165(125) 0.76
55(60) 1.09
422 (235)
276(157)
18(19)
128(82)
39(32)
0.56
0.57
1.06
0.64
0.82
541 (337)
322(214)
30(40)
188(143)
60(63)
535 (309)
333 (205)
30 (27)
171(117)
56 (54)
0.58
0.62
0.90
0.68
0.96
17.94
13.08
2.18
7.98
4.1
-87;-16 .0049
-51; 1 .0561
-10;-2 .0076
-40; -8 .0031
-22;-5.2 .0015
Total number of tests
Cardiovascular topics
Lower abdominal complaints
Upper abdominal complaints
Inappropriate upper abdominal tests
Abbreviations: SD, standard deviation, SE, standard error; CV, Coefficient of variance.
(5= intervention effect = the total change between baseline and follow-up of mean numbers
of tests in the intervention group - total change of numbers between baseline and follow-up
of mean numbers of tests in the feedback group
CV = SO / mean
IMPROVING TEST ORDERING IN PRIMARY CARE
FIGURE. 4 BASELINE AND FOLLOW-UP MEASUREMENTS IN MEAN TOTAL NUMBERS OF TESTS PER 6 MONTHS AT
AGGREGATED LOCAL PCP GROUP LEVEL FOR THE 13 INTERVENTION AND THE 14 FEEDBACK LOCAL PCP GROUPS.
BASELINE I FOLLOW-UP BASELINE ; FOLLOW-UP
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Discussion
A new interactive quality improvement strategy was evaluated and
compared with classic feedback alone among 27 local PCP groups,
including 194 PCPs, in 5 regions. The first success was the easy
recruitment, with PCP groups anxious to participate in the trial. A
considerable improvement in test ordering behavior was found after
one year of intervention. In the intervention group, there was a
statistically significant and clinically relevant decrease in numbers of
tests ordered, in keeping with the national evidence-based guidelines.
The numbers of tests for two clinical problems improved significantly,
and a statistically significant reduction in numbers of'inappropriate'
tests for upper abdominal complaints was seen. During the interven-
tion period the guidelines on cholesterol testing were updated nation-
ally. That may have been one of the reasons for the decrease in
numbers of cardiovascular tests being only marginally significant.
Inter-doctor variation in numbers of tests ordered decreased in both
arms, but more in the intervention arm. The small group quality
improvement meetings successfully discussed the transparent test
ordering data and the national guidelines. Personal interaction and
mutual influencing of colleagues actually occurred, implicitly result-
ing in an individual or group contract.^'"
The role of the medical coordinators as opinion-leaders also seems a
crucial element of the strategy.^'"Questions can therefore be raised
about the impact of written feedback reports in general, if these are
not integrated in a wider system of quality improvement. That may
have been the reason why Eccles and colleagues did not find any effect
in their trial on feedback on test ordering.'*
Some methodological comments may be made on our study. Despite
the large numbers of participating PCPs a difference in baseline
performance was found. It is probably due to chance as the number
of randomization objects was small (n=27). Despite the lower mean
number of tests at baseline the intervention arm succeed to decrease
substantially. Surprisingly, the region appeared to be an important
determinant in PCPs' test ordering behavior, and this finding certainly
needs further investigation. We did not include a non-intervention
control group, since we did not consider this as a relevant contrasting
strategy. Feedback is now a regularly used strategy in primary care in
the Netherlands. Unfortunately, we could not use clinical data, but
since the evidence-based guidelines recommend a reduction in the
total numbers of tests, the decrease we found can be interpreted as a
quality improvement. Moreover, there is empirical evidence that a
general reduction in test use in primary care does not lead to more
referrals or substitution of care."-*' We expect that these limitations
have had only minor impact on the results, and these results may yield
two important conclusions. The first is that this new strategy can be
a powerful innovative instrument to change PCPs' test ordering
behavior. The strategy gives PCPs the opportunity to discuss their test
ordering performance with colleagues on the basis of actual perfor-
mance data, making discussions less non-committal. Our strategy also
seems worthwhile because small group quality meetings can help to
build up a local PCP group focusing on quality improvement. Many
8o
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test ordering problems that PCPs encounter in everyday practice, such
as demands for tests by patients and changing guidelines, can be
discussed and may be solved in an open and respectful discussion
among professionals. Secondly, merely sending feedback reports to
PCPs without extra activities, such as peer discussion or other strate-
gies that fit in with everyday practice, does not have much impact.
More effort is needed and feedback reports must fit in with a more
ambitious continuous quality improvement program. Further,
although our method was applied for test ordering behavior, it also
seems applicable to quality improvement in other issues such as
prescribing and referral behavior, and for other teams of collaborating
physicians. Nation-wide implementation of this new and innovative
strategy would be a logical next step and is now being prepared in
the Netherlands.
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Abstract
Objective
To determine the costs and cost reductions of an innovative strategy
aimed at improving test ordering routines of primary care physicians
(PCPs), compared with a traditional strategy.
Main oufcome measure
Running costs, development costs, and research costs were calculated
for the intervention period per PCP per six months. The mean costs
of tests ordered per PCP per six months were assessed at baseline and
follow-up.
Multicenter randomized controlled trial with randomization at local
PCP group level.
Setting
Primary care, local PCP groups in 5 regions in the Netherlands with
diagnostic centers.
Stady parfic/pflMte
27 existing local PCP groups, including 194 PCPs
The test ordering strategy was systematically developed and combined
feedback, education on guidelines and quality improvement sessions
in small groups. In regular quality meetings in local groups PCPs
discussed each others' test ordering behavior, related it to guidelines
and made individual and / or group plans for change. Thirteen groups
engaged in the entire strategy (intervention arm), 14 groups received
feedback only (feedback arm).
The new strategy was found to cost € 702.00, the feedback strategy
€ 58.00. When including running costs only the intervention was found
to cost € 554.70, compared to € 17.10 per PCP per six months in the
feedback arm. When excluding opportunity costs for the PCPs' time
spent, the intervention was found to cost € 92.70 per PCP per six
months in the intervention arm. The mean costs reduction that PCPs
in the intervention arm achieved by reducing unnecessary tests was
€ 144 larger per PCP per six months, than the PCPs in the feedback
arm. (p=0.048).
On the basis of our findings, including the expected non-monetary
benefits, we recommend further long-term effect and cost effect
studies on the implementation of the quality strategy.
Key woro"s
Quality assurance, health care; costs and costs analysis; diagnostic
tests, routine; feedback
84
COMPARING COST EFFECTS OF TWO QUALITY STRATEGIES
Introduction
In times of limited resources for health care, it is necessary to evaluate
not only the cost-effectiveness of new treatments or procedures for
patient care, but also the cost-effectiveness of new strategies to improve
the quality of health care delivery. Economic evaluations of interventions
aimed at changing primary care physicians' (PCPs') behavior assess
the balance between benefits attained and resources needed.'" Many
strategies have been developed to improve PCPs' test ordering behavior,
because the numbers of tests ordered by PCPs are growing in many
countries, even though established guidelines regard many of these
tests as unnecessary.^ Rigorous studies of the effects of strategies
such as educational materials, reminders, feedback, small group quality
meetings and financial incentives have so far produced heterogeneous
results/' A few studies investigating costs have also yielded contra-
dictory outcomes.'"" We initiated an economic evaluation study to
evaluate the costs and the effects of a strategy, which combines a
traditional feedback strategy with a multifaceted strategy including
feedback, dissemination of and group education on evidence-based
guidelines, and small group quality improvement meetings in a local
PCP group, using social influence as an important motivator for
change."" A genuine effect of this innovative, multi-faceted strategy
has been observed and presented elsewhere."
The present paper provides a method for cost analyses of such quality
improvement strategies, and compares the costs and cost reductions
of the new strategy with one of its elements, classic' feedback, to assess
whether implementation of the innovative test ordering quality strategy
on a national scale would be worthwhile, depending not only on its
effectiveness but also on the costs involved and the savings achieved.
Methods
Setting
The strategy was applied in five regions in the Netherlands with a
diagnostic center, which is an institute, usually associated with a hospital,
where PCPs can order tests without referring patients to the hospital.
Our strategy aimed at local PCP groups, an existing infrastructure of
Dutch PCPs collaborating in a specific region. These groups share
patient care outside office hours and many of them also engage as a
group in small group quality improvement activities, e.g. prescription
quality circles. Local PCP groups with a link to one of these five diag-
nostic centers were eligible for the study. The medical coordinator of
the diagnostic center provided the test ordering data needed, distrib-
uted the feedback reports and supervised the small group quality
improvement meetings.
and measurements
The new strategy was tested in a multicenter randomized controlled
trial. Numbers of tests ordered were assessed over a period of six
months before the intervention (the baseline period) and a period
of six months after the intervention (the follow-up period). The six
months-intervention took place in 1999. Participating local PCP
groups were randomized centrally, stratified by the size of the local
PCP group and the region in order to spread the workload of the
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medical coordinators of the diagnostic center. The intervention
groups (intervention arm) received feedback and guidelines, and
attended small group quality meetings, while the control arm groups
only received feedback (feedback arm).
The intervention consisted of the following elements: a graphical feed-
back report including a comparison of personal test ordering data with
those of colleagues, dissemination of and group education on national,
evidence-based guidelines and quality improvement meetings in
small groups. During the intervention period the participating PCPs
received by mail three feedback reports on the three clinical problems,
together with concise information on the evidence-based clinical test
ordering guidelines for these specific clinical subjects, as developed by
the Dutch College of Primary Care Physicians. Table 1 describes the
clinical problems and the associated laboratory, imaging and function
tests that were included in the experiment. Each report was followed
by a standardized small group quality improvement meeting, at which
the feedback data relating to one of the clinical problems and the
guidelines were discussed. At the end of the session concrete plans for
change, both at individual and local PCP group level, were established.
measures and measuring msfrumenfs
Measwrmg coifs
All costs of producing the feedback reports and organizing the small
group quality meetings were calculated.
Costs were divided into the following categories:
1. Running costs
1.1. Costs of the feedback reports. Staff members of the diagnostic
centers extracted and edited the data. The production costs
partially depended on the number of PCPs who participated;
more PCPs meant more written reports, and hence more
production time and more postage costs. Secretarial time and
paper costs were calculated per feedback report.
1.2. Costs of the quality meetings. Secretarial time spent for orga-
nizing the meeting and the time spent by the medical coordina-
tor preparing and chairing the sessions were calculated per
meeting per PCP.
1.3. Since each meeting lasted 1.5 hours, and we assumed half an
hour for preparation and traveling, one meeting took 2 hours of
the PCPs' time. PCP fees were derived from the Dutch
Government's annual care review. Total national expenditure
for curative PCP care in 1998 was € 1,023,227,100, which
corresponds to an hourly rate of € 77. These costs were oppor-
tunity costs; in the time the PCP attended the meetings, he
could not 'produce' other work.
2. Development costs
These costs covered activities for the continuation of the
project, e.g. administration, organization, the development and
updating of concise guideline information. A software company
developed software for the production of the feedback reports,
and their costs were included as well.
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3. Research costs
Scientific development of the strategy, expert meetings, the
financial compensation PCPs received for participating in this
study with related activities, e.g. completing evaluation forms,
and working up the questionnaires and evaluation forms were
counted as research activities with related costs.
Registration forms measuring the time needed to extract data
and to produce and send feedback reports were completed by
the staff members. Costs were then calculated on the basis of
the salary scales of staff members at the diagnostic center and
the research department.
Cardiovascular topics
Upper abdominal complaints
Lower abdominal complaints
Order
Cholesterol
HDL-Cholesterol
Triglycerides
Sodium
Potassium
Creatinine
Blood urea nitrogen
Electrocardiogram
Exercise electrocardiogram
Bilirubin
Amylase
Serum gluthamic-pyruvate transmaninase
Serum gluthamic- oxaloacetic transmaninase
Lactic dehydrogenase
Alkaline phosphatase
y-Glutamyltransferase
Ultrasound of the hepatobiliairy tract
Prostate specific antigen
X-ray abdomen
Double contrast barium enema
9.17
1.20
1.61
120
120
1136
72.72
120
120
120
120
120
120
120
36.36
7.12
3132
8636
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reductions
Cost reductions were calculated using existing standard tariffs per test
(Table 1). In the Netherlands, costs of laboratory tests are reimbursed
according to standard prices for tests and orders. Reimbursement for
imaging and function tests includes hospital costs and specialists' fee.
Costs reductions were determined by assessing the mean difference
in the costs of tests ordered per PCP and per six months between the
follow-up period and the baseline period, and comparing this differ-
ence between the two arms. Cost reductions of laboratory tests were
analyzed separately, because although they are a minor part of the
cost reductions, they constitute the great majority of tests.
Consistent with the national, evidence-based guidelines for test order-
ing for the three clinical problems included in the study, a decrease in
the numbers of tests was considered to represent improved patient care.
Costs of the intervention and the feedback strategy were calculated
per PCP per six months. Since the unit of randomization was the local
PCP group, the unit of analysis also had to be the local PCP group.
Therefore, multilevel analyses were applied to evaluate whether the
local PCP groups were important determinants of the effects of the
intervention. A three-level model was used with the PCP group as
level 3, the PCPs as level 2, and the numbers of tests as level 1. This
model was analyzed using SAS PROC MIXED. Multilevel baseline
analyses showed that analyses could be performed without the local
PCP groups. All effects were analyzed with analyses of covariance
using the costs of tests during the follow-up period as the dependent
variable and the costs of tests at baseline and the region, which
appeared to be an important determinant, as independent variables.
A sensitivity analysis was performed by varying the inclusion of the
various cost categories and cost reductions.
Results
A total of 38 local PCP groups were invited by open recruitment
to take part in this trial. Twenty-seven local groups with 194 PCPs
immediately expressed their willingness to participate. After random-
ization, the intervention arm included 13 local PCP groups and the
feedback arm 14. Figure 1 describes the study design and shows that
follow-up data were unavailable for 20 PCPs. Table 2 shows that there
were no differences in individual PCP characteristics between the two
arms. There was a large, but statistically not significant, difference in
costs of laboratory and all tests ordered per PCP between the two
arms at baseline.
Costs o/f«e strategy and cosf redwcfions in test ordering
Table 3 shows the total costs of the intervention. Concerning the
running costs of the strategy, the cost of one feedback report per PCP
was € 5.70. The costs per PCP per quality meeting were € 25.20 for
4.25 hours of coordination time, including secretarial, preparation,
meeting and traveling time. The opportunity costs of the PCPs' time
spent attending the meetings were 2 hours x € 77 = € 154 per PCP per
meeting. About the development costs, guidelines were only used in
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38 Local Primary Care Physician Groups Eligible
11 Groups Declined Participation
27 Groups Randomized (194 Primary Care Physicians)
13 Groups Assigned to Arm A
(85 Primary Care Physicians)
Received Entire Strategy
3 Feedback reports
3 Quality Meetings
On 3 Clinical Problems
Cardiovascular Topics
Upper Abdominal Complaints
Lower Abdominal Complaints
14 Groups Assigned to Arm B
(89 Primary Care Physicians)
Received Feedback Strategy
3 Feedback reports
On 3 Clinical Problems
Cardiovascular Topics
Upper Abdominal Complaints
Lower Abdominal Complaints
1 Group Lost to Follow-up
(Practice-Related Data
Registration Problems)
(4 Primary Care Physicians)
6 Primary Care Physicians Lost to
Follow-up
(Absence or Change of Job)
12 Groups Completed Trial
(75 Primary Care Physicians)
FIGURE 1. FLOW OF RANDOMIZED TRIAL
0 Groups Lost to Follow-up
10 Primary Care Physician Lost to
Follow-up
(Absence or Change of Job)
14 Groups Completed Trial
(99 Primary Care Physicians) I
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the intervention group and costs were € 4 per PCP. The total cost of
the intervention was € 65,998: € 702 per PCP per six months for the
intervention arm and € 58 per PCP per six months for the feedback
arm. If only part of the running costs are counted (the opportunity
costs of PCPs for the time spent for the quality meetings are excluded)
the total running costs amount to € 92.70 per PCP for the interven-
tion arm, and € 17.10 per PCP for the feedback arm per six months.
Table 4 shows that the costs of laboratory as well as all tests, decreased
in both arms, but significantly more so in the intervention arm than
in the feedback arm. Per PCP per six months the total cost reduction
in the intervention arm was € 144 more than in de feedback arm.
Table 5 shows results of a sensitivity analysis. When including oppor-
tunity costs for PCPs' attending time, the costs for the intervention
arm exceeded the cost reductions. The cost reductions of the interven-
tion arm exceeded the costs with € 208.30 (€ 301- € 92.70) per PCP
per six months, with only part of the running costs included (exclud-
ing the opportunity costs). The cost reductions of the feedback arm
were larger than its costs for all cost categories, and introducing the
feedback strategy would save € 143.90 (€ 161- € 17.10) per PCP per
six months, when including only running costs.
TABLE 2 STUDY POPULATION CHARACTERISTICS AT INDIVIDUAL PRIMARY CARE PHYSICIAN LEVEL
No. of PCPs
Age (SD), year
Female, No. (%)
No. of patients per physician, mean (SD) *
Patients older than 65y, % mean (SD)
Physician with a part-time working factor, % mean (SD)
Physician with a solo practice, No. (%)
Physician who uses computerized registration system, No.(%)
85
46.2 (6.6)
14(16)
2587(641)
15(6.8)
91 (15)
43(51)
66 (78)
109
46.2 (6.6)
11(10)
2444(416)
15 (6.5)
92(12)
44(40)
75 (69)
•Total practice population for whom the primary care physician is responsible.
9O
COMPARING COST EFFECTS OF TWO QUALITY STRATEGIES
TABLE 3
TYPE OF COSTS
INTERVENTION COSTS FOR THE STUDY POPULATION AND PER PRIMARY CARE PHYSICIAN IN EACH ARM IN € PER 6 MONTHS.
TOTAL INTERVENTION
COSTS PER PCP
INTERVENTION ARM (N= 85)
COSTS PER PCP
FEEDBACK ARM (N= 109)
Running costs
Feedback reports (3x)
Quality meetings (3x)
Opportunity costs*
Development costs ^ ,
Continuation activities
Software development
Guidelines
Research costs
Scientific development/evaluation
PCP compensation
49.014
3.861
13.123
3317
6.427
39.270
2.484
1.000"
377**
4.453
8.670
554.70
22.40
124.90
17.10
75.60
462
12.80
5.20
4.40
22.90
102
TOTAL COSTS
* Based on hourly fees for curative PCP care in 1998 as derived from the Dutch Government's annual care review
"Discounting period 5 years
17.10
18.00
22.90
17.10
12.80
5.20
22.90
TABLE 4
EFFECTS OF THE STRATEGY BY ANALYSIS OF COVARIANCE ADJUSTED FOR COSTS OF NUMBERS OF TESTS AT BASELINE AND FOR THE
REGION ON THE MEAN COSTS IN € (SD) OF LABORATORY AND ALL TESTS ORDERED PER PRIMARY CARE PHYSICIAN PER 6 MONTHS
INTERVENTION ARM (N= 75)
Baseline Follow-up
Total costs laboratory tests
Total costs all tests
FEEDBACK ARM (N=99)
Follow-up
596 (407)
1541(1023)
517(313)
1240(720)
656 (437)
1763(1268)
633 (393)
1602(1016)
-64
-144
66
72
.0027
.048
-106;-23
-287; -2
intervention effect = total change between baseline and follow-up in mean costs of tests in the intervention group - total change in mean costs of tests in the control group
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TABLE 5 COSTS AND COST REDUCTIONS (€) PER PCP PER SIX MONTHS.
All costs'
Only running costs'
Running costs, no opportunity costs'
Cost reductions'
'All costs: include running costs, development costs and research costs of the strategy.
'Running costs: include costs of the feedback reports, small group quality meetings and opportunity costs.
Discussion
701.00
554.70
92.70
301.00
58.00
17.10
17.10
161.00
•Opportunity costs: costs of the primary care physicians'time spent attending the small group quality
meetings. One meeting took 2 hours of the primary care physicians'time (including preparation and traveling
time). A primary care physician hourly rate of € 77 was derived from Dutch Goverment's annual review.
'Cost reductions were differences in costs of test at follow-up and at baseline, and were calculated using
existing standard tariffs per test.
The present paper evaluates costs and cost reductions of an innovative
strategy to improve PCPs' test ordering, involving feedback, education
on guidelines, peer interaction and social influence, by comparing it
with a traditional approach involving only the provision of feedback.
The new strategy improved test ordering more substantially and
consistently, and, besides the favorable clinical effects, appears to bring
about more cost reduction than feedback alone when not counting
the opportunity costs" *". Introducing this effective strategy in the
Netherlands, with its about 7100 PCPs practising, would then save
€ 1,478,930 (7100 x € 208.30) in the first six months.
There are some methodological aspects of our study that need to be
considered. Concerning cost reductions, a reduction in the number
of laboratory tests ordered does not always influence laboratory costs;
for example, a diagnostic apparatus performing fewer tests costs the
same amount of money and only a large reduction can mean that
fewer laboratory staff are needed. We could not include such potential
cost reductions. For instance, not performing a redundant test also
implies that a patient does not have to take time off work. More
importantly, we were unable to assess the cost reductions achieved by
not performing tests that would result in false-positive findings. Such
test results may lead to a cascade of further testing, or inappropriate
treatment or referrals, and as a result of better diagnosing patients
costs are saved in the long run. The limited time frame of the study
prevented us to study these effects, since patients included in our
study should be monitored for several years. For the same reason we
were unable to assess possible learning effects, which could mean that
quality activities may become less time-consuming over time even if
the approach is directed to other clinical problems. Finally, under use
of tests is another possible danger that was not assessed.
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Our study deals with some interesting and important topics for costs
analyses of quality improvement studies. As in many quality improve-
ment studies only intermediate effect measures instead of patient
outcome measures were available. Since negative effects on patient'
outcome are not expected in the quality strategy, these kind of cost
analyses can be seen as cost minimization analyses.*' The analyses
were done from a societal perspective, but the perspective of the
physicians involved may also be important. Further, we focused on the
costs and cost reductions, expressed in monetary units, but with our
new strategy we may expect also non-monetary benefits related to the
strategy, such as improvement of the PCPs' clinical knowledge and job
satisfaction, and, of course, it is difficult to quantify these important
benefits in such a cost analysis. There is some empirical evidence that
participating in such quality improvement activities may increase
PCPs'job satisfaction."" Moreover, we calculated the opportunity
costs for the time spent by PCPs in attending the quality meetings.
In general, these opportunity costs, should be included because they
weigh (in monetary units) the time needed for conducting the
activities considered in this study and not available anymore for other
activities. Which is the reason they are named opportunity costs.
However, it remains debatable if these opportunity costs have to be
accounted for in the Netherlands because here PCPs are obliged to
engage in continuous medical education programs, such as our
quality strategy, up to 40 hours a year, and health insurers partially
include compulsory continuous medical education in the national
tariffs. Furthermore, it was found to be difficult to differentiate
between development and research costs, and we decided to define
only the costs of the expert meetings and the scientific effect evalua-
tions, including the compensation for the research activities of partici-
pating PCPs, as research costs. Nevertheless, it is debatable whether
these costs have to be accounted for, and researchers have to explicit
their choice. In costs analyses research costs usually are excluded, and
it is debatable how to handle development costs, because some of
these costs will be necessary when implementing a strategy at a broader
scale. Concluding, we evaluated costs and cost reductions of our strategy
without counting the scientific and development costs. However,
including the development costs in our sensitivity analysis did not
change our results.
Surprisingly, cost effects have usually not been evaluated in quality
improvement studies, perhaps because, as was mentioned above,
many problems can be expected.** Recently, Mason et al. provided
a framework for exploring the economics of improving quality of care
by means of influencing physicians' behavior, using clinical outcome
data at patient level." The present paper provides a method for cost
analyses of quality improvement strategies, where it is difficult or even
impossible to perform a real cost-effectiveness study because of lack
of clinical data.
In conclusion, in the Dutch situation the innovative test ordering
strategy reveals considerable cost reductions in the first six months
when not counting the opportunity costs for the time spent by PCPs.
Because, contrary to the feedback strategy, also non-monetary benefits
can be expected, we suggest that PCPs organizations stimulate local
PCP groups to participate in this new strategy.
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CHAPTER VII
Abstract
Ob/ecfive
Evaluation of the feasibility of an innovative strategy to improve
GPs' test ordering behaviour, and to further improve continuous
professional development.
Design
Prospective process evaluation of the use and appraisal of the strategy
during the first and second years of a trial.
Seff/ng
General practice, local GP groups, diagnostic centres.
The new strategy combines written feedback, education on clinical
guidelines and continuous quality improvement sessions, quality circles,
in small local GP groups. An important feature of the written feedback
was a comparison of the behaviour of individual GPs with that of their
colleagues. Mutual feedback by working in pairs, discussion on national
guidelines, and making plans for change were important features of
the group sessions. The strategy has an iterative character.
Resw/fs
All 194 participating GPs received the planned six feedback reports.
Data from 156 meetings of 26 local GP groups showed a participation
rate of 81% (95% CI: 77%-85%) in the first year and 73% (95% CI:
68%-77%) in the second. Meetings included mutual feedback by
working in pairs (used in 73% of the sessions in the first year and 61%
in the second year), individual plans for change (96% in the first year,
92% in the second year) and group plans for change (71% in the first
year, 54% in the second year). In the first year GPs expressed their level
of satisfaction with the approach in a score of 7.55 on a scale of 0 - 10
(95% CI 7.46-7.64); average score in the second year was 7.51 (95% CI
7.30-7.74).
Conc/usi'on
The innovative test ordering strategy seems a feasible tool for continuous
improvement of GPs' test ordering behaviour, fitting in well with local
and regional quality improvement efforts for isolated working GPs.
JCey words
quality assurance, health care; evaluation studies, primary health care,
professional practice, test ordering, feedback, guidelines.
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Introduction
Numbers of tests ordered by general practitioners (GPs) is growing,
and inter-doctor variation is shown to be large.'"' It is as yet unclear,
however, what would be the best method to influence GPs' test ordering
behaviour.'' Studies evaluating different types of interventions and
strategies for this purpose have, so far, produced heterogeneous results'"'.
No particular type of intervention was found to be inherently effec-
tive; multifaceted approaches have proved to be superior to single
methods in some analyses, but not in others ^  Audit and feedback
were found to be effective in specific settings*', while written, personal
feedback on test ordering by peers or opinion leaders has also been
found to improve test ordering behaviour.'" It seems particularly
important in this respect to make use of interventions in addition to
professionally oriented interventions, because the success rates of
particular strategies seem to be highly dependent on the extent to
which they fit in with the local context and the practitioners' daily
work routine." A multi-faceted strategy combining comparative
feedback on tests ordered, group education on guidelines, and small
group quality improvement meetings in a local GP group, with social
influence as an important motivator for change, was expected to offer
good prospects.'^" The strategy also fits in well with the work setting
of many GPs in European and non-European countries, which are
often characterised by small practices, relatively isolated settings and
a desire for more contacts with peers.
The favourable clinical effects of this strategy were reported elsewhere. '"*
Nowadays process evaluations of quality improvement strategies are
seen as a necessary addition to effect studies to learn about important
elements of change. " It was therefore important to determine to what
extent the intended elements of the multifaceted strategy were accepted
and actually used by the participants and to assess their opinion on
the key elements of the feedback and interactive quality circles between
colleagues.'*" The present paper focuses on the feasibility of this
innovative strategy in view of a possible implementation at a larger
scale, and it also assesses important elements from the perspective of
further improving continuous professional development (CPD) of
general practitioners.
Methods
Between January 1999 and October 2000, the new strategy was evaluated
in five regions in the Netherlands, and a process evaluation was done
prospectively. Coordination of the feedback and supervision of the
group meetings was provided by the five diagnostic centres, which are
a special facility where GPs can order laboratory, imaging and function
tests without referring patients for specialist care. One of the tasks
of the medical coordinator of these centres is to give feedback to GPs
on their test ordering behaviour.
Local GP groups that referred their patients to one of the five partici-
pating diagnostic centres were invited to take part in the study. Local
GP groups are an existing part of the infrastructure of Dutch GPs
collaborating in a specific region. One of their tasks is to organise care
during out of office hours, while CPD is another important activity in
many of these local groups.
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: tfie /mprovemewr strategy
The intervention consisted of the following elements: personalised
graphical feedback, including a comparison of each GP s own test
ordering data with those of colleagues, guideline dissemination and
continuous quality improvement meetings in small groups, organised
and chaired by the medical coordinator of the diagnostic centre. The
strategy was patient care oriented rather than test oriented, in that it
did not focus on the volume of specific tests, but on specific clinical
problems and associated laboratory, imaging and function tests relevant
to daily GP practice (Table 1). GPs received three different feedback
reports per year on three different clinical problems, together with the
national, evidencebased guidelines on test ordering of these specific
clinical subjects. This was followed by 90-minute structured meeting
two weeks later, at which one of the clinical problems was discussed.
The small group meetings or quality circles consisted of three major
components. The first was mutual personal feedback by peers, who
worked in pairs at the start of the meeting. This was assumed to be a
safe method of peer review. The second component was an interactive
TABLE 1
CLINICAL PROBLEMS / TESTS
CLINICAL PROBLEMS AND ASSOCIATED TESTS USED IN THE TRIAL
CLINICAL PROBLEMS / TESTS
A1 Cardiovascular topics
Cholesterol, subfractions, potassium, sodium, serum creatinine,
blood urea nitrogen, (exercise) EKG
B1 COPD/Asthma
Pulmonary function test, allergic screening test, immunoglobulin E, chest X-ray
A2 Upper abdominal complaints
Alanine aminotransferine, aspartate aminotransferase, lactic dehydrogenase,
amylase, v-glutamyltransferase, bilirubin, alkalic phosphatase, ultrasound scans
of hepatobiliary tract
B2 General malaise /fatigue/ vague complaints
ESR, Haemoglobin + - indices, haematocrit, white blood count, thyreoid
stimulating hormone, monospot
A3 Lower abdominal complaints
Prostate-specific antigen, C-Reactive protein, ultrasound of the kidney, IVP,
double contrast barium enema, sigmoidoscopy
B3 Joint degeneration / complaints
ESR, uric acid, rheumatoid factors, X-rays of lumbar spine,
cervical spine, shoulder, knee, hip
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group education of national guidelines to be able to relate own and
each others' test ordering behaviour with them. The third was the
development of individual and group plans for change to stimulate
GPs to really put their plans into daily practice. This schedule was
repeated a year later, using the same three clinical problems, to assess
whether a GP or GP group had implemented the plans for change and
to initiate further improvements. This iterative aspect was another
important feature of the strategy.
msfrumenfs
The feasibility of the strategy was tested by a prospective process
evaluation, focusing on 6 variables: (1) the timely production and
provision of the feedback reports, (2) the GPs'appreciation of the
feedback, (3) the attendance at the meetings and (4) the GPs' appre-
ciation of the meetings. These four variables were measured by means
of a one-page standardised questionnaire, which was completed by
the attending GPs after each meeting.
Appreciation was measured on a scale of 0-10. (5) With a checklist the
medical coordinators recorded actual activities at the meetings, e.g.
mutual feedback, discussions on guidelines and plans for change. (6)
Finally, individual and group plans for change were drawn up by the
participating GPs, written down and collected by the coordinators of
two regions during the meetings.
Analyses were performed separately for the first and second year, in
view of the iterative aspect of the intervention. For the same reason
differences in attendance between the first and second years were tested
for significance using the McNemar test for paired variables. Subgroup
analyses for regions and for clinical problems were performed for some
of the parameters to see if region and clinical problems were important
determinants for the process evaluation. Because there were differences
in group size, Spearman's correlation coefficients were calculated to
see if group size was correlated with items from the actual activities
questionnaire.
ANOVA and multivariate regression analyses were done on the GPs'
appreciation of the feedback reports, using the clinical problem, the
region and the local GP group as independent variables.
Results
A total of 37 local GP groups were invited to take part in the trial.
The total study population was 193 GPs, belonging to 26 local GP
groups that were willing to participate. Individual GP and GP practice
characteristics were largely similar to those of the Dutch GP population
as a whole, except for type of practice: two-person practices were
under represented, while group practices were over represented.
The mean group size was 7.4 + 2.7(SD), minimum 3, maximum 12. A
total of 1158 (6x193) written feedback reports were sent out, and 156
small group quality improvement meetings were held. A total of 850
GP questionnaires were analysed, 455 in the first year and 395 in the
second. The response by the participating GPs to the questionnaires
was 97 % in the first year and 93% in the second year. The response
by the medical coordinators was 100% in the first year and 99% in the
second year.
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TABLE 2 APPRECIATION OF WRITTEN FEEDBACK REPORTS, FILLED IN BY 193 GPS (MEAN; 95%CI ; SCALE 0-10) .
CLINICAL PROBLEM
Appreciation of written report
CLINICAL PROBLEM
Appreciation of written report
TOTAL
7.46 (7.37-7.56)
TABLE 3
ACTIVITIES PERFORMED DURINGTHE MEETINGS IN THE FIRST AND SECOND YEARS,
DESCRIBED BY MEDICAL COORDINATORS. (PER CLINICAL PROBLEM, IN PERCENTAGES).
PERFORMED ACTIVITIES FIRST YEAR
Appraisal of own behaviour
Pair work
Discussing relation guidelines
Individual plans
Group plans
PERFORMED ACTIVITIES SECOND YEAR
Appraisal of own behaviour
Pair work
Individual plans
Group plans
Discussing previously drawn up plans for change
A1
100
62
100
92
85
A1
100
58
92
50
100
A2
100
75
100
92
50
A2
100
50
100
67
100
A3
100
64
100
100
50
A3
100
58
100
45
100
B1
100
92
100
92
50
B1
100
58
100
58
100
B2
100
92
100
100
85
B2
100
58
92
58
100
B3
100
62
100
100
69
B3
100
69
92
54
100
TOTAL (95% C.I.)
100
73(63-83)
100
96(92-101)
71(60-81)
TOTAL (95% C.l . |
100
61(49-72)
92(86-98)
54(42-65)
100
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Each participant received all six feedback reports as planned. It proved
to be possible to produce and disseminate the feedback in time. The
GPs gave a favourable assessment of the feedback reports in both years
(Table 2). Multivariate regression analysis showed that the region where
the GP practised, the local GP group and the clinical problem had no
significant influence on the appreciation in the first year. In the second
intervention year, the clinical problem did influence the appreciation
of the report (p=0.03), in that the appreciation of the feedback report
on COPD / asthma related tests decreased in the second year.
Attendance at the meetings in the first year was on average 81% (95% CI:
0.77-0.85); in the second year attendance decreased to 73% (95% CI:
0.68-0.77) (p < 0.05, Me Nemar test). Only two of the 196 GPs never
visited any of the meetings. Subgroup analysis showed that there were
no significant differences in attendance per region or per clinical
problem (p > 0.05). Overall, participants expressed favourable opinions
on the new strategy: the average appreciation score was 7.55 (95% CI
7.46-7.64; scale 0-10; min 4; max 10) in the first year and 7.51 (95% CI
7.38-7.65) in the second.
Table 3 describes the actual activities in the meetings during the two
trial years. Discussion of participants' own test ordering behaviour
was performed according to plan in all meetings. As planned, all groups
discussed the relation with the evidence-based guidelines as well -in
the second year- the plans for change made in the first year. In the first
year, participants worked more in pairs than in the second year; in two
out of the five regions less pair work was undertaken. There was a
significant positive correlation of 0.38 (p<0.01) between a larger group
size and more pair work in the first year, which disappeared in the
second year. Table 3 also shows that GPs made individual plans for
change in most meetings. Most groups also made group plans for
change, although this decreased in the second year.
Table 4 gives the most-mentioned individual plans for change per
clinical problem. Most plans concerned a decrease in the number of
tests, except for lung function tests. An example of such an individual
commitment was, "I will order fewer Hb tests, because I realise that
this test does not give much information in patients with vague
complaints". The second year the number of individual plans decreased,
except for the clinical problem general malaise/ vague complaints.
Plans at group level were also made, e.g. the plan to use the same patient
brochure to inform patients about the use of cholesterol tests or the
arrangement to follow the national guideline on delaying testing in
patients with vague complaints. All results show that the quality circles
were an essential element in the improvement strategy.
Discussion
The innovative, multi-faceted strategy for improving test ordering
behaviour was favourably evaluated by a large GP population. All
local GP groups expressed a desire for continuation of the meetings
after the experiment. The new strategy utilised peer influence among
GPs, and gave GPs the opportunity to openly discuss their test ordering
behaviour with colleagues.
The results may be biased, since the study population differed slightly
from the Dutch GP population only regarding the type of practice.
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However, there is no reason to assume that these minor differences
influenced the external validity of the study. The decision to focus on
clinical problems instead of tests was a good choice, since it allowed
the feedback and group work to be linked to national evidence-based
guidelines. GPs appreciated this approach, because it was also closely
related to their everyday work routine. They stated that this type of
feedback definitely had added value, because comparison with colleagues
made them more conscious of their own behaviour and motivated
them to change.'*" Their main criticism was the validity of the numbers
of tests in the feedback and the absence of patient-related data.
Working in pairs to discuss the feedback report at the start of the
meetings made most GPs feel safe, especially in the first year. After a
while, it may become less needed, because participants may then feel
more safe about discussing their own behaviour within the group as a
whole. This is probably why the use of pair work decreased in the
second year. Drawing up concrete individual and, if possible, group
plans for change that are checked later is a crucial and innovative
aspect of this strategy. Most GPs made individual plans for decreasing
the numbers of certain tests.
However, lack of experience in drawing up and GPs were excited to
find in the second year that they had indeed changed in accordance
with their plans, and they were then usually more motivated to
implement further changes. Nevertheless, individual plans for change
were not always adhered to. Making group plans for change can be
difficult, due to lack of confidence or lack of familiarity with entering
into this kind of commitment in a GP group. However, almost two-
thirds of the meetings managed to draw up group plans for change.
An explanation for the slight decrease in the attendance rate in the
second year might be that the same clinical problems were discussed,
with some GPs stating that they did not expect to learn anything new,
and they preferred to discuss a new clinical subject at each meeting in
addition to evaluating previous plans for change.
There is some empirical evidence that participating in quality circles
may increase GPs' job satisfaction, and this powerful, interactive group
strategy fits well within the growing need of transparent health care
with positive use of actual clinical data for continuous professional
development in order to further improve clinical practice.'"" The
following lessons for the CPD of GPs can be learnt. First, GPs appreciate
the combination of individual feedback, discussions about guidelines
and small group quality improvement meetings driven by peer influ-
ence. A second important element is the fact that GPs are prepared to
discuss personal, transparent data openly in a group of colleagues.
Thirdly, another important element is the focus on daily, clinical GP
problems. In our study GPs preferred to talk about clinical problems
and tests linked to these problems, rather than to discuss abstract
phenomena like total test ordering volume or the ordering of specific
tests. Finally, the strategy must fit in with the GPs' daily practice
routine and should be aimed at local collaboration in teams or groups.
to f/ie study by ^^ Dufch Co//ege/or Hea/fJi
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TABLE 4
7IDUAL PLANS FOR CHANGE MADE BY GPS IN TWO REGIONS DURING THE TWO-YEARS PERIOD.
(ONLY ITEMS MENTIONED BY AT LEAST FOUR TIMES WERE COUNTED)
CLINICAL PROBLEMS/ TESTS A
TOTAL N =34 GPS'
A1 CARDIOVASCULAR DISEASES/HYPERTENSION
Decrease:
Cholesterol
Subtractions
Exercise ECG
10
5
4
4
10
B1 UPPER ABDOMINAL COMPLAINTS
Decrease:
ASAT
y-glutamyltransferase
LDH
Alkalic phosphatase
ALAT
Ultrasound scan of hepatobliary tract
Bilirubin
A3 LOWER ABDOMINAL COMPLAINTS
Decrease.
Prostate specific antigen
CRP
IVP
10
10
9
8
6
S
4
6
10
7
5
4
12
11
6
CLINICAL PROBLEMS/TESTS B
TOTAL N = 37 GPS"
A2 COPD/ASTHMA
Decrease:
Immoglobulin E
Allergic screening test
Chest X-ray
/ncrease:
Pulmonary function test
B2 GENERAL MALAISE/VAGUE COMPLAINTS
Decrease-
Leucocytes
MCVand indices
TSH
HB
ESR
Leucocytes differential count
Mononucleosis test
B3 JOINT DEGENERATION/JOINT COMPLAINTS
Decrease:
Uric acid
Rheumatoid factors
X-ray of shoulder
10
8
6
15
9
6
5
4
4
14
4
16
11
6
7
9
4
7
10
4
6
* GPs were allowed to indicate more than one item.
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CHAPTER VIII
Abstract
Ob/'ecfive
To evaluate the value of balanced incomplete block designs in quality
improvement research, and their capacity to control for the Hawthorne
effect: the phenomenon that the mere taking part of a professional in a
trial and his or her awareness being observed influences performance.
Sfwdv des/gw and seffmg
In a clustered trial, GP teams were randomised into three arms and
received a quality improvement intervention on test ordering, relating
to tests for two groups of clinical problems, called A tests and B tests.
In the two trials within the block design we tried to control for the
Hawthorne effect by comparing the complete intervention in both arms
on either the A (arm I) or B tests (arm II); the arms acted as blind
controls for each other. In the classical trial the complete intervention
on B tests (arm II) was compared with a control arm without any
intervention on B tests (arm III).
Our block design had a surplus value compared with the classical
design, in that it allowed us to control for the Hawthorne effect.
Suitable use of block designs may further our knowledge of non-
specific effects in quality improvement research.
Key words
Quality research; design; randomised controlled trial; Hawthorne;
non-specific effects
The authors gratefully acknowledge the financial contribution to the
study by the Dutch Health Care Insurance Council.
The trials with the block design yielded statistically significant changes
in the numbers of A tests ordered (p=0.013), but not in the numbers
of B tests ordered (p=0.29). In the classical design, the complete
intervention reached a marginal significant change in the B tests
(p=0.068). The Hawthorne effect was the same for both arms of the
block design. In the classical design, the effect could to some extent
be attributed to the Hawthorne effect.
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Introduction
To bridge the gap between evidence-based medicine and practice, we
need to learn more about effective quality improvement interventions
for implementation of research findings in daily practice.'"'
Evaluating these interventions demands for rigorous methodology
and is both complex and challenging."~" Randomised controlled trials
are considered as the most robust method of assessing such strategies,
because randomisation normally ensures that known and unknown
biases are distributed evenly between the trial arms.'"' When evaluat-
ing interventions aimed at improving clinical practice, however, there
are a number of non-specific effects which may influence estimations
of the effect of an intervention in randomised trials. These include
positive attention effects, caused by participants knowing that they are
the subject of a study, but also negative, de-motivating effects caused
by being allocated to a control rather than to an intervention group.
These non-specific effects are currently grouped together under the
name 'Hawthorne effect'. If these are imbalanced across study groups
in a quality improvement trial, the resulting effect estimates may be
biased '*~*° However, there is relatively little empirical data about the
potential influence of such non-specific effects.
Randomised controlled trials utilising balanced incomplete block
designs should balance such non-specific effects.''"-' The simplest
such design is a 2 x 2 balanced incomplete block design in which
subjects are randomised into two groups. Group 1 receives the
intervention for condition A and provides control data for condition
B, whereas group 2 receives the intervention for condition B and
provides control data for condition A. The design is balanced because
it ensures that all participants receive the same intensity of interven-
tion and data collection and should therefore balance any non-specific
effects. The design is incomplete because not all participants receive
the complete intervention for both conditions.'*"
We just finished a trial evaluating an intervention aimed at improv-
ing GPs' test ordering performance. Since the Hawthorne effect may
influence the outcome of this trial, the present paper determines
the possible added value of block designs compared with classical
designs in controlling for the Hawthorne effect. Therefore, the
results of a simple classical two-arm trial are compared with the
results of a 2 x 2 balanced incomplete block design within the same
study. To our knowledge, it is one of the first empirical studies in
the health care setting that tries to determine whether balanced
incomplete block designs provide different results compared to
simple two arm trials.
Methods
The aim of the study was to evaluate the effect of a new intervention
to improve general practitioners' test ordering. The intervention
involved: personalised, comparative feedback; dissemination of and
education on national, evidence-based guidelines; and regular quality
improvement meetings in small, existing local GP teams. Two groups
of targeted tests were identified including tests for cardiovascular,
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upper abdominal and lower abdominal problems (A tests) and tests
for pulmonary, non-organ related and degenerative joint complaints
(B tests). More details have been provided elsewhere."
f/ie design
The trial was a three-arm cluster randomised trial with the local GP
team as the unit of randomisation. Figure 1 shows the design of the
study. GP teams randomised to arm I received the intervention for A
tests, while GP teams in arm II received the intervention for B tests. GP
teams in arm III received a minimal intervention for A tests. Data on
A and B tests were collected from all arms of the trial. Arms I and II repre-
sented a 2 x 2 balanced incomplete design, while arms II and III repre-
sented a simple two- arm randomised trial of the intervention on B
tests. Consequently, our design was a combination of a classical two-arm
RCT and a RCT with a block design. Table 1 shows the hypotheses of the
different trials and the possible value concerning the Hawthorne effect.
DESIGNS, HYPOTHESES PER TRIAL AND POSSIBILITY TO ENSURE EQUAL HAWTHORNE EFFECT ACROSS THE ARMS
ARM II- III
Complete intervention for B tests. No intervention on
B tests (control). Minimal intervention on A tests.
Classical If the numbers of B tests in the intervention arm decrease in accordance with
the guidelines and no change occurs in the control arm the intervention has a
favourable effect but without controlling for the Hawthorne effect.
ARM III
Complete intervention on A tests.
Using B tests as control.
Block If the numbers of A tests decrease in accordance with the guidelines and no
change in numbers of B test occurs, the intervention has a genuine effect.
yes
ARMII-I
Complete intervention on B tests.
Using A tests as control.
Block If the numbers of B tests decrease in accordance with the guidelines and no yes
change in the numbers of A test occurs, the intervention has a genuine effect.
1O8
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FIGURE 1. STUDY DESIGN
AND POPULATION
ARM I
Complete intervention on A tests
No intervention on B tests
Data collection on all (A and B) tests
Local GP teams
N=40 (GP teams) with 283 GPs
ARM II
Complete intervention on B tests
No intervention on A tests
Data collection on all (A and B) tests
ARM III
No intervention on B tests
Minimal intervention on A tests
Data collection on all (A and B) tests
N=13 85GPs
Loss to follow-up
6 GPs because of absence, change
of job; one entire group of 4 GPs
because of computer-related
problems
N=13 89GPs
Loss to follow-up
1 GP because of absence
109 GPs
T-Oss to follow-up
10 GPs because of absence,
change of job
N=1
Completed trial
N=12
lOGPs
75GPs
N=0
Completed trial
N=13
1GP
88 GPs
N=0
Completed trial
N=14
lOGPs
99 GPs
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Outcome
GPs gave informed consent to extract data on the volume of A and
B tests ordered, without knowing which test data were actually being
collected. Separate data on A and B tests were collected over a 6-months
period before (baseline period) and a 6-months period after the
intervention period (follow-up period). To evaluate intervention
effects, the following effect measure was defined: the total number
of requested tests per six months per GP for the A tests and for the
B tests. The intervention effect (3 was the total change between base-
line and follow-up in mean numbers of tests in the intervention arm
minus the total change between baseline and follow-up in mean
numbers of tests in the control arm.
TABLE 2 TRIAL EFFECTS OF THE INTERVENTION FOR THE TOTAL GROUP OF TESTS BY WEIGHTED ANALYSIS OF COVARIANCE.
ARM II- III
Complete intervention for B tests. No intervention on
B tests (control).Minimal intervention on A tests.
Classical B tests -32 17 0.068 -66; 2.4
ARM I I I
Complete intervention on A tests.
Block A tests -33 13 0.013 -59; -7.0
ARM I I I
Complete intervention on B tests.
Block B tests -19 18 0.29
-55; 17
P = total change between baseline and follow-up in mean numbers of tests in the intervention group
minus total change between baseline and follow-up in mean numbers of tests in the control group,
corrected for baseline differences and region.
11O
Because the overuse of tests is a common problem in general practice,
and consistent with national, evidence-based guidelines for test
ordering for the included clinical problems a decrease in the numbers
of tests was considered as an improvement in patient care.
Multilevel analyses were done to evaluate the influence of the GP team
level in terms of the effects of the intervention. A three-level model
was used with the GP team as level 3, GPs as level 2, and the assessment
of the numbers of tests as level 1. For reasons of power, effects were
analysed using analysis of covariance with the follow-up assessment
of the numbers of tests as dependent variable and the baseline numbers
of tests and the region, which was found to be an important determi-
nant of test ordering, as the independent variables. Since the point
estimation and standard deviation were about the same in multilevel
analyses as in the analysis of covariance at individual GP level, no
correction for GP teams was needed. Inspection of the residual plots
showed that weighted analysis was necessary in the classical trial design,
and, to be consistent, we also used weighted analyses for the trials with
the block design.
Results
Forty local GP teams, including 283 GPs, were randomised (Figure 1).
Comparing f/ie comp/efe mtervenfJOH on £ fesfs (arm 7/J w;Yn no
iwfervenf/orc o« B fesfs farm 7//J
Table 2 shows that the mean decrease in numbers of B tests per
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GP per six months in arm II exceeded that in arm III by 32 tests,
a difference which was marginally significant (p= 0.068,95% CI -66;
2.4). No changes in numbers of A tests were found between arm II
and III (P = -3, p= 0.80,95% CI -26; 20).
Comparing f/ie comp/ete intervewrion in a b/ocfc design: arm / vs. arm 7/
ana* arm // vs. arm /
The trial effects presented a differentiated picture (Table 2). The effect
on A tests was that the decrease in arm I (complete intervention on
A tests) exceeded that in arm II (the control arm) by 33 tests per GP
per six months (95% CI -59; -7). The effect on the B tests in arm II
(complete intervention on B tests) exceeded that in arm I (the control
arm) by 19 tests per GP per six months (p= 0.29,95% CI -55; 17).
Detailed clinical results of the block design trial have been reported
elsewhere."
The effect on B tests in the classical trial was found to be larger and
marginally significant, compared to the effect on B tests in the block
design trial. In the classical trial the effect of the complete intervention
on the group B clinical problems was larger than in the trial with the
block design. The classical two-arm trial on B tests overestimated the
effect compared with the trial in the block design, because it did not
control for the Hawthorne effect.
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Discussion
The most important conclusion is that our pragmatic design,
a combination of a classical and a block design, evaluating an inter-
vention for improving GPs' test ordering performance, was able to
evaluate a complex, multifaceted intervention in detail. Our design
allowed us to conduct three two-armed randomised trials, one classical
and two block design trials. Both arms of the block design trial involved
the same intervention, and all aspects of data collection was given, so
the Hawthorne effect was equal in both arms. The larger effect in the
classical trial was probably due to the Hawthorne effect and not to the
intervention itself: the more attention given, the greater the effect.
However, in research trying to evaluate such a quality intervention,
which includes attention as an important element, it appeared to be
difficult to assess the magnitude of the Hawthorne effect, because it is
hardly possible to differentiate between the amount of attention given
as part of the intervention and the Hawthorne effect. Hence, because
it seemed possible to control for the Hawthorne effect, the block design
proved to have an added value compared with the classical design.
The present study had some limitations. Financial and organisational
restrictions prevented us from including a real control arm, with no
intervention at all. Such a design might provide more accurate answers
to the problem of the magnitude of the non-specific effects. Moreover,
we did not handle other non-specific effects, such as the fact that contact
between intervention and control physicians can influence outcome,
as physicians talk about the quality strategy under study, an effect
commonly known as 'across subject contamination effect' or 'leaking
effect'.*"We presume this effect is not that large, because GPs normally
do not discuss test-ordering performance amongst themselves and the
teams were located in different regions. For the same reason, we also
assumed that GPs were really blind for the fact that we collected more
test ordering data than the data they were intervened on, and for the
fact that their colleagues received another intervention or the same
intervention on other clinical problems. Finally, although we accounted
for baseline measurements in the analysis of covariance we did not
address the ceiling effect': the fact that there is little room for improve-
ment in high performance scores.*" The ceiling effect in this study may
have been important, since GPs in the Netherlands order considerably
fewer tests than GPs in other countries."
We can conclude that in evaluating an intervention to improve or change
performance, it seems important -where possible- to use a block design.
Since this means that the GPs in both arms of the intervention are
subject to the same level of intervention, the Hawthorne effect is
equalised across the two arms. It is necessary to monitor carefully
how the blocks of a block design are composed, as there must not be
any interference between the two blocks. Contamination, another
non-specific effect, may be a major threat to the validity of block
designs, which may occur when participating physicians improve
their performance not only for topics under study, but also for related
ones. Therefore, it is necessary to gather more data than where the
intervention is focused on to be able to control for this effect.
Although a block design can result in a complex study, a major benefit
of block designs is obviously the possibility to do two randomised
112
BLOCK DESIGNS IN QUALITY IMPROVEMENT RESEARCH
trials with the same intervention on the same cohort of participants.
Finally, since the willingness of GPs to participate in quality improve-
ment research may be a problem, amongst other reasons, because of
the chance of being randomised to a control arm, a block design
ensures that all professionals are randomised to an 'intervention' arm.
We conclude that our block design proved to be an effective design to
evaluate our improvement strategy, allowing us to control for the
Hawthorne effect, although further studies on non-specific effects in
quality research are certainly required.
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Introduction
Transparency and improvement of the care provided to patients are
important topics in current discussions about the future of health care
services. There is much debate about the best way to improve patient
care and there is a demand for new approaches that fit well within the
routines of clinical professionals. One of the aspects that remain to be
identified is the best method to influence the test ordering behaviour
of general practitioners (GPs) or primary care physicians (PCPs).'"
This thesis focuses on improving test ordering performance in primary
care by means of an innovative, multifaceted strategy, which was system-
atically developed by means of a study on the determinants of test
ordering and a systematic literature review. The final strategy consisted
of the following elements: transparency through personalised graphical
feedback, dissemination of and group education on national, evidence-
based guidelines, and small group quality improvement meetings in
existing local GP groups. These GP groups are an existing part of the
infrastructure of Dutch GPs, who collaborate in a specific region and
share patient care outside office hours. We performed a randomised
clinical trial to evaluate the effects, cost effects and feasibility of this
multifaceted and innovative strategy. This chapter summarises the
main findings and discusses methodological aspects of our research
project. It ends with recommendations for implementing this innova-
tive strategy on a larger scale and recommendations fur further research.
Main findings
Sfwc/y OM determinants o/tesf
The study on determinants of test ordering behaviour explicitly included
context-related factors at GP group and regional levels. This enabled
us to focus on the variation in GPs' test ordering behaviour in relation
to both professional and context-related determinants, such as practice
type, different ways of organising test requests or experience with feed-
back on test ordering data. We found large differences in test ordering
between the five regions included in the analysis. Three determinants
were found to be independently associated with the volume of tests,
namely the GPs' involvement in developing guidelines, working in a
group practice, and having had more than one year of experience of
using a problem-oriented form. Nevertheless, the determinant study
could explain only part of the interregional variation.
Literature review
A systematic review of intervention to improve physicians' test ordering
performance, carried out for EPOC Cochrane Library, revealed the
following. Although the results were heterogeneous due to differences
in the type or intensity of the intervention and the setting, and because
of methodological differences between studies, there were some consis-
tent findings. Probably, different strategies are needed for modifying
overuse of tests versus improving appropriateness of test ordering
behaviour. It is not clear that single strategies have less impact versus
multifaceted strategies, but it seems important to focus the interven-
tion at both the professional and the context. Audit and feedback
seem effective for both decreasing absolute test rate and improving
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appropriateness of test use. Reminders by computer aided decision
support improve the appropriateness of test use. Outreach visits,
patient-mediated interventions and small group quality improvement
deserve more attention. The literature considered social influence as
a potentially important strategy to improve test ordering behaviour.
£$"ecte o/a strategy combmi'n /^eedfcacfc, gw/tfef/nes and smafi growp
qua/ify improvemenf
A strategy was developed on the basis of current insights into effective
change in patient care and was evaluated by a multicentre randomised
controlled trial with a balanced, incomplete block design after one year.
The relatively short intervention period (6-months) resulted in a
substantial reduction in the total numbers of tests ordered, as well as
in the numbers of inappropriate tests ordered. These reductions and
the latter reduction in particular were regarded as a quality improve-
ment in terms of test ordering, because these changes were in agreement
with the recommendations in national evidence-based guidelines.
The multifaceted strategy was also compared with a single strategy,
namely classic' feedback only, to evaluate the added value of the small
group quality meetings. In the arm that received the complete strategy,
there was a statistically significant and clinically relevant decrease in
the numbers of tests, in line with the national evidence-based guidelines,
compared with the feedback only arm. The inter-doctor variation in
the numbers of tests ordered decreased in both arms, but more so
in the total strategy arm. Important elements of the strategy are the
discussions on test ordering data, the national guidelines, the personal
interaction with colleagues, and the role of the medical co-ordinator
of the diagnostic centre (a special facility where GPs can order
laboratory, imaging and function tests without referring patients
for specialist care). Merely sending feedback reports to GPs without
additional activities, such as peer discussion or other strategies that
fit in well with everyday practice, seemed to have little impact.
We also developed a framework to evaluate the costs of quality
improvement strategies in the absence of clinical patient data. *""
Running costs, development costs, and scientific costs were determined
for the added value trial. The new strategy was found to result in greater
cost reduction than feedback alone.
Process evaluation of quality improvement strategies is seen as a
necessary addition to effectiveness studies to assess important elements
of change. '* It was therefore important to determine the extent to
which the intended elements of the multifaceted strategy were accepted
and actually implemented by the participants and to assess their opinion
on the key elements of the feedback and the small group quality
meetings. The strategy was favourably evaluated in a prospective proc-
ess evaluation during the trial. Although it was found that organising
the intervention required considerable effort, it did not take up much
of the participating GPs' time (three 90-minutes meetings per year).
All local GP groups expressed a desire for continuation of the meetings
after the experiment. None of the participating GP groups regarded it
as a problem to discuss individual feedback reports openly. By relating
their personal feedback reports to existing national evidence-based
guidelines, and by assessing barriers to and incentives for change,
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GPs were able to develop individual and group plans for change to
improve their test ordering performance. The three key elements of
the quality meetings, mutual feedback by working in pairs, discussing
national guidelines and making individual and group plans for change,
were implemented at a satisfactory level in both intervention years.
GPs appreciated this approach, because it was closely related to their
everyday work routine.
Methodological considerations
The determinants study investigated the influence of context-related
determinants not only at practice level but also at the level of local GP
groups, including differences between GP groups in patterns of collabo-
ration, as well as the regional level, including differences between
regions in quality improvement programmes or methods of organis-
ing test requests. We performed a multilevel multivariable regression
analysis on our baseline data, linked with survey data on professional
characteristics and with data on context-related factors. It was relatively
easy to retrieve data on laboratory tests for the baseline performance
assessment from the diagnostic centres. It was more difficult to retrieve
reliable imaging and function test data, since the registration of these
data was not always computerised. The survey had a high response,
probably because the medical co-ordinators of the diagnostic centres
repeatedly encouraged GPs to fill in the questionnaire.
Although we studied context-related factors at the regional level, such
as differences between regions in quality improvement programmes,
we should perhaps have paid more attention to a wider set of organi-
sational and socio-cultural determinants to allow us to explain more
of the observed interregional variation. However, our finding that the
GPs' involvement in developing guidelines and their experience with
using the problem-oriented order form were independent predicting
variables was new and valuable. Other organisational and socio-cultural
determinants could include regional morbidity figures, methods of
organising test requests or cultural or religious characteristics of the
patient population. One region was a former mining region, which is
well known for its above-average levels of cardiovascular and pulmonary
diseases, but this fact alone was unlikely to explain why the mean
number of tests ordered per GP was almost three times as high in
this region as the region with the lowest mean number of tests
ordered per GP. Additionally, local experts claimed that the regional
Department of General Practice of the regional university had an
important social influence on the behaviour of the GPs in the region
with the lowest mean number of tests ordered by strongly advocating
rational test ordering.
e$ecr studies
The outcome measures in the effect studies were volume data, the total
number of tests ordered per GP per six months, and the number of
specific tests defined as 'inappropriate' according to the guidelines.
Unfortunately, we could not use clinical data, but since the evidence-
based guidelines recommend a reduction in the total numbers of tests
included in the trial, the observed decrease can be interpreted as
a quality improvement. Moreover, there is empirical evidence that a
118
GENERAL DISCUSSION AND CONCLUSIONS
general reduction in test use in primary care does not lead to more
referrals or substitution of care." Although the guidelines recommend
a reduction in total test ordering, it cannot be concluded that the
numbers of individual tests should always decrease. In monitoring
diabetic patients, for instance, it was necessary to increase the number
of serum creatinine tests and the tests for lipid management.
Furthermore, the new guidelines on COPD recommend GPs to order
more lung function tests.
In general, however, the focus of our intervention was on a decrease
in the volume of tests, in accordance with the national evidence-based
guidelines. This means that there was a potential danger of the inter-
vention resulting in underuse of tests. Nevertheless, we do not think
underuse has been a real threat, because our strategy aimed at prevent-
ing inappropriate use, which includes both overuse and underuse of
tests. GPs discussed their feedback data and related them with guide-
lines, and if these guidelines recommended an increase in a specific
test, such as lung function tests, GPs or GP groups made plans for
ordering more tests.
A decrease in 'inappropriate' tests may definitely be regarded as a
quality improvement. According to the guidelines, tests were regarded
as inappropriate for the associated clinical problems for various reasons,
for instance because the results of these tests do not influence the
treatment, because there is a high likelihood of false-positive results,
because there are better alternatives, or because there are negative
side-effects to the tests, such as unnecessary radiation exposure.
We also considered using 'diagnostic yield' as a kind of measure of
quality of test ordering. The diagnostic yield of a test is the percentage
of positive test results divided by the total numbers of this specific
test ordered, which might be a valid parameter in diagnostic testing.
However, this measure was found to be too difficult to interpret for
the participating GPs, because in general practice there may be other
reasons to order a test than diagnostic purposes. In monitoring diabetes,
for instance, a high positive yield of glucose tests would indicate a
poor quality of diabetes control.
A ttew/ramewor/c/or cosf sfucfres o/qua/ify o/care m
Since only intermediate effect measures, rather than patient outcome
measures, were available, a real cost-effectiveness study was not possible.
Since negative effects on patient outcomes were hardly to be expected
in this quality improvement strategy, our cost analyses can be seen as
cost minimisation analysis." However, it would be possible to measure
the effects of quality improvement strategies and the cost effects at
patient level, by following patients for several years in terms of clinical
outcome parameters. This could extend the present study and make it
a true cost-effectiveness study.
The cost minimisation analysis undertaken in our study was done
from a societal perspective, but the perspective of the physicians
involved may also be important. Their perspective is especially
important judging the likelihood that the approach will be widely
implemented.
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Although our study focused on costs and cost reductions, expressed
in monetary units, the new strategy may be expected to yield non-
monetary benefits as well, such as improvement of the GPs' clinical
knowledge and performance in other areas than test ordering or
improved collaboration between GPs, benefits which we did not
measure. However, it is difficult to quantify these important benefits
in such a cost analysis.
Another important aspect of measuring the costs of the intervention
was that of the opportunity costs for the time spent by GPs in attending
the quality meetings. These costs should normally be included, because
such time is not available for other activities. However, it remains debat-
able if these opportunity costs have to be taken into account because
Dutch GPs are obliged to engage in continuous medical education
programmes, such as our quality strategy, for up to 40 hours a year,
and health insurers to some extent include compulsory continuous
medical education in the GPs' fees.
Finally, it was found to be difficult to differentiate between development
and research costs. Cost analyses usually exclude research costs, and
it is debatable how development costs should be handled, because
some of these costs will be necessary when implementing a strategy
at a wider scale.
77ie va/ue o/a fo/oc/c design zw evfl/uafzn^pro/e55;ona/per/brma«ce
Evaluating professional performance demands a rigorous metho-
dology. " " Our research question made a double-blind design infeasible,
because it was not possible to blind subjects in our study for the new
strategy, although it may be possible to blind subjects for a routine
strategy."" The main effect study used a balanced, incomplete block
design." This design is called balanced because both arms in the block
design received the same type of intervention. It is called incomplete
since the content of the intervention differed between the arms.
One of the main problems in effectiveness studies on quality improve-
ment strategies is how to cope with non-specific effects, such as the
Hawthorne effect: the mere fact that a professional is taking part in
a trial and is being observed will stimulate him or her to perform
better, that is, more in accordance with what is expected?' ^
Since both arms of the block design in our study involved the same
intervention and were identical in all aspects of data collection,
the Hawthorne effect was assumed to be equal in both arms. Although
it would have been interesting to determine the magnitude of the
Hawthorne effect, we were not able to do so, because this study did
not include a control group without intervention.
General discussion
Much attention is currently being invested in a systematic development
of new quality improvement strategies. Facilitators and barriers have
to be determined to map interventions, because we need to be cautious
about strategies designed behind a desk." Our determinant study and
systematic review intended to provide valuable input for the design of
a strategy. The determinant study showed that a problem-oriented
laboratory order form had a significant impact on test ordering. This
justified the use of the problem-oriented order form as an inclusion
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criterion for diagnostic centres that wanted to participate. The same
study found that the influence of the local GP group was small, but
that many GPs mentioned the social influence of colleagues as an
important determinant of clinical performance. Moreover, the literature
showed that social influence, was a potentially important element of
the new strategy. Social influence from respected colleagues or opinion
leaders might have a greater effect on changing practice routines than
traditional medical education activities.-'" *' While the social influence
of the group was already incorporated in our strategy, the influence
of the medical co-ordinators of the diagnostic centres probably was
large. These medical co-ordinators, who provided the feedback on test
ordering and could as such be regarded as experts on this topic,
functioned as respected opinion leaders and stakeholders in the field
of quality improvement in test ordering.'" "
77ie effecf sfudies
The effect studies revealed modest, yet statistically significant changes
in test ordering behaviour. The two sets of clinical problems included
in the block design trial were chosen deliberately to prevent contami-
nation between the clinical problems in the two arms. To ensure compa-
rability, both blocks included one clinical problem with tests that are
important for monitoring patients (cardiovascular topics and COPD/
asthma) and two clinical problems for which tests mainly serve to
exclude or confirm certain diseases. It was not possible to prevent all
contamination, as, for example, the clinical problem of upper abdominal
complaints and general fatigue / vague complaints are not entirely
independent. We do not think, however, that this contamination biased
the results. Such contamination would tend to reduce the difference
between the intervention and control condition in terms of the change
in the numbers of tests ordered before and after the intervention,
so the actual effect may even have been underestimated.
In the block design trial, there were obvious differences in effect between
the two arms: test ordering for all clinical problems in the first arm
showed significant improvement, whereas test ordering for all clinical
problems in the second arm tended to improve as well, although the
change failed to reach statistical significance. The reasons for this intrigu-
ing difference in outcome between the two arms are not entirely clear.
One possible explanatory factor is the following. The most important
clinical problem in terms of prevalence in the second arm was vague
complaints / general fatigue. During the small group quality improve-
ment meetings GPs discussed the test ordering guidelines on these
problems, which recommend delayed testing in patients with vague
complaints. Many GPs reported that they found it difficult to imple-
ment this guideline, and indeed, our study hardly found any change
after the intervention.*"* Confronted with such complaints, GPs
probably follow fixed routines, and use laboratory tests to win time or
to negotiate with patients, who often expect or demand such tests.**
A second factor may have been that guidelines on degenerative joint
complaints recommend not to order X-rays of possibly degenerate
joints, because the result of such examinations does not influence the
treatment. However, GPs do not always find it easy to adhere to this
guideline, again because they can use these imaging investigations to
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win time.'" In addition, this guideline does not accord with the daily
practice of orthopaedic surgeons, who always order X-rays when a
GP refers a patient with degenerative joint complaints. A third factor
is that the guidelines for COPD/asthma were updated during the
intervention period, which may have caused the lack of significant
change in test ordering for this clinical problem.
We were unable to study long-term effects of the intervention, and
we do not know whether the effect will persist. We do not expect that
the same decrease in numbers of tests ordered will be found each year.
In time, the volume of tests will probably stabilise, assuming that the
practice population remains stable and there is no changing in the
guidelines. Ideally, there will come a moment when GPs order a specific
test entirely in accordance with the guidelines, which may then may
be seen as the 'benchmark' number for that specific test; with no further
change required. This may imply that future quality meetings could
then focus on a new set of diagnostic tests and procedures. Cost effects
will not be the same each year either, as, for instance, learning effects
may mean that the strategy becomes less time-consuming and less
costly, while on the other hand the effect, that is, savings from the
decrease in test ordering, may also become smaller.
It can be concluded that the intervention was practice-based and
expensive, and led to modest but significant changes after a relatively
short intervention period, while the long-term effects are as yet
unknown. Some intervention studies have achieved greater changes in
test ordering, sometimes using simpler interventions such as changing
the order form or using quality management interventions.
Changing the order form was found to be an effective intervention in
many studies and the quality management intervention focused on
specific cardiac tests. In general, these favourable interventions were
aimed at a few specific tests or focused particularly on knowledge
improvement, rather than performance change. We think that the effect
evaluations and process evaluations we applied to our strategy showed
it to be a powerful and feasible, tailor-made strategy, which fits in well
with routine GP practice and routine professional development in many
(Western) countries. In addition, it is linked to everyday practice work
and it gives GPs the opportunity to discuss their test ordering perfor-
mance with colleagues on the basis of actual performance data, making
discussions less non-committal. Many test ordering problems that GPs
encounter in everyday practice, such as demands for tests by patients
and new guidelines, can be discussed and may be solved in an open
and respectful discussion among professionals.
We also expect that other health care professionals working in teams,
such as medical specialists, dentists, midwives or physiotherapists,
could use this strategy to improve their test ordering behaviour. This
strategy also fits well with the growing need for transparent health
care using clinical data to further improve clinical practice. Of course,
such an innovative strategy is not the sole solution for all aspects of
quality improvement in test ordering performance, and further
improvement may require additional strategies. Finally, although our
method was applied to test ordering behaviour, it also seems appli-
cable to quality improvement in other aspects of general practice,
such as prescribing and referral behaviour. The most important effect
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of our strategy may be that it promotes collaboration in local GP
groups focusing on quality improvement. Our method may result
in the creation of a team of professionals instead of a collection of
individual physicians, which might be a very important 'side-effect'
of the strategy.
Recommendations for implementation
Our intervention was found to be effective, challenging to the partici-
pating GPs and feasible in routine practice. Despite the ease with which
we were able to recruit GPs for our project, it is certainly not always
easy to motivate GPs to take part in new strategies on quality improve-
ment. First, to many GPs quality improvement is to be synonymous
with efficiency, which they feel is mostly relevant from the perspective
of the health insurers. Further, many GPs interpret such new quality
improvement strategies as attempts to show that they are not perform-
ing properly. In such an atmosphere the attitude of GPs will be less
open and more defensive. Finally, lack of time is a commonly given
reason for not taking part. GPs work under pressure and it is not always
possible to make time to participate in quality improvement activities.
Hence, it will take some effort to motivate GPs. Obviously, quality
improvement strategies are intended to improve performance, but
in order to make them easier to implement, they also need to create
more job satisfaction, to be challenging and to be feasible in daily
practice.*'"*' The barriers mentioned above have to be addressed,
for example by using respected opinion leaders, and by reliable
information campaigns that focus on the benefits for both patients
and GPs, such as increased job satisfaction and better collaboration
with colleagues. Although considerable cost-reductions could be
achieved, the new strategy was not cheap, so financial incentives could
also be important in implementing the new quality improvement
strategy.
There are a number of questions concerning the actual implementa-
tion of this strategy at a larger scale, such as, who should organise the
test ordering quality strategy, who should chair the quality improve-
ment meetings, and how GPs are to be compensated in the strategy?
Diagnostic centres, which already exist in a quarter of the Dutch
hospitals and some large cities, and where GPs can order tests without
referring patients to the hospital, seem to be important structures for
implementing the new strategy, as it proved to be possible to implement
this strategy for two years in five regions in the Netherlands with
diagnostic centres. Diagnostic centres have access to the data, and it
is their task to provide feedback to GPs about test ordering. As part
of the project, we developed a software program to make it easier to
produce feedback reports. This program was found to be easy to
implement in the diagnostic centres. The data have to be reliable,
because otherwise discussions will be negatively affected, but reliability
will probably become less of an issue because diagnostic centres nowa-
days are completely computerised. In the future it should be possible
to use not only volume data, but also clinical data on adherence to
guidelines to make discussions even more profound. GP organisations,
hospitals and health insurers should stimulate the setting up of regional
diagnostic centres in all regions.
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We recommend disseminating the national evidence-based test order-
ing guidelines used in the trial among the Dutch GP population. Of
course, these guidelines have to be updated, for example by the Dutch
College of General Practitioners.
While the framework of the quality meetings appeared to be clear and
workable, regional aspects, of course, may result in different approaches.
The iterative aspect requires a long-term effort: how long depends
on the time it will take to cope with all clinical problems and on the
moment when the GPs achieve the 'benchmark' in test ordering. Our
process evaluation showed that GPs preferred to discuss a new clinical
subject at each meeting. Each meeting can start with an evaluation to
assess whether a GP or GP group have implemented the previously
made plans for change and to initiate further improvements. It is
important to plan meetings two to three times a year for a lengthy
period of time, because such a number of meetings can easily be
scheduled into other quality improvement activities of the GP group.
For example, the monthly quality meetings on prescription could also
use our innovative approach and thereby give the GP group enough
experience to become acquainted with it. It should then be possible
to replace two or three prescription quality meetings each year with
meetings on test ordering. Additionally, the process evaluation showed
that six to ten GPs seemed to be the most optimum number of GPs
per group for this strategy, and it was necessary to have support from
trained GPs or opinion leaders who know how to use our strategy.
Finally, in the case of wider implementation, financial incentives for
participating GPs may be important. In the Netherlands, GPs receive
a fixed amount of money per year for attending quality meetings on
prescription. As regards test ordering, we recommend that GP organi-
sations and health insurers enter into an agreement to compensate
local GP groups for participating in the test ordering quality circles,
while GPs then commit themselves to achieve better quality and cost
reductions in test ordering. These cost reductions have to be moni-
tored to assess the feasibility of this agreement.
Recommendations fur further research
Remarkably, the region factor was found to be an important determinant
of GPs' test ordering performance. However, we were not able to deter-
mine this factor in detail, and further studies on regional variation are
warranted, including socio-cultural determinants such as regional
morbidity rates or religion. A better understanding of factors that
influence professional practice is necessary to achieve further scien-
tific progress. Much remains unknown about determinants of test
ordering and ways how to change it. Our study may have added another
level to this research, which has not been explored before yet is an
important level. Future studies should include regional and local as well
professional determinants. Further studies are also necessary to evaluate
differences in determinants of ordering laboratory tests, imaging tests and
function tests. This could lead to different quality improvement strategies
for different types of diagnostic tests. Finally, the influence of the
patients on test ordering needs to be further investigated, because this
influence seems to be increasingly important.
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Our strategy could possibly be improved by combining it with other
strategies: better (i.e., problem-oriented) order forms, the use of GPs'
computerised systems, and the use of (electronic) reminders.
Financial incentives and other organisational interventions also seem
applicable in the GP setting, and deserve more attention, as does the
delegation of GPs' tasks to other professionals, such as GP practice
nurses, who can order glucose tests in the context of their diabetes
surveillance. Further, as mentioned above, it seems useful to study the
effects of introducing our strategy in other domains of general practice,
such as referral or prescription performance, and among other teams
of collaborating professionals.
Although the block design can be applied to several fields of quality
of care research, we do not recommend too rigorous designs in this
research area. Other research methodologies should be developed for
situations where such rigorous designs are not possible. Time series
analyses with enough measuring points would seem a useful design
for, for instance, most organisational interventions.^
Finally, we need valid methods to determine the heterogeneity of
intervention effects and the generalisability of study results in the
quality of care domain. More standardisation of intervention descrip-
tions, outcome measures and data analysis are needed to allow fair
comparisons between studies.
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CHAPTE R X Summary
CHAPTER X
C H A P T E R I introduces the subject of this thesis, the test ordering
behaviour of general practitioners (GPs). The numbers of tests ordered
by GPs are increasing and many of these tests appear unnecessary
according to established evidence-based guidelines. Furthermore,
inter-doctor variation seems to be large. This thesis describes the
variation in test ordering behaviour in primary care, provides a
systematic literature review on the strategies used by others to influence
physicians' test ordering behaviour, and discusses the effects and costs
of an innovative strategy we developed to improve GPs'test ordering
behaviour. The strategy was systematically developed on the basis of
the findings of the literature review. The multifaceted strategy had an
iterative character and included the following elements: personalised
graphical feedback, guideline dissemination and continuous small
group quality improvement meetings. An important feature of the
graphical feedback reports was a comparison between the behaviour
of individual GPs and that of their colleagues. Mutual feedback by
working in pairs, discussing guidelines, and drawing up plans for
change were important features of the small group quality improve-
ment meetings.
The meetings were organised in local GP groups. Local GP groups are
an existing part of the infrastructure of Dutch GPs working together
in a specific region. One of their tasks is to organise care during out-
of-office hours, while continuing medical education is another
important activity in many of these local groups. Co-ordination of
the feedback and supervision of the group meetings was provided by
a diagnostic centre, a facility where GPs can order laboratory, imaging
and function tests without referring patients for specialist care.
One of the tasks of the medical coordinator of the diagnostic centre
is to give feedback to GPs on their test ordering behaviour.
The multifaceted, innovative approach was implemented in five regions
catered for by
 five diagnostic centres, all working with a problem-oriented
test ordering form. It was evaluated in 40 local GP groups by means of
a multicentre trial with randomisation at local GP group level.
C H A P T E R II describes a survey study of the variation in the test
ordering behaviour of the GPs that participated in the test ordering
trial, which tried to establish professional-related and context-related
determinants of GPs' inclination to order tests, by means of a cross-
sectional analysis. The baseline data of the trial, which involved 19
laboratory and 8 imaging tests, combined in a sum score per GP per
year, were analysed to assess determinants of inter-doctor variation.
In a multivariable multilevel regression analysis, these data were linked
with survey data on professional characteristics such as knowledge
about and attitude towards test ordering, and with data on context-
related factors such as practice type or experience with feedback on
test ordering data. The response to the survey was 97 %. Test ordering
data were available for 229 GPs in 40 local GP groups from five regions.
We found that the total median number of tests per GP per year was
998 (interquartile range 663 to 1500), with large differences between
the regions (p<0.001). Factors significantly associated with smaller
number of tests ordered were, at professional level,'individual involve-
ment in developing guidelines' (yes versus no) and at context level
'group practice' (versus two-person or single-handed practices) and
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'more than one year of experience working with a problem-oriented
laboratory order form' (yes versus no). GPs who met these three criteria
ordered 27%, 18%, and 41% fewer tests, respectively, than their col-
leagues. We concluded that, in addition to professional-oriented
determinants, context-related factors are strongly associated with
the numbers of tests ordered. Further studies on GPs' test ordering
behaviour should include local and regional factors.
C H A P T E R III reports on a systematic literature review of strategies
to influence test ordering behaviour, applying rigorous Cochrane
Collaboration methods. It was hypothesised that changing the absolute
rate of test use (which in most cases meant reducing the general
overuse of diagnostic tests) and improving the appropriateness of test
use (usually by means of explicit guidelines for certain disease-defined
patient categories) are different issues that need different strategies.
The second hypothesis was, that multi-faceted strategies would
generally have a greater impact than single strategies. Finally, it was
hypothesised that studies evaluating strategies involving context-
oriented interventions would have a greater impact than exclusively
professional-oriented interventions. A total of 98 studies with 118
comparison groups were included. Overall results were heterogeneous,
due to differences in the type or intensity of the intervention or the
setting, or due to methodological differences between studies.
Modifying the overuse of tests and improving the appropriateness of
test ordering behaviour may require different strategies. In addition
to professional-oriented interventions, it seems important to consider
the use of interventions that focus on organisational factors. It is
not clear whether single strategies have less impact than multifaceted
strategies, but it seems important to focus the intervention on both
the professional and the context. Audit and feedback seem effective in
decreasing absolute test rates as well as in improving the appropriate-
ness of test use. Reminders by computer aided decision support were
found to improve the appropriateness of test use, while outreach visits,
patient-mediated interventions and small group quality improvement
deserve more attention.
C H A P T E R IV evaluates the strategy of combining feedback, guide-
line dissemination and small group quality improvement on the basis
of a multicentre randomised controlled trial with a balanced, incom-
plete block design. The primary outcome measure was the total number
of tests ordered for three different clinical problems per GP per six
months. Arm I consisted of 13 groups receiving the strategy on three
clinical problems, viz., cardiovascular diseases, upper abdominal
complaints and lower abdominal complaints, while arm II consisted
of 14 groups that received the same strategy, but concentrating on
three other clinical problems, viz., COPD / asthma, general malaise /
vague complaints and degenerative joint complaints (see chapter I, figure 1).
The ordering volume of all tests related to the six clinical problems was
monitored in both arms. The GPs were blinded for the intervention on
the three clinical problems included in the other arm. In agreement
with existing national, evidence-based guidelines, decreases in the total
numbers of tests ordered as well as in the numbers of tests ordered
per clinical problem and for some specified inappropriate tests were
regarded as quality improvements. Analysis of covariance showed that
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in arm I, the decrease in the total numbers of tests relating to cardiovas-
cular diseases, upper abdominal complaints, and lower abdominal
complaints was greater than in arm II, the difference being 67 tests more
per GP per six months (p =0.01). For the GPs in arm II the mean change
in the numbers of tests for COPD / asthma, general malaise / vague
complaints and degenerative joint complaints was greater than that in
arm I, the difference being 28 tests (p=0.22). In both arms, there was a
reduction in the ordering of specified inappropriate tests, although the
reduction was not significant for the GPs in arm II. The new strategy,
focusing on guidelines and interaction and feedback between GPs,
thus seems an effective tool for improving GPs' diagnostic testing.
C H A P T E R V assesses the added value of small peer group quality
improvement meetings for improving test ordering behaviour com-
pared to one of the elements of the strategy, viz., simple feedback, on
its own. This research question was evaluated by comparing arm I
(see chapter IV) with a third arm including GPs receiving feedback on
the same three clinical problems as in arm I (cardiovascular diseases,
upper abdominal complaints, and lower abdominal complaints). The
complete strategy was applied in 13 GP groups with 85 GPs (arm I),
while 14 GP groups with 109 GPs received feedback only (arm III)
(see chapter I, figure 1). Analysis of covariance showed that in arm I
the decrease in the mean total number of tests (51 fewer tests per GP
per six months) was far more substantial than that in the feedback
arm (p=0.0049). Five tests deemed 'inappropriate' for the clinical
problem of upper abdominal complaints' showed a greater decrease
in arm I than in the feedback arm, the difference being 13 tests per
GP per six months (p=0.0015). Inter-doctor variation decreased more
in arm I. This implies that if audit and feedback are to be effective,
they need to be integrated in an interactive, educational environment.
C H A P T E R VI provides a framework for cost evaluations of quality
improvement strategies. Cost analyses were done on the trial arms
reported in Chapter V, that is the complete strategy, involving feedback,
guidelines, and small group quality improvement, versus feedback only.
Regular costs, development costs, and scientific costs were determined.
Costs per GP of the new strategy were € 92.70 per six months in the
total strategy arm, € 17.10 per six months in the feedback arm. An
analysis of covariance was performed with the mean costs per GP per
six months after the intervention as the dependent variable, and the
costs of tests at baseline and the district as independent variable. The
total strategy arm achieved a mean cost reduction of € 301 per GP
per six months (p=0.001), while the feedback only strategy GP saved
€ 161 per GP per six months. Within the proposed framework, it is
imperative to account for non-monetary benefits. We concluded that
our strategy is a useful quality instrument. In line with the cost analysis
framework for this kind of behavioural intervention, it seems useful
to implement this strategy on a larger scale
C H A P T E R VII evaluates the use and applicability of a multifaceted
strategy to improve GPs' test ordering behaviour by means of a prospec-
tive process evaluation during the first and second years of the trial.
All 193 GPs participating in arm I and arm II received the planned
six feedback reports. Data from 156 quality meetings of 26 local GP
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groups showed a participation rate of 81% (95% CI: 77%-85%) in the
first year and 73% (95% CI: 68%-77%) in the second year. The three key
points of the quality meetings, viz., mutual feedback by working in pairs,
drawing up individual plans for change and drawing up group plans for
change, were performed satisfactorily in both intervention years. In the
first year, GPs expressed their level of satisfaction in a score of 7.55 on
a scale of 0 - 10 (95% CI 7.46-7.64); the average score in the second year
was 7.51 (95% CI 7.30-7.74). We concluded that the strategy is a feasible
tool for continuing improvement of GPs' test ordering behaviour,
which fits in well with local and regional quality improvement efforts.
To assess the value of balanced incomplete block designs in quality
improvement research, and their capacity to control for the Hawthorne
effect, C H A P T E R VIII evaluates the study design of our trial. Local
GP groups were randomised into to three arms. The GP groups in
arm I received the total strategy to improve the quality of their test
ordering, focusing on tests used for cardiovascular diseases and upper
and lower abdominal complaints. GP groups in arm II received an
identical intervention, but focusing on tests used for COPD / asthma,
general malaise / vague complaints, and degenerative joint problems.
GP groups in arm III received a minimal (feedback) intervention on
the same tests as the GPs allocated to arm I (chapter I, figure 1). The
numbers of tests related to all six clinical problems were monitored in
all arms. The GPs were blinded for the interventions in the other arms.
Three 2-arm comparisons were made, two within the block design,
between arm I and arm II, and one with a classical design, between
arm II and arm III. The block design involved analysing intervention-
specific effects on changes in the number of tests ordered controlling
for any Hawthorne effect. Since the GPs in both arms of the block
design were subject to the same level of intervention, the Hawthorne
effect was assumed to be equal in both arms. To gain insight into other
potential threats to the study's validity, data on tests ordered for
COPD / asthma, general malaise / vague complaints and degenerative
joint problems were compared for the GPs in arm II, who had
received the complete intervention with the GPs in arm III, who
had only received a minimal intervention on the other three clinical
problems. In the classical design the effect could to some extent be
attributed to the Hawthorne effect. We concluded that the block
design had a surplus value compared with the classical design. Clever
use of block designs may further our understanding of non-specific
effects in quality improvement research.
C H A P T E R IX presents the general discussion and conclusions of the
entire research project and the lessons to be learnt from it for the intended
nation-wide implementation. Of course, innovative strategies like these
are not the ultimate solution for all aspects of quality improvement in
test ordering performance, and further improvement may require
additional strategies. Outcome measures were volume data: the total
number of tests. Unfortunately, we were unable to use clinical data.
Furthermore, no long-term effects were studied. Nevertheless, the new
strategy seems an innovative and practicable, efficient and cost-efficient
quality instrument which can be usefully integrated within local and
regional quality improvement programmes in an attempt to consis-
tently improve GPs' test ordering behaviour.
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SAMENVATTING
Dit proefschrift behandelt het diagnostisch aanvraaggedrag van
huisartsen: het klinisch handelen van huisartsen met betrekking tot het
aanvragen van aanvullend diagnostisch onderzoek, op het gebied van
laboratorium, beeldvormend en functie onderzoek. In vele Westerse
landen, inclusief Nederland, vragen huisartsen steeds meer diagnosti-
sche testen aan, terwijl volgens de evidence-based richtlijnen een deel
daarvan overbodig is. Het proefschrift besteedt verder aandacht aan
de grote interdoktervariatie tussen huisartsen wat betreft het aanvragen
van diagnostische tests en een literatuur review behandelt strategieen
om het aanvraaggedrag van artsen te beinvloeden.
HOOFDSTUK I geeft een globaal overzicht van dit proefschrift. Om
het aanvraaggedrag van huisartsen te verbeteren, dus het realiseren
dat meer aanvragen volgens bestaande richtlijnen worden aangevraagd,
werd op systematische wijze een innovatieve strategic ontwikkeld,
genaamd het DTO: Diagnostisch Toets Overleg. Deze meervoudige
strategic bestond uit een combinatie van persoonlijke, grafische feed-
back rapporten, richtlijnen verspreiding en intercollegiale toetsingsbij-
eenkomsten. De vergelijking van het aanvraaggedrag van de individuele
huisarts met zijn collegas uit de HAGRO en uit de regio was een
belangrijk kenmerk van de schriftelijke feedbackrapporten.
De belangrijke kenmerken van de intercollegiale toetsingsbijeenkomsten
waren de open bespreking van de feedback rapporten in tweetallen
aan het begin van de bijeenkomsten, discussies over de nationale
richtlijnen en het maken van individuele en groepsvoornemens
op het gebied van aanvullende diagnostiek. De strategic heeft een
continu karakter omdat het belangrijk is te evalueren of individuele
en groepsvoornemens inderdaad leiden tot daadwerkelijke verande-
ringen van het aanvraaggedrag.
De meeste aandacht in dit proefschrift gaat uit naar de effecten van
deze nieuwe strategic op het klinisch aanvraaggedrag van huisartsen
en welke kosten en kostenbesparingen deze interventie met zich mee
bracht. Deze effecten en kosteneffecten werden door middel van een
gerandomiseerde studie onderzocht in een grote huisartsenpopulatie
van ongeveer driehonderd huisartsen, samenwerkend in 40 huisartsen-
groepen (HAGRO s) in vijf regio's in Nederland. Behalve waarneming
voor elkaar, scholen veel HAGRO's gemeenschappelijk na, b.v. in veel
HAGROs vindt tegenwoordig toetsing over prescriptiecijfers plaats
(Farmacotherapeutisch Overleg: FTO). De coordinate van de strategic,
feedback en de supervisie, organisatie van de toetsingsgroepen lag
bij de verschillende diagnostische centra. Een diagnostisch centrum
is een instituut, dat meestal verbonden is aan een ziekenhuis waar
huisartsen laboratorium, beeldvormend en functie onderzoek kunnen
aanvragen zonder hun patienten te verwijzen. Ongeveer een kwart
van de ziekenhuizen in Nederland heeft momenteel een dergelijk
diagnostisch centrum. Het geven van feedback aan adherente huisart-
sen over hun aanvraaggedrag is een van de taken van de medisch
coordinator van het diagnostisch centrum.
HOOFDSTUK II behandelt de variatie in het diagnostisch aanvraag-
gedrag tussen huisartsen. Professionele en contextgerelateerde determi-
nanten die deze variatie zouden kunnen verklaren werden onderzocht.
Daarvoor werd een cross-sectionele analyse gedaan van de som van
19 laboratorium en 8 beeldvormende onderzoeken, verzameld in de
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vijf diagnostische centra in 1997. De samenstelling van de onderzoeks-
populatie maakte analyses op een drietal niveaus mogelijk: huisarts /
praktijk niveau, HAGRO-niveau en regio. In een multivariate, multilevel
analyse werden deze aanvraagdata gekoppeld aan gegevens uit een
enquete onder de deelnemende huisartsen over hun professionele
houding ten opzichte van het aanvragen van diagnostische onderzoeken
en met contextgerelateerde gegevens zoals het praktijktype of de
ervaring met feedback vanuit een diagnostisch centrum. 229 Huisartsen
konden in deze studie worden ingesloten. De respons op de enquete
was 97%. Het totale aantal testen per huisarts per jaar was 998 (P25-P75:
663 tot 1500), met grote verschillen tussen de vijf regio's. Op profes-
sioneel niveau was'actieve betrokkenheid bij het maken van richtlijnen'
(ja/nee ) en op praktijk niveau groepspraktijk' (vergeleken met solo- of
duo-praktijken) en op regionaal niveau 'meer dan 1 jaar ervaring met
het probleemgeorienteerd laboratoriumformulier' (ja/nee), geassocieerd
met respectievelijk 27%, 18% en 41% minder aanvragen. De conclusie
luidt dat behalve de professionele determinanten, ook ander context-
gerelateerde determinanten van invloed zijn op het aanvraaggedrag.
Toekomstige studies zullen zeker rekening moeten houden met locale
en regionale factoren.
HOOFDSTUK HI beschrijft de resultaten van een systematische
literatuur review, volgens de richtlijnen van de Cochrane Collaboration,
van strategieen om het aanvraaggedrag van (huis-)artsen te beinvloeden.
Een drietal hypothesen werden onderzocht. Ten eerste: of het verande-
ren van het absolute aantal testen, meestal door overdiagnostiek te
verminderen, andere strategieen zou vergen dan pogingen om het
juist gebruik van diagnostische testen (meestal door expliciete richtlij-
nen) te bewerkstelligen. Ten tweede is het de vraag of meervoudige
strategieen mogelijk meer effect zouden hebben dan enkelvoudige en
als laatste of interventies die zich richtten op de context een meerwaarde
zouden hebben vergeleken met interventies die zich alleen richtten op
de professional. Achtennegentig studies met 118 vergelijkingsgroepen
werden geincludeerd.
De resultaten waren niet eenduidig, omdat de interventies niet steeds
vergelijkbaar waren en er veel methodologische verschillen bestonden
tussen de studies. Behalve algemeen geaccepteerde regels zoals het
zorgen dat de te onderzoeken strategic aansluit bij de praktijk en met
name rekening houdt met de weerstand tegen verandering die bij
professionals vaak bestaat, is ook het doel van de interventie van
belang: vermindering van het overmatig diagnostisch handelen vs.
meer aanvraaggedrag volgens de richtlijnen. Deze laatste twee doelen
vergen inderdaad verschillende strategieen. Enkelvoudige strategieen
bleken niet minder impact hebben dan meervoudige.
Het lijkt wel belangrijk om te focussen op zowel de professional als
de context. Intercollegiale toetsing en feedback lijken zowel het aantal
overbodige testen als de 'kwaliteit van het diagnostisch handelen'
positief te beinvloeden. Computerondersteunende reminders verbeteren
de kwaliteit van het aanvraaggedrag.
Het blijkt steeds belangrijker ook belangrijk organisatorische inter-
venties te onderzoeken. Verder lijken strategieen die gebruik maken
van patientenoordelen en intercollegiale toetsing zeker meer aandacht
behoeven in wetenschappelijk onderzoek omdat ze in potentie een
positieve invloed hebben.
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In HOOFDSTUK IV wordt de DTO-strategie geevalueerd in een
multicentre gerandomiseerd experiment met een gebalanceerd,
incomplete blockdesign. De primaire uitkomstmaat was het aantal
testen dat een huisarts aanvraagt per half jaar voor drie verschillende
klinische beelden. De studiepopulatie bestond uit 26 HAGRO s. Arm I
bestond uit 13 groepen die de totale interventie (feedback, richtlijnen
en intercollegiale toetsing) kregen over testen behorende bij de drie
klinische beelden cardiovasculaire ziekten, bovenbuikklachten en
onderbuikklachten. Arm II bestond uit 14 HAGRO's die dezelfde
interventie ondergingen met betrekking tot drie andere klinische
beelden COPD/astma, vage klachten en degeneratieve gewrichtsafwij-
kingen. (Zie hoofdstuk I, figuur 1) Van alle deelnemende huisartsen
werden de aantallen testen van alle zes klinische beelden gemonitored.
De huisartsen uit de ene arm waren blind voor het feit dat de andere
groep dezelfde interventie onderging maar met betrekking tot drie
andere klinische beelden. Volgens de bestaande nationale, evidence-
based richtlijnen werd een daling van het totaal aantal testen waarop
geintervenieerd werd en een daling per klinisch beeld opgevat als een
verbetering van de kwaliteit van het aanvraaggedrag. Verder werden
enkele 'overbodige' testen gedefinieerd die volgens de richtlijnen niet
meer door huisartsen hoefden te worden aangevraagd. Covariantie
analyses lieten zien dat voor huisartsen in arm I de daling in aantallen
testen voor de klinische beelden cardiovasculaire ziekten, bovenbuik-
klachten en onderbuikklachten per huisarts per half jaar gemiddeld
67 meer was dan voor huisartsen in arm II (p=0.01). Van huisartsen
in arm II daalde het aantal testen voor de klinische beelden COPD/
astma, vage klachten en degeneratieve gewrichtsafwijkingen met 22
meer dan voor huisartsen in arm I maar die verandering was niet
significant (p=0.22). Ook de overbodige testen daalden in beide armen,
hoewel die daling voor de huisartsen in arm II niet significant was. De
conclusie was dat de nieuwe strategic die zich richtte op het gebruik
van richtlijnen en sociale interactie en feedback tussen huisartsen,
een effectief kwaliteitsinstrument kan zijn om het aanvraaggedrag
van huisartsen te verbeteren.
In HOOFDSTUK V wordt de meerwaarde onderzocht van de richtlijnen
en intercollegiale toetsing op het gebied van de verbetering van het
diagnostisch aanvraaggedrag, vergeleken met klassieke feedback. Het
design was een multicenter trial met randomisatie op HAGRO-niveau.
De totale strategic werd in 13 groepen met 85 huisartsen uitgevoerd
(arm I, dezelfde als uit hoofdstuk IV), terwijl de feedback strategic in
14 groepen met 109 HAGRO's werd gedaan (arm III). Deze huisartsen
kregen feedback over drie dezelfde klinische beelden (cardiovasculaire
ziekten, bovenbuikklachten en onderbuikklachten), waarover de huis-
artsen in arm I de DTO-strategie ondergingen (Zie hoofdstuk I, figuur 1).
Volgens de richtlijnen kon een absolute daling van het aantal testen
opgevat worden als kwaliteitsverbetering.
Covariantie analyses lieten een significante daling van gemiddeld 51
testen per huisarts zien vergeleken met de feedback arm (arm III). Vijf
overbodige' testen voor het klinisch beeld bovenbuikklachten gaven
een significante gemiddelde daling van 13 testen meer per huisarts per
half jaar dan bij de huisartsen die alleen feedback kregen. De inter-
doktervariatie daalde meer in de arm die de totale interventie kreeg
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dan in de feedback arm.Vergeleken met het alleen maar toezenden
van feedbackrapporten, verbeterde de DTO-strategie het aanvraag-
gedrag van huisartsen duidelijk meer en meer consistent. Dat betekent
dat toetsing en feedback effectiever zijn als ze geintegreerd zijn in een
interactieve en educatieve omgeving.
In H O O F D S T U K VI wordt een raamwerk gegeven voor kostene-
valuaties van kwaliteitsbevorderende strategieen. Een kostenevaluatie
werd gedaan met dezelfde trialarmen als in hoofdstuk V. Lopende
kosten, ontwikkelingskosten en researchkosten werden vastgesteld.
Per huisarts in de totale interventie arm (arm I) kostte de nieuwe
strategic € 92.70 per half jaar, en in de feedback arm (arm III) waren
de kosten voor de feedback strategic € 17.10 per huisarts per half jaar.
Covariantie analyses met de gemiddelde kostenreductie per huisarts
als onafhankelijke variabele en de gemiddelde kosten per huisarts
bij de nulmeting en de regio als onafhankelijk variabele, gaven een
significante hogere kostenreductie van € 144 per huisarts per half
jaar voor de totale interventie arm vergeleken met de feedback arm
(p=0.001). In het raamwerk behoren ook niet-geldelijke voordelen
meegenomen te worden. De conclusie was dat de DTO-strategie een
waardevol kwaliteitsinstrument is en dat bovendien de kosten en
kostenreducties van deze nieuwe strategic het wenselijk maken verder
te onderzoeken hoe deze op grotere schaal te implementeren.
In HOOFDSTUK VII wordt het gebruik en de toepasbaarheid
van de DTO-strategie beschreven met behulp van een prospectieve
procesevaluatie tijdens de interventieperiode van twee jaar.
Alle 193 huisartsen van arm I en II kregen de geplande 1158 feedback-
rapporten. Gegevens van 156 toetsingsbijeenkomsten gaven een
opkomstpercentage van 81 % in het eerste jaar (95% BI: 77%-85%)
en 73% (95%BI: 68%-77%) in het tweede jaar. De drie belangrijkste
elementen van de toetsingsbijeenkomsten: paarsgewijze bespreking
van de rapporten, relateren van het aanvraaggedrag aan de richtlijnen
en het maken van individuele en groepsvoornemens werden in beide
jaren voldoende uitgevoerd. In het eerste jaar gaven de huisartsen de
totale strategic een 7.55 (95% BI: 7.46-7.64) op een 10-puntsschaal en
7.51 (95% BI: 7.30-7.74). Het DTO bleek implementabel in de dagelijkse
praktijk en lijkt goed inpasbaar in locale en regionale nascholings-
en toetsingsprogramma's.
In HOOFDSTUK VIII wordt de meerwaarde van het blok design
bepaald ten opzichte van een klassieke design met twee armen, o.a. in
het omgaan met non-specifieke effecten zoals het Hawthorne-effect.
Deze studie werd gebaseerd op de totale 3-armige studie. HAGRO's
uit arm I kregen de totale strategic over testen, behorend bij de klinische
beelden hart- vaatziekten, boven- en onderbuikklachten. HAGRO's
uit arm II kregen de complete interventie over testen, behorend bij
de klinische beelden COPD/asthma, algemene malaise en moeheid
en degeneratieve gewrichtsafwijkingen.
HAGRO's uit arm III kregen de minimale feedback interventie over
testen behorend bij de klinische beelden hart- vaatziekten, boven-
en onderbuikklachten (Zie hoofdstuk I, figuur 1). In alle armen werden
van alle huisartsen alle testen behorend bij een van de zes klinische
beelden geregistreerd. Huisartsen waren blind voor de interventie in
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de andere armen. De huisartsengroepen uit de eerste twee armen
waren controlearm van elkaar. Drie 2-armige vergelijkingen waren
mogelijk, twee binnen het blokdesign en een klassiek design tussen
arm II en arm III w.b. de testen behorend bij de klinische beelden
COPD/asthma, algemene malaise en moeheid en degeneratieve
gewrichtsafwijkingen.
In het blokdesign werden interventie-specifieke effecten geanalyseerd,
waarbij gecontroleerd werd voor het Hawthorne-effect. Omdat de
huisartsen uit de armen van het blokdesign dezelfde mate van inter-
ventie ondergingen maar wel over verschillende klinische beelden
werd het Hawthorne-effect gelijkelijk verdeeld over deze twee armen.
In het blok design trad geen verbetering op voor de testen waarop niet
geintervenieerd werd. In het klassieke design kon het effect voor een
deel worden toegeschreven aan het Hawthorne-effect en dus had het
blok design een duidelijke meerwaarde ten opzichte van het klassieke
design. Een juist gebruik van het blok design in kwaliteitsonderzoek
kan de kennis van de invloed van non-specifieke effecten in kwaliteits-
onderzoek verbeteren.
HOOFSTUK IX tenslotte gaat over de algemene conclusies van het
hele project. Conclusies uit de determinantenstudie, het literatuur
review en de klinische en kosteneffecten van de DTO-strategie worden
nogmaals kritisch beschouwd. Het is belangrijk te constateren dat in
dit onderzoek de lange termijn effecten niet onderzocht konden worden
en dat vooral kwantitatieve uitkomstmaten gebruikt werden. Het bleek
(nog) niet mogelijk om klinische data te gebruiken. Natuurlijk is de
DTO- strategic niet de ultieme oplossing om het aanvraaggedrag
van huisartsen blijvend te verbeteren. Waarschijnlijk zijn ook andere
strategieen mogelijk en nodig. Toch wordt geconcludeerd dat het
ontwikkeld kwaliteitssysteem het diagnostisch aanvraaggedrag van
huisartsen op een effectieve, kostenefficiente en, in de dagelijkse
praktijk toepasbare manier, kan verbeteren. Deze strategic kan zeker
ook gebruikt worden voor andere vormen van intercollegiale toetsing
bijvoorbeeld over verwijscijfers of prescriptiecijfers. Niet alleen huis-
artsen kunnen er hun voordeel doen mee doen, ook andere samen-
werkende professionals kunnen (elementen uit) deze methode toepassen.
Een bredere invoering van het DTO wordt aanbevolen.
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IN MEMORIAM
Wi7/y Dufeois-
TV/dens mi/'n prowiofiefra;ec( was nef p/ofse/mge
over/i/den van Wi'Z/y een fri/zonder verdnefige
^ebewrfeww. Hef «5 nauweZi/fc fe bev««e« da(
iemanii die acf;e/j5 WMMCM nef o«derzoe/c p/ofseZ/ng
f. De eerste v«er;aar van /ief pro/'ecf was
WiZ/y verfrofc op 7 jwni 2002 met /ia«r man naar 7faZ/e voor ee«
va/canf;e. D/'e vrZ/da^oc/ifena' vroe^ werden Wi'ZZy en Ziaar man, nog mnar
iO m/nuten onc/erwe^, gefro/fen door net nood/of. Ze fcregen een
waarby WiZZy om nef /even icivani en Tneo zeer ernshggeivond raafcfe.
VroZyfc, vnende/«/fc a«en( en met veeZ ;nzef deed ze vana/begm i998 Ziaar
aZs researc/iass/sfenfe. Ze toonde een grofe befrofc/cenZieid me( de onderzoefcers
en /iaar coZZega-assi'sfenfes. Ze was een vraagfoaafc voor /edereen.
WiZZ)' Ziad veeZ inferesses en wi'Zde zic/i breed on(w/'A:fceZen in naar vafc.
Ze Ziad ambiYies en w/'Zde groeien aZs researcnass/sfenfe.
£n(nous/asf verfeZde W(7/y over aZZerZe; andere zafcen d/e Ziaar frezigZiieZden.
Hoorn speZen in de Ziarwonie van Vi7(, de Zie/de voor naar nond, de tu;n en
/(a/icja«s Zeren, »fant /faZie was een passie van WiZ/y en 77ieo sawen.
Zonder naar nad dif/»rq/ec( n/ef fcunnen sZagen en ifc Ztadgraag wef naar
WiZZy werd sZechfs 38 jaar.
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Dankwoord
Naar het schrijven van dit stuk heb ik jaren uitgekeken. Het dankwoord
is het meest en best gelezen deel van een proefschrift. Het is inderdaad
een feest om te promoveren. Promoveren doe je niet alleen, gelukkig
maar, anders was ik er nooit aan begonnen. Ik wilde altijd al promove-
ren. Ik vond dat ik als huisarts van teveel dingen te weinig afwist en
wilde me een aantal jaren bezighouden met een onderwerp. Toevallig
(toeval bestaat niet?) werd het dit onderwerp. En via dit onderwerp
heb ik veel geleerd over wetenschappelijk onderzoek, schrijven,
publiceren maar ook over huisartsgeneeskunde en de huisartsen. Op
het huisartseninstituut heb ik veel gemotiveerde jonge basisartsen en
gezondheidswetenschappers gezien die onderzoek deden binnen de
huisartsgeneeskunde. Prima, maar als we met z'n alien wetenschappe-
lijke vooruitgang belangrijk vinden, moeten we ook vanuit de dagelijkse
huisartsenpraktijk ervaren huisartsen stimuleren om en de kans geven
te promoveren. Er is meer minder positiefs te vertellen over het instituut
promoveren. Ik zou een grondige discussie hierover toejuichen.
De ongeveer 300 deelnemende huisartsen wil ik als eerste hartelijk
danken. Jullie hebben geheel vrijwillig twee jaar deelgenomen aan deze
studie. Jullie enthousiaste readies gaven mij aan, nog meer dan de
uiteindelijke positieve klinische effecten, dat we op de goede weg zaten.
Huisartsen lopen echt voorop als we het we het hebben over het verant-
woording afleggen voor het klinisch handelen.
Ik heb met bijzonder veel plezier samengewerkt met mijn (co-)
promotores: Richard Grol, Jeremy Grimshaw en Trudy van der Weijden.
Richard, je hebt dit dankwoord nog niet eerder gelezen. Ik weet zeker
dat je er graag nog commentaar op had willen geven. Je hebt gezien
dat ook het wetenschappelijk deel me gelukt is. Je was verbaasd dat
mensen je streng vonden. Nou, laat ik je uit de droom helpen: je bent
echt streng maar van jou kan ik het hebben. Vooral omdat je je verant-
woordelijk opstelt, zonder verborgen agendas. Ik vind het prettig met
je verder te kunnen samenwerken. Ik wil ook in de toekomst bijdragen
aan de verdere ontwikkeling van de WOK.
And you, Jeremy, I'm happy that you were willing to participate in this
study. It was difficult to plan your visit to Maastricht today, but of course
I postponed my defence so you could attend it. I will always remember
our nice days in Dublin, Maastricht and Utrecht. It was an honour
discussing my papers with you while you had just woke up in Ottawa,
drinking your first cup of coffee. I hope to meet you at many scientific
occasions.
En jij, Trudy, dankzij jou is het me echt gelukt. Nooit te beroerd om
me weer vooruit te helpen; ik heb veel van je geleerd. Je moest me
regelmatig afremmen en me duidelijk maken dat ik met een weten-
schappelijk onderzoek bezig was en niet met het schrijven van een
krantenartikel. Ik hoop nog vaak met je te kunnen samenwerken en
let op je sleutels.
Ik dank mijn promotiecommissie voor de tijd die ze hebben gestoken
in het beoordelen van dit proefschrift. Prof. De Leeuw, Prof. Engelshoven,
Prof. Voorn, Prof. Buntinx en Prof. Koes.
Onze interventie werd gedaan vanuit vijf medisch coordinerende
centra. De toetsgroepen in de verschillende regio's werden begeleid
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door mijn collega-medisch coordinatoren van de diagnostische centra.
Luuk van Paridon (Ede-Wageningen, Louis Reichert (Sittard),
Jan Hermsen (Nijmegen), Ivo Smeele, Hans Vlek en Wim van Geldrop
(Helmond). Het was plezierig om met deze enthousiaste groep samen
te werken. Ik ben vele malen bij jullie op je centra geweest, het was
iedere keer hartelijk en inspirerend. Jullie secretariaten hebben veel
werk verricht en jullie hebben ervoor gezorgd dat we steeds respons-
percentages van boven de 90% hadden. Ik wil jullie daarvoor hartelijk
danken. Ivo en Jan bovendien dank voor jullie bijdrage in de project-
groep en het meeschrijven van artikelen.
In die projectgroep zaten ook nog Frits van Merode, Gerben ter Riet,
Marianne Meulepas en Ron Winkens. Frits, vooral in het begin hebben
we veel samengewerkt rondom de kostenaspecten van onze interventie.
Jouw inbreng was daarbij onmisbaar. Ik vond vooral je adequate en
snelle readies op mijn vragen en voorstellen prettig. Gerben, tijdens
het onderzoek, ging je werken in Engeland en Zwitserland, en uit-
eindelijk naar Amsterdam. Dat je desondanks betrokken bleef bij mijn
onderzoek zegt genoeg. Ik heb veel van je geleerd en vond de discus-
sies met je diepgaand en zinvol. We hebben nog een paar klussen af te
maken, daar verheug ik me op. Vooral in het begin was ook Marianne
Meulepas betrokken. Zeker rond de theoretische onderbouwing van
de interventie en de expertmeetings daarover. Ron, dank voor je
kritische ondersteuning bij de uitwerking van de gegevens en het
schrijven van artikelen.
Voor het schrijven van Engelstalige artikelen heb ik veel steun gehad
van Jan Klerkx. Bedankt. En de onovertroffen voorkant van het proef-
schrift en de verschillende hoofdstukken is van Jaime van Eijkelenborg.
Minstens duizend mensen hebben de afgelopen jaren meegewerkt aan
het verwerken en analyseren van de gigantische hoeveelheid gegevens.
Ik noem alleen de belangrijkste: Willy Dubois (t), Paula Vilters,
Paula Rinkens, Anuschka Weekers, Jildou Sijbrandij, Arnold Kester,
Frans Tan. De mensen van de verschillende afdelingen die mij aan
gegevens hielpen: Ad Hoeks van het Sint Joseph Ziekenhuis, van het
SCDC Helmond Helen Bilik, Cecile Smeets-Goevaers en Bea Heesakkers,
van Meetpunt Kwaliteit van de DHV-Eindhoven, vooral Hennie van
Bavel. Een hoogtepunt was toch het feit dat enkele medewerkers van
het laboratorium uit het ziekenhuis van Sittard twee weekenden lang
handmatig de aantallen labaanvragen uit 1997 van de huisartsen daar
hebben geturfd. Ik blijf het ongelooflijk vinden.
Ik had jaren een onmogelijke agenda, nog steeds trouwens.
Marjo van Ham en Peggy Veugen zorgden ervoor dat mijn agenda
overzichtelijk bleef, tenminste voor mezelf. Ook het bestuur van het
Medisch Integratie Centrum Kempenland in het toenmalig St. Joseph
Ziekenhuis dank ik voor het vertrouwen dat jullie in mij stelden en
de mogelijkheid die ik van jullie kreeg om dit onderzoek uit te voeren
in de adherentie van het ziekenhuis.
We hadden een heerlijke kamer op onze vakgroep: Rogier Hopstaken
(jij bent de volgende), Ben van Steenkiste (Ben, hoe moet dat ook
alweer met Endnote?), Sjoerd Hobma (zullen we samen lunchen?) en
Sandra Kuiper (jou gun ik deze kamer). Met jullie heb ik veel humor-
voile momenten gemaakt. In de eenzaamheid van een promotietraject
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was een uur lachen met jullie vaak een ontlading en ontspanning.
Daarna kon ik er weer weken tegen. Ik had ook prettig contact met nog
veel meer mensen van de vakgroep en ik vind het vervelend jullie achter
te laten in een voor jullie zo onzekere periode, maar het komt echt
goed. Ine Siegelaer, Jos op't Root, Karin Vaessen, Marie-Louise Dumont,
Bernadette Zinsen, Paddy Hinssen, Jelle Staffers, Paul Zwietering,
Jim Tatipata, Marga van der Aa, Piet Portegijs, Job Metsemakers,
Geert-Jan Dinant, Paul Houben, Tanja Maas, Saskia Mol, Paul Knipschild,
Loes van Bokhoven en alle anderen.
Er zijn buiten het onderzoek nog een heleboel mensen die me op
hun manier gesteund hebben. Mijn collegae van de Commissie
Wetenschappelijk Onderzoek van het NHG. Regelmatig hebben we
de afgelopen jaren de vorderingen van mijn onderzoek besproken.
En steeds even inspirerend als kritisch. Ook nu zie ik weer belangrijk
huisartsgeneeskundig onderzoek (ontstaan) binnen de CWO waar
ik graag meer van wil horen. Ook de mensen van mijn bude' huisartsen-
groep. Ik hoop dat we nog lang regelmatig bij elkaar blijven komen
(tot en met onze rollatorfase?)
Mijn maatjes van de supervisiegroep: Pirn, Vincent, Joost (niet meer
de enige doctor), Els.WimB (nog steeds honderdmaal dank dat je me
bij deze groep haalde), Albert, Jasper en Marian. Deze tent heb ik mooi
alleen opgezet. En natuurlijk Toos Willemsen, onze niet-overtroffen
supervisor: bedankt voor je vele wijze lessen die ik ook in mijn onder-
zoek goed heb kunnen gebruiken.
Rond mijn promotie mis ik mijn ouders. Jullie zouden reuzentrots
geweest zijn op me. Ik vind het nu vooral jammer niet meer te kunnen
zeggen hoe trots ik op jullie ben dat ik dit allemaal mede door jullie
kan meemaken. Familie en vrienden: binnenkort heb ik weer tijd (?).
Geert, jij vertegenwoordigt mijn vijf broers. Henk, Rene, we kunnen
eindelijk naar Berlijn.
En veruit het belangrijkste: thuis. Thuis was er vooral veel warmte
en gezelligheid. Het was altijd plezierig thuiskomen in een liefdevolle
en enthousiaste omgeving. Lieve Marlie, bedankt dat je er bent en hoe
je er bent, ik was (ben?) niet altijd even gemakkelijk. En Josephine,
Barbara en Pieter, lieverds: de feestkleren zijn gekocht....
Het feest kan beginnen.
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ITOWARDS OPTIMAL TEST ORDERING IN PRIMARY CARE
To bridge the gap between evidence-based medicir? and practice,
we need to learn more about factors and interventios that art
important for the implementation of research findiqs in clinical
j^ ratcRic^ .Ttef>enj'i mAirhj*cfe»PSaiEAyQrk\^ teaJfesr\»ay-16 improve
patient care and there is a demand for new approaches that fit well
within the routines of clinical professionals. Transparency and
improvement of the care provided to patients are important topics
in current discussions about the future of health care services.
In many countries, the number of diagnostic tests ordered by general
practitioners is growing, and inter-doctor variation is shown to be
large, while according to established evidence-based guidelines,
many of these tests are seen as unnecessary. This thesis describes
variation in test ordering behaviour in primary care, strategies used
by others to influence physicians'test ordering behaviour in a
systematic literature review, and effects and costs of an innovative
strategy to improve general practitioners'test ordering behaviour.
The aim of the study reported in this thesis was the systematic
development and assessment of an innovative and multifaceted
strategy to improve general practitioners'test ordering behaviour.
The multifaceted strategy had an iterative character and included
the following elements: personalised graphical feedback including
comparative data, guideline dissemination and continuous small
group quality improvement meetings.
The new strategy seems an acceptable and feasible quality instru-
ment to reduce the general practitioners'test ordering volume in an
efficient way, and can be integrated within local and regional quality
improvement programmes.
